Design principles and control mechanisms of signal transduction networks by Binder, Bernd
Design principles and control mechanisms of
signal transduction networks
D I S S E R T A T I O N
zur Erlangung des akademischen Grades
doctor rerum naturalium
(Dr. rer. nat.)
im Fach Biologie
eingereicht an der
Mathematisch-Naturwissenschaftlichen Fakulta¨t I
Humboldt-Universita¨t zu Berlin
von
Herr Dipl.-Phys.BerndBinder
geboren am 06.08.1970 in Ilshofen
Pra¨sident der Humboldt-Universita¨t zu Berlin:
Prof. Dr. Mlynek
Dekan der Mathematisch-Naturwissenschaftlichen Fakulta¨t I:
Prof. Thomas Buckhout, PhD
Gutachter:
1. Prof. Dr. Reinhart Heinrich
2. Prof. Dr. Hans-Peter Herzel
3. Prof. Dr. Thomas Ho¨fer
eingereicht am: 31. Januar 2005
Tag der mu¨ndlichen Pru¨fung: 31. Ma¨rz 2005
ii
Ignorance more frequently begets confidence than does knowledge: it is those who know
little, not those who know much, who so positively assert that this or that problem will
never be solved by science.
Charles Darwin, The Descent of Man, 1871
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Abstract
This work is based on the hypothesis that signal transduction networks in living cells are
the result of an evolutionary development which is governed by mutation mechanisms
and natural selection principles. This concerns their structural design as well as kinetic
parameters. Therefore, it can be assumed that these properties have adopted values
which imply certain optimal features with respect to the biological function of signal
transduction.
Based on this working hypothesis, two approaches are presented to investigate the
structural design and control mechanisms of signal transduction networks. Both strate-
gies have as a common research objective the explanation of these properties of signalling
networks using certain efficiency criteria.
In the first approach, covered in chapter 2, a model is developed to analyse the
structural design of signalling networks. A simplified model is used to describe sig-
nalling systems consisting of receptors, kinases and phosphatases. This description in-
cludes important systems like MAP kinase pathways, the PI3K pathway, but also larger
networks which exhibit complex crosstalk activations. Following the hypothesis men-
tioned above, optimisation principles have been applied to determine optimal network
structures regarding certain biological functions. Two dynamic features of signalling
systems are assumed to be crucial for the organism’s surviving capacity: (i) To avoid
autoactivation, e.g. due to stochastic fluctuations of receptor ligand or kinase concen-
trations, the signal off-state must be dynamically stable. (ii) The signal output should
be of considerable magnitude, therefore the system should rather amplify than dampen
the signal. To characterise network structures fulfilling both criteria simultaneously, a
systematic analysis is performed for small networks consisting of up to seven kinases.
The investigations reveal that for such networks the following two design principles hold
true: (i) With increasing network size the connectivity decreases connoting an increasing
specificity of kinase activities. (ii) The number of feedback cycles decrease with increas-
ing network size indicating a decreasing tendency of downstream kinases to activate
upstream kinases.
Based on the effect of small structural perturbations on the dynamic functions, a
quantitative definition of the robustness of signalling networks is provided. Ratios of
phosphatase and kinase activities maximising this robustness are identified.
The general validity of these design principles is supported by the analysis of a large
kinase network containing 86 kinases which has been retrieved from the TRANSPATH
database. This network is indeed characterised by a very low connectivity and a lack of
positive feedback cycles.
This large signalling network is further investigated regarding several design prop-
erties. It is shown that the kinases group into two functional classes. About half
of them can be regarded as “distributors” which means that they possess significantly
more downstream targets than upstream activators. The other kinases act as“receivers”,
i.e. they possess more upstream activators than downstream targets. One identifies 25
input kinases which are not activated by other kinases and 27 output kinases without
downstream targets.
All possible pathways from every input to every output kinase are calculated and the
distribution of shortest pathway lengths is obtained. Interestingly, the most frequent
shortest path length amounts to three corresponding to the length of MAPK pathways.
Including also G-proteins leads to a signalling network of 94 components in which the
most frequent shortest path length amounts to four, again corresponding to the length
of MAPK pathways whose first kinase is activated by a G-protein.
When comparing the design and dynamic features of the TRANSPATH network
to random networks, significant differences are observed: (i) Most random networks
have feedback cycles. (ii) The total number of pathways tends to be larger in random
networks. (iii) The fraction of shortest pathways is much higher in the TRANSPATH
network. (iv) In the TRANSPATH network the relative frequency of pathway pairs
without crosstalk is significantly higher. (v) The amplitudes and the signal durations
of the kinase activation profiles tend to be less correlated in the TRANSPATH network
than in random networks.
In order to understand evolutionary principles leading to acyclic networks, the pro-
cedure to generate random networks is altered by avoiding small cycles. Surprisingly,
this additional constraint significantly increases the probability to generate cycle free
networks.
In the second approach, described in chapter 3, control mechanisms of different
signal transduction networks are analysed by applying Metabolic Control Analysis to
transient activation profiles. Control coefficients on the signal amplitude, signal duration
and integrated response are calculated.
First, the control mechanisms of a simple cascade model are compared to inhibitor
experiments. The results confirm the predictions formulated by Heinrich et al. [2002]
that kinases exert higher control on amplitude than on duration of the signal output,
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whereas phosphatases have stronger control on duration.
Second, the control coefficients of activation profiles of ERK and other important
components of a large EGF signalling model proposed by Schoeberl et al. [2002] are
analysed. It can be observed that: (i) Only few reactions have considerably high control
coefficients for the three characteristics amplitude, duration and integrated response. (ii)
Kinase reactions generally have positive control on these features, while phosphatases
tend to have a negative control. (iii) There is a high correlation between the control
of duration and integrated response of the signal output (ERK), whereas the control
coefficients of amplitude and duration are not correlated, i.e. these two features are
independently controlled. (iv) The largest amplitude control coefficients are found for
the MEK kinase indicating the highest average sensitivity to variations of reaction rates.
A more fundamental question regarding the design of signalling cascades is addressed
in section 3.4. The optimal length of cascades which maximises the average sensitivity
of the signal amplitude is detected. Whereas for pathways with mono phosphorylation
steps the average sensitivity is almost independent of pathway length, cascades with
dual phosphorylation steps show a maximal sensitivity for a pathway length of three or
four kinases.
The presented results show that the structural properties of signalling networks dras-
tically differ from those of random networks. Moreover, import characteristic features,
such as the length of signalling cascades can be explained by optimisation principles.
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Zusammenfassung
Diese Arbeit basiert auf der grundlegenden Annahme, dass Signaltransduktionsnetz-
werke in lebenden Organismen als das Ergebnis eines evolutiona¨ren Prozesses betrach-
tet werden ko¨nnen, der sich durch Mutations- und Selektionsprinzipien auszeichnet. Dies
betrifft sowohl das strukturelle Design als auch die kinetischen Parameter. Des-halb kann
angenommen werden, dass diese Eigenschaften so beschaffen sind, dass sie bestimmte
optimale Merkmale hinsichtlich der biologischen Funktion von Signaltransduktionsnetz-
werken mit sich bringen.
Basierend auf dieser Hypothese werden zwei Ansa¨tze vorgestellt, um strukturelles
Design und Kontrollmechanismen von Signaltransduktionsnetzwerken zu untersuchen.
Beide Strategien haben als gemeinsames Forschungsziel, Eigenschaften von Signaltrans-
duktionsnetzwerken zu erkla¨ren, indem bestimmte Kriterien hinsichtlich ihrer Funkti-
onsfa¨higkeit angelegt werden.
Beim ersten Ansatz in Kapitel 2 wird ein Modell entwickelt, welches das strukturelle
Design von Signalnetzwerken analysiert. Ein vereinfachtes Modell wird benutzt, um
Signalsysteme, bestehend aus Rezeptoren, Kinasen und Phosphatasen, zu beschreiben.
Diese Beschreibung schließt Systeme wie MAP Kinase Wege, den PI3K Weg, aber auch
gro¨ßere Netzwerke, die komplizierte “Crosstalk”-Aktivierungen aufweisen, ein.
Es wird angenommen, dass zwei dynamische Eigenschaften dieser Systeme fu¨r die
U¨berlebensfa¨higkeit der Organismen eine besonders wichtige Rolle spielen: (i) Um eine
Autoaktivierung zu verhindern, z.B. gegenu¨ber stochastischen Schwankungen von Re-
zeptorliganden oder Kinasekonzentrationen, muss der Signal-Aus Zustand dynamisch
stabil sein. (ii) Das Ausgangssignal sollte eine betra¨chtliche Sta¨rke aufweisen, weshalb
das Signal eher versta¨rkt als geda¨mpft werden sollte. Um Netzwerk-Strukturen zu cha-
rakterisieren, die beide Kriterien gleichzeitig erfu¨llen, wird eine systematische Analyse
von kleinen Netzwerken, die bis zu sieben Kinasen umfassen, durchgefu¨hrt. Die Un-
tersuchungen machen deutlich, dass fu¨r solche Netzwerke die folgenden zwei Design-
Eigenschaften gelten: (i) Mit steigender Netzwerkgro¨ße verringert sich die Konnekti-
vita¨t, was einer steigenden Spezifita¨t der Kinasen gleichkommt. (ii) Die Anzahl der
“Feedback”-Zyklen nimmt mit zunehmender Netzwerkgro¨ße ab, was eine abnehmende
Tendenz anzeigt, dass “nachgeschaltete” Kinasen “vorgelagerte” Kinasen aktivieren.
Basierend auf den Auswirkungen von kleinen, strukturellen Sto¨rungen auf das dy-
namische Verhalten wird eine quantitative Definition von Robustheit von Signalnetz-
werken angegeben.
Die allgemeine Gu¨ltigkeit dieser Design-Eigenschaften wird durch die Untersuchung
eines großen Kinase-Netzwerks gestu¨tzt, das aus der Datenbank TRANSPATH entnom-
men wurde und 86 Kinasen umfasst. Das Netzwerk ist tatsa¨chlich durch eine sehr niedri-
ge Konnektivita¨t und durch das Fehlen von positiven “feedback”-Zyklen gekennzeichnet.
Dieses große Signalnetzwerk wird hinsichtlich verschiedener Strukturmerkmale wei-
tergehend untersucht. Es wird gezeigt, dass sich die Kinasen in zwei funktionelle Grup-
pen einteilen lassen. Ungefa¨hr die Ha¨lfte von ihnen kann als “Signalverteiler” betrachtet
werden, d.h. sie besitzen bedeutend mehr nachgeordnete Zielkinasen als vorgeschaltete
Kinasen. Die anderen Kinasen verhalten sich als “Signalempfa¨nger”, d.h. sie haben mehr
vorgeschaltete, aktivierende Kinasen im Vergleich zu Zielkinasen. Man identifiziert 25
Eingangs-Kinasen, die nicht von anderen Kinasen aktiviert werden und 27 Ausgangs-
Kinasen, die keine Zielkinasen aktivieren.
Alle mo¨glichen Signalwege von jeder Eingangs-Kinase zu jeder Ausgangs-Kinase wer-
den berechnet; anschließend wird die Verteilung der ku¨rzesten Wegla¨ngen erstellt. In-
teressanterweise ist die am ha¨ufigsten auftretende Wegla¨nge drei, was der La¨nge von
MAP Kinase Wegen enstpricht. Wenn auch G-Proteine einbezogen werden, ensteht ein
Netzwerk aus 94 Komponenten, in welchem die ha¨ufigste, ku¨rzeste Wegla¨nge vier ist.
Dies stimmt ebenso mit MAP Kinase Wegen u¨berein, deren erste Kinase von einem
G-Protein aktiviert wird.
Wenn man das Design und die Dynamik des TRANSPATH Netzwerks mit den Eigen-
schaften von Zufallsnetzen vergleicht, zeigen sich aussagekra¨ftige Unterschiede: (i) Die
meisten Zufallsnetze besitzen “feedback”-Zyklen. (ii) Die gesamte Anzahl von Signal-
wegen ist typischerweise ho¨her in Zufallsnetzen. (iii) Der relative Anteil von ku¨rzesten
Wegen ist im TRANSPATH Netzwerk viel ho¨her. (iv) Im TRANSPATH Netzwerk ist
die relative Ha¨ufigkeit von Paaren von Signalwegen, die keinen “Crosstalk” aufweisen,
wesentlich ho¨her. (v) Die Amplituden und Signaldauern der Aktivierungsprofile von
Kinasen im TRANSPATH Netzwerk neigen dazu, weniger stark korreliert zu sein als in
Zufallsnetzen.
Um evolutiona¨re Gesetzma¨ßigkeiten, die zu zyklenfreien Netzwerken fu¨hren, besser
verstehen zu ko¨nnen, wird die Methode zur Erzeugung von Zufallsnetzen so gea¨ndert,
damit insbesondere die Enstehung von kleinen Zyklen verhindert wird. Erstaunlicher-
weise erho¨ht diese zusa¨tzliche Nebenbedingung die Wahrscheinlichkeit, Netzwerke ohne
Zyklen zu generieren, betra¨chlich.
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In einem zweiten Ansatz, der in Kapitel 3 beschrieben wird, werden Kontrollmecha-
nismen unterschiedlicher Signaltransduktionsnetzwerke analysiert, indem die Metaboli-
sche Kontroll Theorie auf transiente Aktivierungsprofile angewendet wird. Es werden
Kontrollkoeffizienten fu¨r die Signalamplitude, Signaldauer und das Integrierte Signal
berechnet.
Zuna¨chst werden die Kontrollmechanismen eines einfachen Kaskaden-Modells mit
Inhibitor-Experimenten verglichen. Die Resultate besta¨tigen die Vorhersagen (Heinrich
et al. [2002]), dass Kinasen eine ho¨here Kontrolle auf die Amplitude als auf die Si-
gnaldauer des Signalausgangs ausu¨ben, und dass Phosphatasen in sta¨rkerem Maße die
Signaldauer kontrollieren.
Zweitens werden Kontrollkoeffizienten von Aktivierungsprofilen der ERK Kinase und
anderen wichtigen Komponenten eines großen EGF Signal Modells analysiert, das von
Schoeberl et al. [2002] vorgeschlagen wird. Es zeigt sich: (i) Nur wenige Reaktionen haben
nennenswert große Kontrollkoeffizienten fu¨r die drei Kenngro¨ßen Amplitude, Signaldauer
und Integriertes Signal. (ii) Kinasereaktionen u¨ben im Allgemeinen eine positive Kon-
trolle auf diese Gro¨ßen aus, wa¨hrend Phosphatasen diese negativ kontrollieren. (iii) Es
gibt eine hohe Korrelation zwischen der Kontrolle der Signaldauer und des Integrierten
Signals des Signalausgangs (ERK), wa¨hrend die Kontroll-koeffizienten der Amplitude
und der Signaldauer nicht korrelieren, d.h. diese beiden Merkmale werden unabha¨ngig
voneinander kontrolliert. (iv) Die gro¨ßten Amplituden-Kontrollkoeffizienten werden fu¨r
die MEK Kinase gefunden, was die ho¨chste, durchschnittliche Sensitivita¨t hinsichtlich
der Variation von Reaktionen anzeigt.
Eine grundsa¨tzlichere Frage zum Design von Signalkaskaden wird in Abschnitt 3.4
behandelt. Die optimale La¨nge von Kaskaden, welche die durchschnittliche Sensitivita¨t
der Signalamplitude maximiert, wird ermittelt. Wa¨hrend fu¨r Signalkaskaden mit einfa-
chen Phosphorylierungs-Schritten diese Sensitivita¨t fast unabha¨ngig von der Kaskaden-
La¨nge ist, zeigen Kaskaden mit zweifacher Phosphorylierung eine maximale Sensitivita¨t
fu¨r eine Kaskaden-La¨nge von drei oder vier Kinasen.
Die dargestellten Resultate zeigen, dass sich die strukturellen Eigenschaften von
Signaltransduktionsnetzwerken auf drastische Weise von denjenigen von Zufallsnetz-
werken unterscheiden. Daru¨ber hinaus ko¨nnen wichtige charakteristische Merkmale wie
die La¨nge von Signalkaskaden, ausgehend von Optimierungsprinzipien, erkla¨rt werden.
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Chapter 1
Introduction
1.1 Historical overview
Compared to metabolic networks, which are among the most thoroughly studied bio-
logical systems in the field of mathematical modelling, modelling of signal transduction
is yet in an early stage. Nevertheless in recent years, an enormous amount of informa-
tion has been accumulated about the components of various signalling pathways and
their interplay. Such information is increasingly accessible in specific databases, such as
TRANSPATH (Schacherer et al. [2001]) and STKE (Gough [2002]).
The MAPK signalling pathway has been modelled in successively greater detail since
the early 1990s, and now boasts a greater proliferation of models than almost any other
signalling pathway. The MAPK cascade as we know it today is a three-tiered cascade
of kinases: MAPKKK −→ MAPKK −→ MAPK. It took several years to resolve even
this basic topology of the cascade. In 1990 it was still not clear whether the kinases in
the cascade were sequentially or simultaneously activated (Ahn and Krebs [1990]). A
two-tiered ordered arrangement of the kinases had been proposed in 1991 (Ahn et al.
[1991]), and in the span of two years from 1991 to 1993, the three-tiered core structure
of the MAPK cascade was identified (Kyriakis et al. [1992]). Further refinements to
the topology were made by the discovery that the MAPK cascade may involve scaffold
proteins (Choi et al. [1994]).
The first simulations of the MAPK cascade were carried out in 1996 (Huang and
Ferrell [1996]) in a kinetic model of MAPK demonstrating ultrasensitivity. This model
uses experimental data, but also relies on estimations of certain rate constants. In 1997,
Ferrell and Bhatt revealed that MAPKK phosphorylates p42 MAPK by a two-collision
distributive mechanism rather than a single-collision processive mechanism (Ferrell and
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Bhatt [1997]). This experimental model provided a mechanistic basis for understanding
of how the MAPK cascade can convert graded inputs into switch-like outputs. In the
same year, Burack and Sturgill confirmed by experiments and kinetic analysis of available
data that the mechanism of ERK2 (a specific MAPK) activation by MEK1 (a specific
MAPKK) in vitro is indeed non-processive (Burack and Sturgill [1997]). In 1998, Ferrell
and Machleder showed that the MAPK cascade is activated essentially in an all-or-none
fashion during Xenopus oocyte maturation (Ferrell [1998]). This behavior was proposed
to arise from two known properties of the oocyte’s MAPK cascade, a positive feedback
loop and the cascade’s intrinsic ultrasensitivity.
Following these initial model approaches, in the next phase additional components
of the MAPK cascade were analysed and its dynamics were explored in detail. In 1999,
Bhalla and Iyengar used simulations based on kinetic data available to propose that
the MAPK cascade might participate in a bistable feedback loop (Bhalla and Iyengar
[1999]). This MAPK model was one of the earliest to incorporate EGF activation in its
description. In the same year, Kholodenko modelled the EGF signal transduction from
the receptor to the RasGTPase (Kholodenko et al. [1999]) and in 2000, he suggested
an oscillatory mechanism in a MAPK cascade model (Kholodenko [2000]). Levchenko
et al. [2000] explored effects of scaffolding on the MAPK cascade. His model proposed
that scaffold proteins may biphasically affect the levels of MAPK signalling and thereby
reduce its threshold properties. Brightman and Fell [2000] showed through quantitative
modelling that feedback inhibition of the MAPK cascade determines the duration of
cascade activation. A further study on the MAPK system dynamics by Asthagiri and
Lauffenburger [2001] demonstrated that negative feedback could enhance an upstream
signal in the MAPK cascade.
Apart from incorporating still further cell biological details such as receptor traffic
and transcriptional control, in the most recent phase of modelling another trend became
apparent: Recent studies have begun to utilise both experiments and simulations in an
integrative fashion. Schoeberl et al. [2002] have modelled the effects on MAPK due to
receptor internalization of EGF receptors. In 2002, Bhalla et al. combined experiments
and modelling to support MAPK involvement in a bistable feedback loop (Bhalla et al.
[2002]). This study also considered transcriptional activation of MKP-1 as an important
component of the history dependence of the cellular response. Swain and Siggia [2002]
modelled the multisite phosphorylation of MAPK and suggested that it acts to improve
signalling specificity. In a theoretical study, Somsen et al. [2002] showed that scaffolding
could induce selectivity in different MAPK modules even if they shared the same kinases
at some levels in the cascade. Mathematical models of other specific signalling processes
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have also been proposed recently. An example is a model for the Wnt-pathway which is
essential for cell differentiation in early cell development (Lee et al. [2003]).
All these kinetic models describe the combined action of participating reactions, such
as stimulation of receptors, phosphorylations and dephosphorylations, binding to adap-
tor proteins, scaffolds or transcription factors. Some models are confined to stationary
states (Huang and Ferrell [1996]), whereas others explore dynamic features (Kholodenko
et al. [1999]; Schoeberl et al. [2002]; Asthagiri and Lauffenburger [2001]). These models
are very valuable for understanding the behaviour of specific signalling pathways for
which experimental data is available. Apart from describing the dynamics of these sys-
tems, the models have already revealed interesting regulatory properties, for example
switch-like response or bistability. However, since the topology, that is the wiring of
the participating components of these signalling networks, has to be provided as input,
all these models are not capable to explain the underlying structural design. A first
general approach to investigate how certain structural features influence the functional
properties was developed by Heinrich et al. [2002]. It is described how a limited num-
ber of structural and kinetic key parameters, such as cascade length, crosstalk activity
and divers rate constants, affect the functional properties signal amplification, signalling
time and duration as well as stability of the signal off-state.
1.2 Research objectives
Although modelling of specific signalling processes is becoming more advanced, there is,
in this field, a lack of general theory which can provide a basis for deeper understanding
of design principles in general and the relation between the structural and the functional
properties of signalling pathways in particular.
For metabolic systems, first promising approaches to relate structural and functional
characteristics have been developed (Mele´ndez-Hevia et al. [1997], Stephani et al. [1999];
Ebenho¨h and Heinrich [2003]). However, a straight forward transfer of these methods to
signalling networks proves difficult due to several crucial differences between these two
types of systems. Whereas the function of metabolism is to chemically convert initial
substrates into final products, thereby creating a mass flow, in signalling systems infor-
mation is transmitted without a net conversion of the participating compounds. More-
over, in metabolism one encounters two different kinds of components: the biochemical
reactants undergoing conversions and the enzymes catalysing these conversions. In sharp
contrast to that, the participating components in signalling pathways exert a multitude
of different functions, as receptors, kinases, phosphatases, G-proteins, exchange factors,
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adaptors, scaffolds, transcription factors etc. Further, reactants and catalysts are not
strictly distinguishable since many enzymes are found in both roles, for example kinases
which may either catalyse phosphorylations or act as target substrates. In considera-
tion of these basic differences a new strategy has to be applied to disentangle structural
principles of signalling networks.
One objective of this work is to understand which structural design properties enable
such networks to perform their biological function. Here, the term “structural design”
refers to the following characteristics:
- length of a kinase cascade,
- the phosphorylation mechanisms: dual or mono phosphorylation steps,
- number of cross activations (crosstalk) between distinguishable pathways,
- total number of interactions (network connectivity) among all kinases in a network,
- number of feedback cycles which can be counted in a network,
- distribution of signal outputs and inputs which the set of kinases in a network
possess.
To a large extent, the biological function is determined by the dynamic behaviour of a
signalling system. One can characterise this behaviour by means of the following key
values of transient activation profiles:
- dynamic stability of the signal-off state, defined as the state when there is no
receptor activation,
- signal amplification,
- signal duration,
- integrated response of an activation profile.
Chapter 2 focuses on the interrelations between these two sets of structural and
functional quantities. Among others, the following problems are addressed: (1) Are
there any general rules how a pathway should be structurally designed to allow for
signal amplification? (2) How do signalling networks consisting of hundreds of mutually
interrelated kinases maintain a stable signal off-state, thus avoiding self-activation in the
absence of receptor stimulation? (3) What are the requirements for a signalling network
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to remain robust against changes in their interconnections resulting from mutations
or the action of drugs? (4) Why are there only few positive feedback cycles found in
signalling networks compared to negative feedback regulations?
A general treatment of these problems will certainly run into extreme difficulties.
Not only is the number of interacting compounds generally very high, they also exert
a multitude of different functions as mentioned above. In the present work, first steps
are presented towards a theory which interrelates in a general way structural features of
signalling pathways with their dynamic properties. For the sake of simplicity the analysis
of this chapter is confined to networks consisting exclusively of kinases, phosphatases
and receptors. Of particular interest are their amplification properties and their dynamic
stability depending on (i) kinase and phosphatase activities and (ii) the wiring of the
network.
The basic strategy is to describe a vast number of structurally different, alternative
designs to identify those with optimal dynamic features and compare their design prop-
erties with those actually found in contemporary cells. This task is performed by taking
into account existing information on kinase interactions as documented in the signal
transduction database TRANSPATH1. It is further shown that the structural and dy-
namic properties of the networks retrieved from TRANSPATH significantly differ from
those of random networks.
Besides the structural design, functional properties depend strongly on regulatory
mechanisms. In chapter 3, the regulatory principles of various signalling networks are
investigated by applying Metabolic Control Analysis (MCA). The main challenge in
conveying MCA to signalling systems is that here the transient states are more important
than steady state conditions.
As a starting point (section 3.2), experiments with kinase and phosphatase inhibitors
are described to underpin previous theoretical predictions (Heinrich et al. [2002]) about
regulation of signal amplitude and signal duration of kinase cascades. For a direct
comparison with the results of these experiments, a simple cascade model is used to
study competitive and non-competitive inhibitors in silico. In section 3.3, it is analysed
how the control on amplitude and duration of the activation profiles of different signalling
components (e.g. of G-protein Ras and the kinases Raf, MEK and ERK) is distributed
within a large model of the EGF network published by Schoeberl et al. [2002].
In section 3.4, an optimal cascade length is identified by applying optimisation cri-
teria. In metabolic systems similar problems are often tackled by maximising certain
fluxes. As an objective function of signalling pathways, the maximisation of the over-
1http://www.transpath.de
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all sensitivity – defined as the standard deviation of control coefficients – of the signal
amplitude is proposed. This objective function can be interpreted as an average “con-
trollability” of the signal output. This approach seeks to extend earlier investigations
(Goldbeter and Koshland [1981]; Goldbeter and Koshland [1982]; Huang and Ferrell
[1996]) which focus on zero-order ultrasensitivity as an important attribute of signalling
cascades.
Of particular interest in the present approach is a comparison between cascades con-
sisting of mono phosphorylation cycles with cascades consisting of dual phosphorylation
cycles. One finds that the average amplitude sensitivity of cascades consisting of mono
phosphorylation steps is independent of the cascade length. In sharp contrast to that,
cascades with dual phosphorylations possess an optimal cascade length of three or four
activation steps in a wide range of parameters.
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Chapter 2
Structural design of signal
transduction networks
In this chapter a strategy is presented for understanding the interrelations between
the structural design and dynamic properties of signal transduction networks. The
basic hypothesis says: Stability of the signal off-state as well as signal amplification
were important targets at the evolutionary optimisation of signal transduction networks.
Stability of the steady state, when there is no signal present at the receptor (signal-off
state), is of importance for signalling networks if they do not want to run the risk of
autoactivation. Morover, a signal should be amplifyied or at least not damped out on
the way from the cell membrane to the its target site. In search of structural designs
which provide both characteristics, full sets of in principle possible network designs
with a specific number of kinases and phosphatases are considered. The set of possible
topological designs with seven kinases contains already more than 8.8 · 108 networks
and marks therefore the upper limit of computational feasibility. Each network design
of a given set is analysed with respect to its dynamic characteristics and structural
properties. In this theoretical approach it is shown that the stability is closely related
to the number of kinases, the total number of kinase activations and the number of
feedback cycles within the network. Signalling networks with a high number of kinases,
high kinase connectivities and/or cycles tend to be more unstable and therefore run
the risk to display autoactivation. In contrast to that increasing phosphatase activity
stabilises the off-state.
By regarding the effect of structural changes of signalling networks on their dynamic
properties one arrives at conclusions concerning the robustness against such mutations
(Ebenho¨h and Heinrich [2003]).
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The methods presented here are based on nonlinear differential equations for the
concentrations of the participating kinases and algorithms for generating and analysing
directed graphs.
Finally, the theory is applied to a real network by taking into account existing in-
formation on kinase interactions as documented in databases for signal transduction.
The design of a large kinase network retrieved from the database TRANSPATH shall
be investigated. This analysis reveals that several structural characteristics required for
pathway stability are indeed fulfilled for a kinase network of such large size.
The kinase network is then further investigated with respect to other significant
design and functional properties. This involves the length of all distinguishable pathways
therein, the distribution of signal inputs and outputs of the kinases, crosstalk strength
and the correlation of amplitudes and signal durations of kinase activation profiles.
To evaluate to what extent the values of these measures are significant for the kinase
network under consideration, they are compared to properties of randomised networks
of the same size (Milo et al. [2002]). It can be shown that there are significant differences
in this regard.
2.1 The model
2.1.1 Basic model assumptions
Signalling networks which are analysed in this chapter consist of receptors, kinases and
phosphatases and have the following properties: (1) each kinase may occur in an active
and in an inactive form; (2) activation of kinases takes place by phosphorylation; (3)
in their active forms kinases may phosphorylate other kinases; (4) inactivation of the
kinases takes place by dephosphorylation, catalysed by phosphatases which are consti-
tutively active, i.e. they are not considered to be variable in time. Effects of multiple
phosphorylation and auto-phosphorylation of single kinases are ignored. So far, the
actions of adaptor proteins or scaffolds are also not considered. Accordingly, it is as-
sumed that initial activation of kinases occurs by its direct interaction with a stimulated
receptor R, i.e. the receptor itself has a kinase activity.
Three examples of signalling networks are given in Figure 2.1.1 where the active
and inactive forms of kinase i are denoted by X∗i and Xi, respectively. Each dashed
arrow indicates an activating effect of one kinase on another kinase. Arrows pointing
from active forms to inactive forms of kinases denote the action of phosphatases. To
allow for a large variety of pathway structures, the possibility that a given kinase may
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be activated by more than one other kinase and that a single kinase is able to activate
several other kinases (Bhalla and Iyengar [2001]) is considered. This gives rise to pathway
structures, some of which feature different branches or feedback cycles. The first of
the three examples, Network A, represents the most simple arrangement of a receptor
and three pairs of kinases and phosphatases in form of a linear cascade resembling
the classical MAPK pathway. The other two networks in Figure 2.1.1 represent more
complex structures which are also found in real cells (Kyriakis and Avruch [2001]).
In network B one of the kinases activates two kinases, and in network C one of the
kinases receives two activating inputs. For the latter network these interconnections
give rise to a feedback cycle. In the lower panel the same three networks are described
in a more compact representation by directed graphs. The nodes represent kinases
and the arrows their mutual activations. Whereas these graphs focus on the action of
kinases, it should be kept in mind that to each node a reaction is attached representing
a deactivation process by a phosphatase. Our dynamic analysis is based on the following
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Figure 2.1: Different network structures with three kinases and three phosphatases.
Upper panel: Interconversions of active and inactive forms of kinases catalysed by other
kinases and by phosphatases. Lower panel: compact graph representation of the same
networks.
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set of differential equations (Heinrich et al. [2002])
dX∗i
dt
= ρ′iR(t)Xi +
n∑
k 6=i
α′ikXiX
∗
k − βiX∗i . (2.1)
The parameter n denotes the total number of kinases involved in a given pathway.
Activation rates of kinases i by other kinases k are described by bimolecular terms
α′ikXiX
∗
k where the factors α
′
ik are second order rate constants. The first order rate
constants βi characterise the dephosphorylation of the kinases by phosphatases. The
first term in Eq. (2.1) describes kinase activation by the receptor. The corresponding
rates are also written as bimolecular terms in which R(t) denotes the time dependent
concentration of the stimulated receptor and ρ′i the corresponding second order rate
constant. A transient stimulation of the receptor is described by an exponential decay,
that is R(t) = R · exp(−λt), where λ characterises the half life of its active form. The
case λ → 0 results in R = const. describing a sustained receptor activation. The
concentrations of complexes resulting from protein–protein interactions are considered
to be negligibly small, i.e. these complex concentrations do not appear as separate
variables in the model. According to the reaction schemes in Figure 2.1.1 and the systems
equations Eqs. (2.1), only the concentrations of active and inactive forms contribute to
the total concentrations of kinases leading to conservation relations:
Xi +X
∗
i = Ci = const. (2.2)
This equation can be used to eliminate Xi from Eq. (2.1) resulting in
dX∗i
dt
=
(
ρiR(t) +
n∑
k 6=i
αikX
∗
k
)(
1− X
∗
i
Ci
)
− βiX∗i , (2.3)
where ρi = Ciρ
′
i and αik = Ciα
′
ik denote pseudo-first order rate constants.
2.1.2 Structural properties of signalling networks
As already shown in the lower panel of Figure 2.1.1 the signalling networks can be drawn
as directed graphs. They consist of nodes representing the kinases, and of arrows repre-
senting activation of these kinases by other kinases. These graphs focus on the kinases
whose interactions perform the signalling routes. However, the dynamic behaviour of
the networks described by Eq. (2.3) also depends on the phosphatases acting on each
kinase.
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In the following, only those networks which cannot be decomposed into subnetworks
of lower size shall be taken into account. In these network types, each node is connected
to at least one other node (weakly connected graphs). Any of these graphs representing
a special signalling network can be characterised by the following structural properties:
the number n of nodes, the number e of edges for the activations, and the number cL
of cycles of length L. A cycle of length L in a directed graph is defined as a closed
loop consisting of L edges, and no node may occur more than once within this loop.
The outdegree and the indegree of a node are defined by the number of edges leaving
this node or entering this node, respectively. The mean outdegree d of a network which
equals its mean indegree and a related property, the network connectivity κ, are defined
by
d =
e
n
(2.4)
and
κ =
e
n(n− 1) =
d
n− 1 , (2.5)
respectively. These measures indicate how many activations are taking place among a
given number of kinases. In biological terms κ characterises on average the unspecificity
of kinase activations in a given network, and its value varies in the range of 1/n ≤ κ ≤ 1.
As n(n− 1) is the maximum number of activations within a network of n kinases κ = 1
holds for the fully connected network in which every kinase activates all other kinases
(see graph No.1 in Figure 2.1.2). Similarly a scaled measure σ for the number of cycles
in a certain network with n nodes can be introduced. The cycles are counted irrespective
of their length L, and this number c is scaled by the maximum number of cycles cmax
which can in principle occur in networks of size n. Thus, cmax is calculated as the total
number of cycles in the fully connected graph of size n. The cycle density σ is defined
as follows:
σ =
c
cmax
, with cmax =
n∑
i=2
n!
i(n− i)! , (2.6)
and its value varies in the range of 0 ≤ σ ≤ 1.
In Figure 2.1.2 all possible network designs of three kinases are depicted together
with their structural properties. As previously stated, nodes represent active kinases
and directed edges represent activations between kinases. In Table 2.1 the numbers of
possible network designs with n = 2 . . . 7 nodes are listed. The maximum number of
feedback cycles for each set of n-networks is also given. The number of networks, which
must be at least weakly connected, increases strongly with the number of kinases n and
11
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Figure 2.2: The full set of different network structures with three kinases (n = 3). The
nodes depict the active kinases and the edges show the activations. Graphs No.12, 9,
and 10 refer to the three examples considered in Figure 2.1.1.
can be found using an application of the Po´lya enumeration theorem (Harary [1994]).
These networks differ significantly from each other which means that no permutation of
nodes can transfer one network into another. They are described as non-isomorphic to
each other. For a more detailed list of numbers of network designs see Appendix A.2.
number of nodes n = 2 n = 3 n = 4 n = 5 n = 6 n = 7
number of designs 2 13 199 9, 364 1, 530, 843 880, 471, 142
max. number of cycles 1 5 20 84 409 2, 365
Table 2.1: Numbers of network designs and maximum numbers of cycles depending on
the number of nodes (kinases).
Concerning the primary activation of all kinases, one must accurately attach appro-
priate receptors to specific kinases in the network. Hence, a minimum set of receptors is
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considered whose stimulation results in a subsequent activation of all kinases. For some
networks the attachment of a receptor to a single input kinase may be sufficient. This is
the case if the corresponding graph contains directed paths from this kinase to all other
kinases. For other networks one might initially have to stimulate more than one kinase
by receptors. This is particularly the case if a network contains several kinases without
activations from other kinases. There are also networks where each kinase is equally
suited for a primary activation. In this case the corresponding graphs are strongly con-
nected and a receptor is attached to a kinase where the best amplification performance
is guaranteed (for a definition of amplification see the next section 2.1.3. If a kinase i is
activated by a receptor, then ρ′i in Eqs. (2.1) differs from zero.
2.1.3 Dynamic properties of signalling networks
For the time independent states for the concentrations X∗i only solutions of Eqs. (2.3)
within the range 0 ≤ X∗i ≤ Ci are of interest since otherwise the concentrations of active
or inactive kinases would be negative. Positive steady state solutions for permanent
receptor activation (R 6= 0) can generally not be written in an explicit form due to
the nonlinear character of Eqs. (2.3). For R = 0, equation system (2.3) always has a
time independent solution, X∗i = 0, representing the signalling off-state. In this case,
another stationary state with X∗i 6= 0 resulting from autoactivation of the pathway may
also exist. As an example, a network is considered which contains a cycle of length
L = 2 between kinases 1 and 2 both of which activate a third kinase (see network 3 in
Fig. 2.1.2). The steady state conditions read in this case
X˙∗1 = α12X
∗
2
(
1− X
∗
1
C1
)
− β1X∗1 = 0 (2.7)
X˙∗2 = α21X
∗
1
(
1− X
∗
2
C2
)
− β2X∗2 = 0 (2.8)
X˙∗3 = α32X
∗
2
(
1− X
∗
3
C3
)
+ α31X
∗
1
(
1− X
∗
3
C3
)
− β3X∗3 = 0. (2.9)
Besides the off-state, X∗1 = X
∗
2 = X
∗
3 = 0, this equation system has the steady state
solution
X∗1 =
C1C2(α12α21 − β1β2)
α21(α12C2 + β1C1)
, X∗2 =
C1C2(α12α21 − β1β2)
α12(α21C1 + β2C2)
, (2.10)
where the corresponding X∗3 -value is obtained by introducing the solutions for X
∗
1 and
X∗2 into Eq. (2.9). The solutions for all X
∗
i are proportional to the factor α12α21−β1β2.
13
Eq. (2.10) describes an autoactivated state which only exists when the phosphatase
activities are low compared to the kinase activities, that is, for
α12α21 > β1β2. (2.11)
It can easily be proven that also for other networks autoactivated states may only occur
if the corresponding graphs contain cycles (see Appendix A.3).
An intriguing question concerning the proper functioning of a signal transduction
pathway is, if in the absence of receptor activation the off-state is dynamically stable.
Stability means that the signalling network returns to this state after small perturbations
such as those resulting from spurious activation of the kinases. In the case of instability,
autoactivation may occur where the network will spontaneously leave the off-state, ap-
proaching a stationary state with non-zero concentrations for the active forms of some
kinases, as in the state represented by Eq. (2.10). Stability analysis is performed by
considering the spectrum of the eigenvalues of the Jacobian J = (Jik) of the differential
equation system (2.3). For the off-state the Jacobian reads
Jik = αik − βiδik ,
 αik 6= 0 if kinase i activates kinase kαik = 0 otherwise (2.12)
δik denotes the Kronecker symbol. Stability requires that the eigenvalues of this matrix
have only negative real parts. For example, stability analysis of the signalling off-state
for the network represented by graph 3 in Figure 2.1.2 reveals that the autoactivated
state Eq. (2.10) is stable whereas the off-state is unstable. When condition (2.11) is not
met, the autoactivated state does not exist and the off-state is stable. Concerning the
stability of the off-state it is worth mentioning that the results presented in this work
for mass action kinetics are also representive for less simplified kinetic rate equations,
for example Michaelis-Menten or Hill equations. This is due to the fact that pathway
stability against small perturbations is determined by the properties of the Jacobian
of the off-state. This state becomes independent of saturation phenomena, i.e. also in
more complex cases the Jacobian J for X∗i = 0 is nevertheless described by Eq. (2.12).
During transduction of a signal from a stimulated receptor to a target kinase, am-
plification or dampening may occur. As examples the transient activation of the three
pathways A, B, and C depicted in Figure 2.1.1 are considered. Receptor stimulation
occurs for t = 0. Figure 2.1.3 shows the exponentially decreasing concentration of the
active receptor for t > 0, and the three other curves are the time dependent activation
curves of the third kinase for the respective pathway. For pathways A and B the off-states
14
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Figure 2.3: Time dependent changes of receptor R(t) and kinase concentrations X∗3 in
the networks A, B and C from Figure 2.1.1. In each network the receptor is attached
to kinase 1 and has the same activation profile. Parameter values: αik = 1.0, βi = 0.9,
λ = 0.1. Signalling amplitude S, duration ϑ, time τ and integrated response I (shaded
area) are indicated for the output kinase of network A: S3 ≈ 0.47, ϑ3 = 6.7, τ3 = 11.3,
I3 = 6.4.
are stable. Accordingly, the target kinases are transiently activated and the networks
return eventually to their off states. Compared to these responses, pathway C shows a
completely different behaviour. The off-state is unstable and the network approaches a
stable activated state which persists even after the decay of active receptor.
Different definitions for amplification or dampening may be envisaged. A conve-
nient characterisation of amplification properties is based on a comparison between the
concentrations of the active forms of kinases having different positions in the pathway
or by comparing these concentrations to the concentration of the stimulated receptor.
For complex signalling networks as depicted in Figures 2.1.1 or 2.1.2 it is convenient to
define an overall amplification (or overall dampening) by comparing the highest values
of the concentrations of the active kinases with the initial concentration of the receptor
(R(0)). According to this definition pathway B amplifies the signal whereas in pathway
A dampening occurs for the given parameter values. This concept of amplification is
applicable to transient activation of pathways but also to stationary states which are
15
attained for permanent receptor stimulation (λ→ 0).
Amplification properties of the various networks can be analysed in principle by
solving Eq. (2.3) numerically. However, determining the maxima of the concentrations
of active kinases may render to be rather cumbersome. It is therefore more convenient
to analyse amplification in terms of average activation amplitudes Si. This idea refers to
the concept of averaged signalling amplitudes introduced in Heinrich et al. [2002]. For
a given kinase i such an amplitude is defined as follows:
Si =
Ii
2ϑi
, (2.13)
where the “integrated response” Ii (Asthagiri and Lauffenburger [2001]) and ϑi are de-
fined in the following way:
Ii =
∫ ∞
0
X∗i (t) dt, (2.14)
ϑ2i =
1
Ii
∫ ∞
0
t2X∗i (t) dt− τ 2i with τi =
1
Ii
∫ ∞
0
tX∗i (t) dt. (2.15)
The quantity Ii corresponds to the area under activation curve X
∗
i (t), ϑi characterises
signal duration and τi denotes the average signal propagation time to the kinase i (Hein-
rich et al. [2002]). How these dynamic quantities are related to each other is depicted in
Figure 2.1.3 for the activation profile of the third kinase of network A. The amplitude
S is the height of a rectangle whose length is 2ϑ and whose area equals I (shaded). A
signal is considered to be amplified in a network if a kinase i exists with Si ≥ R(0).
Also according to this defintion in pathway A dampening occurs because not only the
maximum value of the activation profile is smaller than R(0) but also S3 (see legend
to Figure 2.1.3). In that respect network B has an optimal structural design (for the
given parameter values) because it possesses a stable off-state and additionally amplifies
signals.
2.1.4 Dynamic properties of networks depending on their size,
connectivity, number of cycles and kinetic properties
Concerning amplification, a proper choice has to be made for initial kinases, activated by
the receptor, and for a final output kinase to which the signal is transmitted. Eventually
that kinase is selected as the signal output for which a maximum amplification, i.e. a
maximal average amplitude, is observed. As already mentioned, input kinases are those
to which receptors have to be attached, in order to ensure that all kinases in the network
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are activated after receptor stimulation. Note that stability of off-states is independent
of the choice of input and output kinases and the strength of the receptor activation λ.
To obtain explicit solutions and a qualitative description of the interrelation of structural
design and dynamics properties, the kinases as well as the phosphatases are assumed to
have identical kinetic properties as characterised by their rate constants: αi = α and
βi = β. This allows for dividing the equation system (2.3) by α which equals a time
rescaling (t→ t′ = tα). In a more compact form Eq. 2.12 can be rewritten as
J = AT − β
α
I, (2.16)
where AT describes the transposed adjacency matrix of the underlying graph and I
denotes the unity. To obtain also explicit solutions for the calculation of the signal
amplitudes it is moreover assumed that the component kinases are in a low activated
state (Heinrich et al. [2002]), i.e. they are phosphorylated to a low degree (X∗i ¿
Ci). This particular assumption leads to a linearisation of equation system (2.3) (see
Appendix A.1). Due to this simplification the kinetics of signalling networks can be
described with one parameter, β/α, which reflects the phosphatase activities normalised
to the kinase activities.
First the stability of off-states and amplification properties of the family of 13 net-
works consisting of three kinases is analysed. Which kinases are chosen as signal input
and signal output are listed in Table 2.2. The kinase numbers refer to the numbering
of kinases in Fig. 2.1.2. In the following “stable network” simplifying denotes a network
network 1 2 3 4 5 6 7 8 9 10 11 12 13
input kinase 1 2 1 1 1 2 1 1 1 1 1 1 2 and 3
output kinase 3 2 3 3 1 2 1 3 3 2 3 3 1
Table 2.2: Choice of input and output kinases for 3-kinase networks. Input kinases are
those for which a minimum set of receptors can be attached to get a fully activated
network. If more possibilities are available those kinases are chosen as receptor inputs
for which a maximum amplification is guaranteed. An output kinase is chosen under
similar criteria: the output kinase exhibits the maximum amplification. The numbering
refers to Figure 2.1.2.
possessing a stable off-state.
Figure 2.4 gives an overview of the stability and amplification properties of the family
of 13 networks consisting of only three kinases. The ordinate represents the values of
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the normalised rate constant β for phosphatases. On the abscissa of the diagram the
networks are grouped according to the mean outdegree of the corresponding graphs. The
blank part of any bar characterises that region of β-values for which the corresponding
network is unstable. The shadowed part is the region where the corresponding network
is stable and displays amplification. In all cases β-values above the shadowed parts
of the bars result in stable networks with dampening properties. The results of this
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Figure 2.4: Stability and amplification of signalling networks with three kinases and
three phosphatases for permanent receptor activation with λ = 0 (A) and for transient
receptor activation with λ = 0.1 (B). Depending on the normalised activity of phos-
phatases and on the mean outdegree of the corresponding graphs one obtains regions of
unstable off-states (blank parts of the bars) and of stable off-states together with signal
amplification (shaded parts). For β/α-values above the bars the signal is dampened.
analysis can be summarised as follows:
1) The four graphs without any cycle (networks 9, 11 to 13) are always stable, but
they show slight differences in their amplification properties. For example, network
13 displays an amplification over a larger range of phosphatase activities than the
other three graphs. This results from the fact that the output kinase of network
13 receives activation from two kinases which themselves are activated by the
receptor.
2) All networks with cycles have a region of β-values where the off-states are unstable.
The networks with only one cycle (networks 3, 5, 7, 8, 10) have the same critical
β-value below which instability occurs. With an increasing number of cycles the
boundaries for instability are shifted toward higher β-values, with some slight
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differences in the effects of cycles of length 2 or 3. Network 1 which is represented
by a totally connected graph, has a maximum number of 5 cycles and is therefore
characterised by the largest region of instability.
3) There is a general tendency that networks with higher numbers of interactions are
less stable, as becomes evident by an increase of the instability region with an
increasing mean outdegree.
4) Compared to the case of permanent receptor activation (Fig. 2.4A, λ = 0) transient
receptor activation (Fig. 2.4B, λ = 0.1) results in narrowing of the region of β-
values where amplification is observed. Since the critical β-values for instability
of the off-states are independent on the receptor only upper boundaries of the
amplification regions are affected when decreasing the life-time of the receptor.
Figure 2.5 shows regions of stability and regions of amplification for networks consist-
ing of more than three pairs of kinases and phosphatases. The abscissa represents the
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Figure 2.5: Effect of network connectivity κ and phosphatase activity β/α on stability
and signal amplification for networks of different size. In the grey shaded parameter
region networks exist which have a stable off-state and exhibit signal amplification.
network connectivity κ which, according to Eq. (2.5), is directly related to the mean out-
degree d. Due to normalisation with respect to the number of kinases, κ is better suited
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for comparing the properties of signalling networks of different size. Figure 2.5 shows
that for each family of networks having the same size n there are three distinct regions
A, B, and C in the (κ, β/α)-plane, characterising parameter combinations leading to
different dynamic properties of the networks. In region A all networks of a given family
have an unstable signal off-state, in region B (shaded) stable networks exist showing
amplification properties, and in region C all networks of the given family have a stable
signal off-state and show a dampening in the signalling amplitudes. The borders be-
tween regions A and B and between B and C are shifted towards higher β-values when
n increases, that is, networks with a higher number of kinases tend to be more unstable.
Keeping in mind that biological cells contain several hundred different types of kinases,
one may draw the conclusion that real kinase networks (see section 2.2) must exhibit a
low connectivity to avoid autoactivation.
To illustrate the counteracting effect of network size n and phosphatase activity on
stability, the distributions of maximum eigenvalues λmax of Jacobians are considered.
The histograms in Figure 2.6 show the distributions of the real parts of maximum
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Figure 2.6: Distribution of largest eigenvalues λmax of the Jacobians of signalling net-
works with 4, 5 and 6 kinases. Depicted are the real parts of λmax (spectral radius).
The rate constants of phosphatases are set to β/α = 1.0.
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eigenvalues for the full set of networks for three different system dimensions (n = 4,
5, 6). The rate constants of phosphatases are always set to β/α = 1.0. The abscissa
represents the real part of maximum eigenvalue and the ordinate the number of networks
with a certain λmax-value within small intervals (∆Real(λmax) = 0.1). The percentage of
stable networks (Real(λmax) < 0) decreases towards higher system dimension. For the
given parameter values there are about 13%, 3% and 0.4% stable systems, respectively.
Similarly the relative number of networks with Real(λmax) = 0 decreases with higher n.
These particular networks contain exactly one cycle. On the other hand the percentage
of systems with stable off-state becomes higher with increasing phosphatase activity.
Increasing β/α results in a shift of the histograms to the left which becomes clear by
the definition of Jik (see Eq. (2.16)). In Figure 2.7 the dependence of the percentage of
stable networks (Nst./(Nst. + Ninst.)) is depicted as a function of β. The plateaus for
0 < β/α ≤ 1 are due to the fact that there are no networks for −1 < Real(λmax) < 0
(when β/α = 1), which can be seen in Figure 2.6. Changing β/α from 1 to 0 keeps the
number of stable networks constant.
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Figure 2.7: Dependence between the fraction of stable networks and phosphatase activity
for networks of size n = 4, 5, 6.
The grey shaded (β/α, κ)-parameter region B in Figure 2.5 contains signalling net-
works which are stable and amplifying at the same time. Therefore, this area can be
considered as the biologically meaningful parameter region of signalling networks. Only
within this region, networks exhibiting the two characteristics simultaneously exist. On
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closer inspection one finds a more detailed partitioning. A distinction can be drawn
between four different subregions B1, B2, B3, B4. They are distinct from each other
with respect to different combinations of dynamic characteristics the networks exhibit
therein. In Figure 2.8 the composition of the four subregions is illustrated by consid-
ering, as an example, the biological meaningful parameter region of networks of size
n = 6. Markers on the outer lines indicate the discrete character of the κ-values existing
κ
β/α
1/6 1/2 1
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connectivity,
Figure 2.8: Detailed analysis of effect of network connectivity κ and phosphatase activity
β/α on stability and signal amplification for networks of size n = 6. B1) Subregion below
the dotted and concomitant below the dashed line: Some networks might be unstable
and others stable but all stable networks are also amplifying. B2) Subregion above
dotted and below dashed line: All sorts of networks can be found here. Stable as well
as unstable ones, and stable networks can either be amplifying or dampening. B3)
Subregion above the dotted and concomitant above the dashed line: All networks are
stable, but only some are amplifying, whereas others are dampening. B4) Subregion
below the dotted and concomitant above the dashed line: All networks are stable and
amplifying.
for networks of such size. The dashed line denotes the “stability line”: Above this line
all networks are stable. Some of them are dampening whereas others are amplifying.
The dotted line displays the “amplification line”: Below this line all networks which are
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stable are definitely amplifying. The legend of Figure 2.8 describes in more detail by
what characteristics the subregions are categorised. There is only a small area within the
(κ, β/α)-plane, indicated with B4, where all networks are stable and also amplifying.
As a second structural design property, besides network-connectivity, the number of
feedback cycles is considered. An increasing number of cycles have the same tendency as
increasing connectivity, namely to make networks less stable. To quantify this tendency
and to investigate the influence of the network size n, a scaled measure σ for the number
of cycles in a certain network with n nodes is introduced in definition (2.6). In Figure 2.9
the (σ, β/α)-plane is depicted. The abscissa displays the density of cycles, i.e. the
cycles,  σ
β/α
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Figure 2.9: Effect of the total number of cycles within a network and phosphatase
activity β/α on stability and signal amplification for networks of size n = 5, 6. A) All
networks possess an unstable off-state. B) Networks exist which have a stable off-state
and exhibit signal amplification. C) All networks are stable but dampening.
total number of cycles counted within a network normalised by the maximum number
of cycles a network of size n can possess (σ = c/cmax). Again one identifies three
regions A, B and C, representing parameter combinations with unstable, amplifying
and dampening networks, respectively. The grey region indicates the parameter region
for which networks of size n = 5, 6 exist which have a stable off-state and are amplifying
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at the same time. It can be seen that the more feedback cycles a network with a given
β/α-value contains, the more unstable it gets. This effect is even more pronounced
compared to the unstablising tendency of higher connectivities κ. A small number
of cycles has already a high destabilising effect on the network. There are, indeed, no
records about (direct) positive feedback cycles found in protein kinase networks hitherto.
Such feedbacks only exist via transcriptional and translational delay mechanisms, which
bring about an additional stabilising effect (Matten et al. [1996]).
2.1.5 Mutations of signalling networks
In the previous sections the structural design of signalling networks has been analysed.
The present section treats the question how structural changes of signal transduction
networks affect their dynamic properties. In principle there are two different scenarios
where structural changes in signalling networks are conceivable.
On a short time scale: incorporation or elimination of kinases due to alteration in
gene expression or protein degradation.
On a longer time scale: changes in the network structure during evolution. Mu-
tations may lead to a loss or gain of function of kinases to activate certain other
kinases. It is also possible that certain mutations of a kinase can stop (or addi-
tionally initiate) other kinases to act as activators thereof.
Possible transitions from a given network to another network which differs from the
initial one in exactly one kinase interaction (∆e = 1) are of interest. Such structural
changes which are called mutations in the following define relationships among different
networks (mutation neighbours). The presented strategy refers to the concept intro-
duced for metabolic pathways in Ebenho¨h and Heinrich [2003]. The basic hypothesis is
that those signalling networks (and network populations) which can in principle mutate
to a high number of networks with similar dynamic properties, are robust and in that
respect they have an evolutionary advantage. For a fixed value of β/α different muta-
tions of a given network can be classified via the dynamic properties of the resulting
network. Given the initial network being stable and amplifying, each mutation may
lead to a functioning network, i.e. a network that is still stable and amplifying, or to a
network that has lost one or both dynamic properties. As an example, Figure 2.10 shows
all possible mutations of a particular network (network 1) with four kinases and seven
interactions. Out of seven possible mutations of network 1, four take place by losing one
interaction (networks 2, 3, 4, 5) and three by gaining one additional activation (networks
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Figure 2.10: Complete set of possible mutations of an initial network with n = 4 ki-
nases and their effects on dynamic properties (β/α = 2.1). The “mutation arrows” are
partitioned in different colours according to the properties of the mutation neighbours.
Black mutation arrows indicate amplification (network 1 and 6), dark grey dampening
(2, 3 and 4), light grey instability (7 and 8) and blank arrows denote a mutation leading
to an unconnected network (5).
6, 7, 8). For the given parameters value (β/α = 2.1), the initial network 1 has a stable
off-state and is moreover amplifying, which is indicated by the black coloured part of
the mutation arrow. After gaining one additional interaction only network 6 remains
amplifying, whereas networks 7 and 8 loose this capacity and become unstable. Insta-
bility is indicated by a light grey part of the mutation arrow. This harmful effect is a
consequence of the emergence of feedback cycles the impact of which has been analysed
in the previous section. Losing an interaction by mutation can also result in dampening
networks 2, 3, 4 (dark grey) and in a disconnected network 5 (blank). By identifying
possible mutations of all networks of a given size n one arrives at an undirected graph,
where the nodes are the signalling networks and the edges are the possible mutations
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Figure 2.11: Mutation graph for networks of size n = 4. The 215 nodes represent
networks with four kinases and the undirected edges represent possible mutations. Black
nodes indicate stable, dark grey dampening, light grey unstable networks for β/α = 2.1.
Blank nodes denote disconnected networks. Crosses mark the eight example networks
from Figure 2.10.
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Figure 2.12: Mutation graph for networks of size n = 4. The 215 nodes represent
networks with four kinases and the undirected edges represent possible mutations. Black
nodes indicate stable, dark grey dampening, light grey unstable networks for β/α = 1.5.
Blank nodes denote disconnected networks (c.f. Figure 2.11).
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transforming one network into another.
As an example, the mutation relationships of all networks of size n = 4 are depicted
in Figure 2.11 for β/α = 2.1. Besides the 199 connected networks also 16 disconnected
networks are depicted since in an evolutionary scenario these networks can also be
generated if a connected network with four kinases mutates. Therefore 215 networks
are considered in the mutation graph which can mutate at least to one other network
which is (weakly) connected. The networks are grouped within the mutation graph
according to their connectivity κ (abscissa). The smallest connectivities κ = 2/12 arise
after a mutation from a connected network with 3 edges (κ = 3/12). Like in Figure 2.10
disconnected networks are indicated with blank circles. Black circles indicate signal
amplifying networks, dark grey circles signal dampening and light grey unstable networks
for the specific phosphatase activity. The eight example networks of Figure 2.10 which
may arise after a mutation of network 1 are marked with a cross. As a second example
Figure 2.12 displays the situation when the phosphatase activity is lower (β/α = 1.5)
which brings about more networks to be unstable.
Of particular interest is the total number of network designs (connected and uncon-
nected) which can emerge when a connected network mutates. The distribution of these
numbers for all 199 connected networks of size n = 4 is depicted in the lower panel of
Figure 2.13. The histogram shows the frequencies of networks with a certain amount
of mutation neighbours (abscissa). The lowest possible number of mutation neighbours
is 1. One single network shows this mutation character: the fully connected network
which can only mutate to the network with κ = 11/12. A striking feature is that 100
out of 199 networks can mutate to 12 different network designs. This is the maximum
number of mutations which can happen in a network with four kinases. Accordingly the
maximum number of mutation neighbours that a network of size n = 4 can possess is
Nmax = n ·(n−1) = 4 ·3 = 12. Networks with small numbers of mutation neighbours are
those which show high symmetry concerning the arrangement of their kinase activations.
This is because some mutations of such networks result in the same network design.
Mutation graphs consisting of networks of size n > 4 show similar properties with
respect to “mutation connectivities”. Figure 2.13 shows distributions of mutation neigh-
bours for mutation graphs consisting of networks with four, five and six kinases. It
should be pointed out that the ordinates which give the frequencies of networks with
a certain amount of mutation neighbours have logarithmic scales. It can be seen that
irrespective of the size n, most of the networks possess a high variability concerning
their mutation potential. Most networks can mutate to all possible mutation neigh-
bours a network of size n can possess. For example 7, 536 networks (out of 9, 364) of
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Figure 2.13: Distributions of numbers of mutation neighbours for mutation graphs con-
sisting of n = 4, 5, 6 kinase networks. The ordinates have logarithmic scales. On the
abscissa fully connected networks mark the lower bound of mutation neighbours. Net-
works exhibiting the maximum variability, concerning mutations to other networks, mark
the upper bound (Nmax = n · (n− 1)).
size n = 5 can mutate to 20 different network designs which is more than 80%. In the
case of n = 6 there are 1, 428, 852 networks (out of 1, 530, 843) which can mutate to the
maximum number of 30 mutation neighbours (93%).
As described in the previous sections quantitatively, dynamic properties of signalling
networks change with higher or lower phosphatase activities. For example in Figure 2.11
a specific parameter combination is chosen as β/α = 2.1. For this particular value a
certain set of networks is stable and amplifying (black circles). Highest connectivities
within this set of networks are found to be κ = 0.5. Increasing β/α will make networks
with higher connectivities κ become stable and instantaneously amplifying, whereas
networks with lower κ will become dampening. Together this shifting of the value for β/α
results in a maximum for the number of amplifying networks at a certain phosphatase
activity. Figure 2.14A shows how the number of amplifying (nA) and the number of
dampening (nD) networks depend on β/α. The dashed line marks the total number
of 199 networks with n = 4. For phosphatase activities up to β/α = 1.0 there is a
constant amount of stable and at the same time amplifying networks (nA = 24) which
are exclusively those without any feedback cycles (c.f. Figure 2.7). As the plotted
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Figure 2.14: Numbers of amplifying and dampening networks, mutation neighbours of
exclusively amplifying networks and structural robustness of 4 kinase signalling net-
works. These numbers depend on the phosphatase activity β/α. A) Total number of
networks (= 199, dashed line). Number of amplifying (nA, straight line) and dampening
(nD, dash-dotted) networks. B) Mutation neighbours of the ensemble of amplifying net-
works. Total number (Ntotal, dashed line), number of amplifying (NA, straight line) and
dampening neighbours (ND, dash-dotted). C) Strong global robustness rstrong: fraction
of mutation neighbours which are stable and amplify signals. Weak global robustness
rweak : fraction of mutation neighbours which possess at least stable signal-off states.
straight line shows, most networks (nA = 80) are stable and amplifying for β/α ≈ 1.5.
For β/α > 3.07 all networks are dampening.
A concept for structural robustness of a certain network is introduced by considering
the dynamic properties of all mutation neighbours of this network. Appropriately the
considered network is assumed to function properly, i.e. it is stable and amplifying,
before the mutation occurs. In that respect a network is said to be structurally robust
if a high fraction of mutation neighbours is also stable and amplifying. The robustness
of a network depends on the phosphatase activity β/α. Instead of considering the
robustness of single networks, a global robustness is introduced. For this purpose all
mutation neighbours of all stable and amplifying networks (nA) at a certain β/α-value
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are accounted for. NA (ND) denotes all stable and amplifying (dampening) neighbours
which can be generated by a mutation of any of the nA networks. Figure 2.14B shows
how NA (straight line), ND (dash-dotted) and the total number of neighbours Ntotal
(dashed) of the nA networks depend on β/α. These numbers have maximum values for
intermediate phosphatase activities, since nA is also highest for these β/α-values. In
the range 0 < β/α < 1 a total number of Ntotal = 94 different network designs can be
generated from mutations of the nA = 24 amplifying networks. Out of these 94 mutation
neighbours 70 networks are unstable, whereas NA = 24 remain stable and, moreover,
amplifying. Thus, in this range of phosphatase activities all stable and amplifying
networks possess at least one mutation neighbour which is also stable and amplifying.
Therefore there is no“isolated”stable and amplifying network in the mutation graph, i.e.
every such network can be “reached” by one mutation nA = NA = 24. However, β/α-
values exist for which not all stable and amplifying networks can mutate to neighbours
which remain amplifying, i.e. such networks are isolated from other amplifying networks
within the mutation graph for these particular β/α-values.
If NA and ND are related to the total number of mutation neighbours Ntotal, a
measure for (global) strong and (global) weak robustness of the set of nA networks is
obtained as follows:
strong robustness: rstrong =
NA
Ntotal
,
(2.17)
weak robustness: rweak =
ND +NA
Ntotal
.
In both cases the robustness is defined for a certain β/α-value. These definitions reflect
how likely it is on average for a set of proper functioning, i.e. stable and amplifying
networks, to remain functioning after a mutation. In Figure 2.14C it is shown how weak
and strong robustness depend on β/α. The value for strong robustness of networks
with 4 kinases in the range of 0 < β/α < 1 is rstrong = 24/94 = 0.2553. Because
dampening networks are lacking in this range it holds rstrong = rweak. In the case of
strong robustness one finds the most robust scenario for β′max ≈ 1.45. This is similar to
the β/α-value for which a maximum number of stable and amplifying networks nA can
be found at about β/α = 1.5 (see maximum of straight line in panel A). However in
the case of weak robustness which refers to all stable mutation neighbours, which might
be either amplifying or dampening, the most robust scenario is found at β′max ≈ 2.45.
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This value is significantly higher than the one, for which one finds a maximum number
of amplifying networks.
2.2 Design and dynamics of the kinase network from
a signalling database
In the previous sections, general relations between the structure and dynamics of a
large class of signalling networks consisting of a relatively low number of kinases has
been considered. Some estimations could be made concerning the expected connectivity
and the number of feedback cycles of larger kinase networks. Now, signalling networks
as can be found in living cells are examined with regard to these estimations.
The network depicted in Figure 2.15 has been deduced from the database TRANSPATH.
It includes 86 kinases. The actual number of entries for the keyword ”kinase”is much
higher (1100). However, many of these entries concern complexes of kinases with other
proteins or are ortholog kinases in different species. A comparison of different kinomes,
that is, the totality of protein kinases in cells, shows that specific kinase families, and
sometimes individual kinases, are conserved even between very divergent organisms, a
property which highlights the basic roles of kinases in many cellular processes. An even
higher overlap of kinases is assumed for different mammalian kinomes (Manning et al.
[2002]).
Additionally to the kinases one obtains from the database the information of mutual
activations between kinases. They are annotated as “Reaction downstream” and “Reac-
tion upstream”. A more detailed analysis reveals that some of the interactions remain
unclear, in particular concerning the question of direct or indirect interaction mode.
Taking into account the quoted literature and more recent publications to minimise
uncertainty, one arrives at 171 direct mutual activations together forming a (weakly)
connected kinase network. Isolated kinases which do not activate other kinases or being
itself activated are not taken into account.
The database TRANSPATH also contains information on small G-proteins which
may switch between an inactive GDP- and an active GTP-form. Adding these G-
proteins and their activating effects to the kinase network results in the network shown in
Figure 2.16. Compared to the network containing only kinases the number of compounds
is enlarged to 94 and the number of interactions to 199.
The networks have been visualised by using the program graphviz1, comprising a
1http://www.research.att.com/sw/tools/graphviz/
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Figure 2.15: Signalling network from the database TRANSPATH. It contains 86 kinases
(encircled nodes) which, according to present knowledge, perform 171 mutual activations
(edges).
set of graph drawing tools. The layout algorithm produces layered drawings of directed
graphs. As far as possible edges are drawn in the same direction (e.g. top to bottom, or
left to right) and edge lengths are reduced. Moreover, crossing of edges is avoided when
possible. Visualization by this program reveals already several interesting characteristics
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Figure 2.16: Signalling network deduced from the database TRANSPATH. It contains 86
kinases (encircled nodes) and 8 small G-proteins (in boxes) which, according to present
knowledge, perform 199 mutual activations (edges).
of the network such as symmetry, parallelism or regularity. In the kinase network de-
picted in Figure 2.15 one may perceive a layered structure reflecting groups of upstream
and downstream kinases. For example, well known components like MAP kinases (e.g.
ERK, JNK, p38), MAPK kinases (MEK, MKK) and MAPKK kinases (Raf, MEKK)
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are assigned to three consecutive layers.
2.2.1 Feedback cycles, connectivity and pathway lengths
Closer inspection of the kinase network reveals that it does not contain cycles of any
length, which is, in view of the high number of interconnections, a rather remarkable
property. Inspection of the network containing small G-proteins shows that even this
network still contains no cycles.
To asses if this is a special property of the signalling network under consideration, the
probability that corresponding random networks do not contain cycles is evaluated. To
allow for an appropriate comparison random networks which have the same single-node
characteristics as the kinase network in Figure 2.15 are considered (null hypothesis).
Specifically, each node of the randomised networks has the same number of incoming
and outgoing edges as the corresponding node in the database network (see Figure 2.17).
For generating these random networks the method described in Milo et al. [2002] is
used. The idea behind this procedure is to use the real network as a starting point
and to exchange for two randomly chosen edges the target nodes or the nodes of their
origin. Applying this reshuffling process many times, the network structure changes
considerably but the numbers of incoming edges and outgoing edges are for each node
the same as for the original network.
In the present study 100, 000 different random networks are generated from a copy
of the TRANSPATH network. In each case the edges are reshuffled 5, 000 times. This
high number of exchanges ensures that the networks undergo sufficiently large changes
and that the resulting networks are, despite of the conservation of the node degrees, not
biased towards the structure of the initial network. Whereas it is rather cumbersome to
determine the exact number of cycles in each case, one may easily calculate the number of
networks containing no cycles at all. One obtains the result that within the full ensemble
of 100, 000 networks under consideration only 37 networks do not contain cycles. This
suggests that the probability of finding a Directed Acyclic Graph (DAG) among the
randomised networks is extremely low. A rough estimate might yield PDAG ≈ 0.04%
for this probability. One may conclude therefore, that the absence of cycles is a very
striking feature of the transpath network
For further structural characterisation the connectivity κ of the two kinase networks
from the database are calculated. According to formula (2.5) one obtains for the network
with only kinases and the one with additionally G-proteins κ = 0.0234 and κ = 0.0228,
respectively. This means that each single component has on average about two inter-
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action partners. These low numbers support our hypothesis that realistic signalling
networks of large size must be characterised by a low connectivity in order to avoid
autoactivation in the absence of any receptor stimulus.
A more detailed characteristic of the interconnections concerns the number of acti-
vations received or performed by any given kinase. For example PDK1 is activated by
two upstream kinases and itself activates eight other kinases (see Figure 2.15). MEK1
behaves in an opposite way: It has ten upstream and only two downstream kinases.
The diagram in Figure 2.17 shows how many kinases are found having given numbers of
upstream and downstream interactions. There is a recognizable tendency of the kinases
Figure 2.17: Unspecific interactions within the kinase network of Figure 2.15. The
entries give the numbers of kinases characterised by given numbers of input and output
activations.
to divide into two groups. Some act predominantly as signal distributors having many
downstream kinases as substrates but few activating kinases. They are represented by
numbers above the diagonal in the diagram of Figure 2.17). Kinases of the second group
act as signal receivers having more upstream kinases than downstream targets (numbers
below the diagonal).
A remarkable property of MAP kinase pathways is that they consist of three to four
consecutive levels of a phosphorylation cascade. It is an intriguing question, if such a
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pathway length is typical also for other pathways which can be identified in the whole
network. As pathways all routes of activations are considered starting from an input
kinase which do not have activating upstream kinases and leading to an output kinase
which does not activate other downstream kinases. The network contains 25 input
kinases and 27 output kinases constituting 675 pairs of kinases between which routes
could in principle exist. Inspection shows that not all output kinases are reachable by
routes from any input kinase and that routes (of various lengths) only exist between
Nio = 222 input/output kinase pairs. The total number of routes amounts to P
total =
1272 meaning that there are, on average, six routes between each pair of connected
kinases. As a specific feature the lengths of the shortest pathways between any two
connected kinases are calculated. The histogram in Figure 2.18A shows how many
shortest routes of a given length L exist. It can be seen that no route is longer than
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Figure 2.18: Lengths distribution of shortest pathways between input and output kinases
of (A) the kinase network in Figure 2.15 and (B) the network of kinases and small G-
proteins in Figure 2.16.
six and there are a considerable number of routes consisting of only one step. Routes
of length L = 3 occur more often than shorter or longer routes. The typical lengths of
routes in this network correspond therefore to that of MAPK-pathways. In Figure 2.18B
the distribution of pathway lengths is shown for the network depicted in Figure 2.16
which also involves G-proteins. Although the number of additional components is only
slightly increased by the inclusion of G-proteins (from 86 to 94), there is a rather strong
effect on the lengths’ distribution. Compared to the kinase network the number of the
longest routes with six activations is increased by a factor of more than four. Moreover,
the most frequent route length is shifted from three to four. This corresponds, for
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example, to the situation within the MAPK pathways whose first kinases are activated
by a G-protein.
Among the 222 connected pairs of kinases in the TRANSPATH network of Fig-
ure 2.15 there are 57 pairs which are connected by only one route. In another class
which contains 134 pairs there exist several routes but all of them are of equal length,
that is, all of these routes represent shortest routes. There exist only 31 pairs which
are connected by routes of different lengths. Within the latter class the longest routes
between two kinases comprise 10 activations steps. These results indicate that kinases
are typically interconnected by shortest routes. To compare this structural feature with
the distribution of pathway lengths of other networks for each connected pair i of kinases
the fraction of shortest routes is introduced:
fi =
si
Pi
, (2.18)
where si and pi denote the number of shortest routes and the total number of routes,
respectively, between the two kinases of pair i. The fraction of shortest routes among
all routes within the network is defined as
F =
1
Nio
Nio∑
i=1
fi, (2.19)
with 0 < F ≤ 1. High values of F indicate that a network is rather homogenous in
the sense that it consists mainly of shortest routes between connected kinases. For the
TRANSPATH kinase network one obtains F ≈ 0.86.
Pathway lengths can also be calculated for random networks. For the corresponding
study 100 networks randomised in the way explained above are considered. Since the
original network does not contain cycles randomisation is performed under the constraint
that the resulting networks also do not contain cycles. Since the degrees of the nodes
are preserved all these networks have the same number of input kinases (25) and output
kinases (27) as the TRANSPATH kinase network. However, the number of connected
pairs is generally different as depicted in the histogram shown in Figure 2.19A. The
range of the Nio-values lies between 168 and 349, and on average the networks contain
approximately 253 pairs of connected kinases. For a comparison with the distribution of
Nio-values the histogram in Figure 2.19B depicts the distribution of the total numbers
of routes which can be found in the random networks. These P total-values range from
680 to 5659. The fraction of shortest routes for each randomised network is also calcu-
lated leading to the result depicted in Figure 2.19C. Compared with the TRANSPATH
network (whose F -value is indicated by an arrow) the fraction of shortest routes within
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randomised networks is generally much lower, meaning that random networks show a
much more diverse distribution of pathway lengths.
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Figure 2.19: Pathway composition in 100 random networks. A) Distribution of numbers
of input/output kinase pairs Nio which are connected by routes. Nio is equal to the
number of shortest pathways within a network. B) Distribution of total numbers of
pathways P total found in each random network. C) Distribution of fraction of shortest
pathways F .
As special examples three randomly generated networks, with the lowest, a medium
and the highest Nio-value (168, 253, and 349, respectively) are considered in more detail.
The histograms in Figure 2.20A–C show the distributions of shortest routes of these
particular random networks. Interestingly, the typical lengths of shortest routes is again
L = 3−4 and also the shape of the distributions are similar to that of the TRANSPATH
network. However, shortest pathways which are longer than L = 6 also exist. The
longest routes which one finds therein comprise 10, 14, and once more 14 activations
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Figure 2.20: Lengths distribution of shortest pathways between input and output kinases
of three example random networks with 86 kinases and 171 activations. The total
number of shortest pathways amounts to 168 (A), 253 (B), and 349 (C), respectively.
steps, respectively. The fact that the random networks involve also longer routes is
reflected by the corresponding fractions of shortest routes, F = 0.66, F = 0.53, and
F = 0.44, respectively, that is of values which are much smaller than that for the
TRANSPATH network. The results suggest that real kinase networks have been selected
for a more uniform distribution of pathway lengths favouring the shortest routes.
In the next section 2.2.2 the 1272 pathways which are found within the TRANSPATH
kinase network are analysed in more detail with respect to crosstalk.
2.2.2 Signalling crosstalk
It is a known phenomenon that although different MAP kinase cascades run in par-
allel, there is a considerable degree of crosstalk between them, which creates multiple
opportunities for modulating or fine-tuning responses to different signals (Cowan and
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Storey [2003]). Moreover, specificity of the MAP kinase signalling pathways is greatest
at the level of specific MKK activation of individual MAPKs, where there is the least
amount of crosstalk. There is often considerable crosstalk at the MAPK substrate level,
e.g. transcription factors are phosphorylated by many MAP kinase signalling pathways.
The MAPKKKs are also involved in crosstalk, although much remains to be elucidated
at this level. Figure 2.21 outlines various known crosstalk interactions among MAP
kinase pathways. The differences, regarding the amount of crosstalk within consecutive
Figure 2.21: Summary of MAPK signalling pathways, showing mutual crosstalk (figure
from Cowan and Storey [2003]). A striking feature is the different magnitude of crosstalk
within the three levels of the cascades.
levels, can be clearly observed. Instead of focusing on this particular property, a more
general question is discussed in the present section by introducing a measure to quantify
crosstalk between two distinct pathways. The aim is to investigate, if the global distri-
bution of crosstalk strengths, which is encountered in the TRANSPATH network, differs
significantly from the distributions in random networks. Therefore, all 1272 pathways
are considered pairwise. However, some of these pathways contain common kinases.
Crosstalk can be defined most conveniently between pathways which do not contain a
common kinase, i.e. which are fully disjoint. Provided that each considered pair does
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not have a kinase in common, one ends up with 670, 282 pairs to account for. This
number is about 20% lower than the total number of pathway pairs (including also pairs
of overlapping pathways) which amount to 1/2× 1272× 1271 = 808, 356.
The strength of crosstalk between a pair of pathways (P1, P2) is measured by count-
ing all cross interactions (edges) between the kinases of P1 and P2. This method is
illustrated with two disjoint example pathways P1 and P2 in Figure 2.22A. The path-
ways have lengths of 3 and 2, respectively. The dashed arrows indicate two existing
cross-activations between P1 and P2. There is a maximum number of activations which
are in principle possible between two distinct pathways of certain size. This can be
seen in Figure 2.22A, where the light grey arrows mark additional 6 cross-activations
which would also be possible between P1 and P2. These eight in principle possible cross-
activations constitute the maximum number of activations between disjoint pathways of
length 2 and 3.
To obtain a scaled measure for crosstalk, the ratio of existing interactions to the
maximum interactions which are in principle possible between two pathways is consid-
ered:
η =
actual number of interactions between two distinct pathways
total number of possible interactions between two distinct pathways
. (2.20)
Using this definition for the crosstalk between the example pathways in Figure 2.22A
one calculates ηP1,P2 = 2/8 = 0.25. The distribution of crosstalk η of the TRANSPATH
kinase network is shown in Figure 2.22B. For comparison η-values of random networks
without cycles are calculated. As an example, the distribution of η values of the single
random network with Nio = 253 – containing a total number of 1632 pathways – is
depicted in Figure 2.22C. Both distributions mainly have η-values between 0 and 0.5.
Although the number of input and output kinases is kept constant, random networks
tend to have many more pathways (higher P total-values) and accordingly more pairs of
pathways have to evaluate for crosstalk. η-distributions are calculated for 100 random
networks. However, since they look similar in their shape (cf. Figure 2.22C), the η-
distribution of only one random network is shown as an example distribution. Two main
characteristics might be recognised in the crosstalk distribution of the kinase network
from TRANSPATH:
1) One finds a comparably high number of pathway pairs which do not show any
crosstalk at all (η = 0).
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Figure 2.22: Crosstalk between two pathways. A) Example: Disjoint pathways P1 and
P2 (black solid arrows) exhibit two crosstalk interactions (dashed arrows). The maxi-
mum number of crosstalk activations (dashed and grey arrows) which can in principle
be encountered between pathways of these lengths is 8 (⇒ ηP1,P2 = 2/8 = 0.25). B)
Distribution of crosstalk η within the kinase network of Figure 2.15: 1272 pathways
give rise to 670, 282 disjoint pairs of routes to evaluate. C) Distribution of crosstalk
within a single randomly generated network without cycles and Nio = 253. It contains
P total = 1632 pathways giving rise to 1, 010, 082 disjoint pairs of routes and the same
number of η-values.
2) There is a rather monotonous decrease of the number of those pairs which exhibit
higher crosstalk strengths. In contrast, random networks exhibit considerably
more intermediate crosstalk, i.e. around a certain mean value of η.
These calculations show that design principles with respect to pathway crosstalk in the
database network are considerably different from the structure of random networks.
Cross-interactions in “real” kinase networks are not arranged arbitrarily, but they seem
to be rather “designed”.
Hitherto, random networks have been used as a “null hypothesis” to assess the sig-
nificance of structural features of the TRANSPATH kinase network. In the next sec-
tion 2.2.3, random networks – also based on the same node degrees as the TRANSPATH
network – are interpreted differently, namely in association with a possible evolutionary
strategy of kinase networks to avoid the emergence of feedback cycles.
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2.2.3 A possible strategy to avoid cycles
Besides the basic constraint which preserves the degrees of all nodes in random networks,
it is moreover interesting to apply additional constraints with respect to certain small
substructures of the initial kinase network. For example in Milo et al. [2002], randomised
networks are used to calculate the significance of certain subgraphs of size m in a real
network by preserving the same number of appearances of all (m − 1)-node subgraphs
found in the real network. This strategy ensures that a high significance is not assigned
to a pattern only because it has a highly significant subpattern. It emphasises that a
possibly frequent occurrence (or absence) of larger substructures in the reference network
is not the result of a combination of smaller substructures.
In section 2.1.4, the dangerous effect of cycles – particularly for large signalling net-
works – is studied analytically. Therefore, during evolution a kinase network might aim
to avoid such direct positive feedback mechanisms. To test if the TRANSPATH kinase
network has the intrinsic potential to avoid such cycles – and if so, by which mechanisms
– random networks based on the TRANSPATH kinase network are generated by apply-
ing further constraints. As a mechanism to avoid cycles entirely, the impact of inhibiting
the emergence of small cycles in random networks is taken into account. Claiming that
small cycles must not occur in the considered random networks will certainly increase
the probability of finding networks without any cycles (PDAG). For example, claiming
additionally that the random network algorithm only generates networks without feed-
back cycles of length two (C2 = 0) increases PDAG to about 0.6%. Table 2.3 lists how
PDAG depends on the constraints on small cycles for random networks generated on the
basis of the kinase network from TRANSPATH.
constraints: only node degrees degrees & degrees & degrees &
are conserved C2 = 0 C2 = C3 = 0 C2 = C3 = C4 = 0
PDAG ≈ 0.04% 0.6% 7% 61%
Table 2.3: Probabilities of finding a structural design without any feedback cycle (PDAG)
among randomised signalling networks. A copy of kinase network from TRANSPATH is
taken to generate 100, 000 random networks, i.e. the node degrees of all 86 kinases are
in every case the same as in Figure 2.17. Besides this constraint, all random networks
are generated with four different additional constraints by excluding small cycles: 1)
No constraints on cycles, 2) C2 cycles are excluded, 3) C2, C3 cycles are excluded, 4)
C2, C3, C4 cycles are excluded.
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In contrast to the calculations where random networks are taken as a null hypothesis
for an estimation of how likely it is to find cycles or certain pathway lengths in random
networks, the interpretation is different in the present case: The random networks with
additional constraints to avoid small cycles may be interpreted as carrying the same
potential as the TRANSPATH network (on the basis of the degree distribution) to
avoid cycles entirely by a specific mechanism.
The results can be summarised as follows: The more consequent smaller cycles are
excluded from random networks with the same degree distribution as the network from
TRANSPATH, the more likely it becomes that these networks can avoid cycles entirely.
The calculations so far show that for signalling networks which aim to avoid cycles, a
good strategy is to avoid in particular small feedback cycles of length 2 − 4 during an
evolutionary process. This would dramatically increase the probability that the evolving
kinase network remains without any cycles. Many scaffold proteins are thought to ar-
range three consecutive kinases properly to allow for a signal to be transduced (Yoshioka
[2004]). Such an arrangement might ensure that the last scaffold-bound component is
prevented from activating the upstream components, thereby avoiding autoactivation.
Since the design of kinase networks have evolved as a result of an interplay with their
dynamic properties, section 2.2.4 investigates the dynamic behaviour of the TRANSPATH
network.
2.2.4 Dynamic behaviour of network components
In the present section, the dynamic properties of this network are analysed. Thereby
the question of how the signal spreads out through the network is of interest. For this
purpose, the same kinetic model as in section (2.1) which is based on ordinary differential
equations and uses mass action kinetics (see Eqs. 2.3) is used. As the network contains no
cycles, its signal-off state is dynamically stable, irrespective of the kinetic parameter β/α.
To assess the dynamic characteristics of the network, one has to choose an appropriate
receptor attachment to certain input kinases. For full activation of the network one must
attach receptors to all input kinases. The parameter for the receptor decay is chosen
as λ = 1. Parameters describing the ratio between the phosphatase and kinase activity
are all set to be equal (β/α = 1.0) and a situation for weakly activated pathways is
assumed (X∗i ¿ Ci). Under these conditions, the amplitudes Si, signalling durations ϑi
and signalling times τi of the activation profiles of all 86 kinases are calculated. All input
kinases have the same time profile and therefore the same dynamic key values. Because
of the specific design, some other kinases within the network have the same amount and
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kind of upstream signalling routes leading to them which brings about identical profiles
for these kinase. One ends up with 42 discriminable time profiles and consequently
(τ, S)-values and (ϑ, S)-values, respectively. The result for the (τ, S)-values is shown in
Figure 2.23. The abscissa describes the signalling time τ and the ordinate the signal
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Figure 2.23: Dynamic properties of the kinase network from TRANSPATH. Abscissa:
signal time τ . Ordinate: signalling amplitude S. Receptors R(t) are attached to all 25
input kinases. Example kinases with significantly high amplitudes are indicated in the
graph: p70S6K, MAPKAPK2, Mnk, MSK, PFK2.
amplitude S of the kinases. In this depiction, there is one single source node, standing
for the (τ, S)-values of all 25 input kinases where a receptor is attached. Some of the
other nodes also stand for multiple kinases which have the same profiles and thereby
(S, τ)-values.
Whereas the signalling times are confined within one order of magnitude 2 . τ . 8,
the amplitudes vary between 0.4 . S . 40. Kinases with significantly high amplitudes
are marked in the figure. As know from textbooks they are involved in metabolic
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processes and the translation machinery. For example, the ribosomal kinase p70S6K
is a positive regulator of the S6 ribosome subunit. Mnk phosphorylates and thereby
activates Eukaryotic translation initiation factor 4E (eIF4E) which binds to the mRNA
and brings the mRNA into a complex with other protein synthesis initiation factors and
ribosomes. The kinase MAPKAPK2 is known to be involved in mRNA stabilisation.
Asthagiri et al. [2000] has shown that during cell cycle progression the integrated
response I of certain downstream kinases (ERK kinase) provide an appropriate met-
ric for quantifying the dependence of DNA synthesis on the degree of the activation
of these kinases. Cell proliferation and DNA synthesis must coincide with cell growth,
and therefore with the efficiency of the translation machinery. Thus, the integrated
responses I of certain kinases might be of particular interest for a proper protein trans-
lation process. For the network under consideration, those kinases with high values for
integrated response also possess high amplitude values (data not shown). The distribu-
tion of amplitudes and integrals of kinases give reason to ask if there is a distinction
of kinases with respect to their activation strengths. Compared to “upstream” kinases
which may act solely as information transmitters, the total activation strengths of the
“downstream” kinases involved in the translation process (p70S6K, MAPKAPK2, Mnk,
MSK) are likely to be of special importance.
Distributions of the three dynamic characteristics are depicted in Figure 2.24. The
upper panel shows the distribution of amplitudes which is quite non-uniform. As one
can already see in Figure 2.23, most kinases have small amplitudes and only very few
exhibit high signal amplification with S > 10. Both signalling times and durations are
more dispersed. The high peak for small values of all three characteristics is due to the
activation profiles of the input kinases which are exactly the same. Values for τ and
ϑ exhibit a high correlation with a correlation coefficient of R2τ,ϑ ≈ 0.98. Amplitudes
of kinases and signalling times or durations show much lower correlation (R2S,τ ≈ 0.6,
R2S,ϑ ≈ 0.6). These calculations have been performed with a specific set of parameters
(β/α = λ = 1.0). However, other values would merely shift the time scales, thus
maintaining qualitatively the distributions and correlation patterns.
To assess the dynamic characteristics of the transpath network more thoroughly, 100
randomised networks are generated for a direct comparison. These random networks are
not allowed to contain cycles which ensures that they possess stable off-states. Thus,
for the dynamic simulations the same parameters can be used as for simulations of the
transpath network. Moreover, the same 25 input kinases can be deployed for receptor
attachments, because the algorithm for generating random networks does not change
node degrees and thereby keeps the number of input kinases of the initial TRANSPATH
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Figure 2.24: Dynamic properties of the kinase network from TRANSPATH. Distribution
of kinase amplitudes Si (A), signalling times τi (B), and signalling durations ϑi (C). The
correlation coefficient between amplitudes Si and signalling times τi is R
2
S,τ ≈ 0.6. A
similar value is obtained for the correlation between amplitudes and signalling durations
of the kinases (R2S,ϑ ≈ 0.6). In contrast to that, the correlation between the values of τi
and ϑi is higher: R
2
τ,ϑ ≈ 0.98.
network.
Similar to the TRANSPATH network, the distributions of signalling times and du-
rations for the random networks are also rather evenly distributed (data not shown).
However, unlike the kinase amplitudes in the TRANSPATH network, the amplitudes of
kinases in random networks are more uniformly distributed. Moreover, in each of these
random networks, kinase amplitudes and signalling times or durations tend to be more
correlated. To illustrate these differences with respect to the distributions of key values
appropriately, the correlation coefficients R2S,τ (A), R
2
S,ϑ (B) and R
2
τ,ϑ (C) for all 100
random networks are calculated and shown in Figure 2.25. The correlation coefficients
R2S,τ and R
2
S,ϑ of random networks are rather normally distributed (Figure 2.25A and
B). In both cases the smallest values are slightly smaller than 0.6. Interestingly, the val-
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Figure 2.25: Dynamic properties of 100 randomised kinase networks. Correlation co-
efficients of kinase amplitudes and signalling times R2S,τ (A), kinase amplitudes and
signalling durations R2S,ϑ (B) and signalling times and signalling durations R
2
τ,ϑ (C).
ues of the two corresponding correlation coefficients of the TRANSPATH network (see
legend of Figure 2.24) are at the lower limits of correlation coefficients which are appar-
ently possible between kinase amplitudes and signalling times (or signalling durations)
in networks of the same size.
Such a “decoupling” would make sense in the light of a kinase network evolution
which selectively prefers those designs enabling long signalling durations (or signalling
times) with moderate amplitudes (or vice versa) simultaneously.
Figure 2.25C depicts the distribution of correlation coefficients between signalling
times and duration. For random networks as well as the TRANSPATH network these
two characteristics are highly correlated.
2.3 Discussion
Although signalling pathways are becoming increasingly a subject of mathematic mod-
elling, the explanation of the design of these systems is still an unsolved problem. This
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might be partly due to the fact that – in contrast to metabolic networks – signalling
networks consist of a higher variety of distinct components (adaptor proteins, scaffolds,
several kinds of G-proteins, kinases and phosphatases) and regulatory mechanisms. The
present model is an extension of previous investigations by Heinrich et al. [2002].
In contrast to simulation models which refer to specific pathways, large sets of net-
works with different structures and size are studied. This allows for identifying groups of
network designs with specific dynamic properties such as signal amplification or dynamic
stability.
The family of networks with four kinases is investigated analytically with respect to
their structural robustness. Therefore, one considers the fraction of stable and ampli-
fying networks which can emerge after a mutation of an initial (stable and amplifying)
network. Specific values for β/α can be figured out which yield the most robust scena-
rios indicated by a maximum fraction of networks remaining stable (weak robustness)
or stable and moreover amplifying (strong robustness) after a mutation. For future
projects, it is planned to extend these calculations to larger networks, and as a long-
term strategy it might also be interesting to compare β/α-values derived from this type
of studies to values from the literature.
Based on the analysis with small networks, predictions are made concerning an op-
timal design of larger signalling networks in terms of network connectivity and number
of cycles. The kinase network retrieved from the database TRANSPATH has indeed a
very low connectivity, and no cycles are found. Calculations with random networks (null
hypothesis) show that the probability of finding acyclic networks at random is very low
(PDAG ≈ 0.04). Further empirical studies on the structure of the kinase network from
TRANSPATH reveal other serious deviations from a random structure, demonstrating
that this system can be regarded as the outcome of mutation and selection processes.
In the TRANSPATH network, the sets of routes between input and output kinases
are composed mostly of pathways of the same (shortest) length. In contrast to that, the
set of routes between input and output kinases in random networks consist mostly of
pathways of multiple lengths.
A measure η evaluates the crosstalk strength between all pathway pairs which do
not contain a common kinase (disjoint routes). Two pathways having a small η value
possess only few cross interactions compared to the maximum cross interactions which
would in principle be possible. In the TRANSPATH network, a relatively high number
of pathways do not show any, and many exhibit only little crosstalk. There is a rather
monotonous decrease of the number of pathway pairs displaying higher η values. The
picture is different for random networks, where the frequencies of η values are rather
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normally distributed. A possible extension of this type of crosstalk studies might be
to consider more closely the differences in the amount of crosstalk within consecutive
layers of cascades (see Figure 2.21). Signalling pathways defined differently from the
approach used here may also be considered, e.g. pathways which are distinguished from
each other by additional biological information.
Scale-freeness and the small world property refer to a specific distribution of connec-
tivities of components in metabolism. These properties are often discussed in conne-xion
with the property of robustness and vulnerability of metabolic networks. Similarly, one
may ask for reasons of the specific distribution of kinase connectivities in signalling net-
works. Interestingly, random networks with the same node degrees as the TRANSPATH
network, generated with additional constraints concerning small cycles, show a tendency
to avoid cycles entirely. Assuming that only properly arranged kinases lead to a pathway
activation, scaffold proteins may also be regarded as a mechanism to avoid small cy-
cles, i.e. that downstream kinases activate upstream kinases. It will be worth analysing,
whether in other networks, e.g. gene regulatory networks, cycles may emerge more easily
by structural mutations, since they might play an important role therein.
Dynamic properties of the design of the kinase network are studied by carrying out
simulations with ODEs. In contrast to random networks, only few kinases have signifi-
cantly high amplitudes (kinases involved in protein translation). Another distinguishing
feature is that amplitudes are less correlated to signal durations than in the case of ran-
dom networks – a characteristic indicating that the design is appropriate for a decoupling
of (high) signalling amplitudes and (long) signalling durations.
Low connectivity, low number of cycles, a characteristic composition of pathways and
a characteristic distribution of crosstalk intensities may be considered as design prop-
erties of the TRANSPATH network which are the outcome of an evolutionary selection
process. A remaining task to corroborate these results is to update the kinase net-
work by taking into account more recent information accumulated in the TRANSPATH
database as well as information of other databases. This may further increase the degree
of reliance concerning the wiring of the network.
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Chapter 3
Control mechanisms of signal
transduction networks
Signal transduction is of crucial importance to cells to reach cellular decisions with re-
spect to division, differentiation and apoptosis. The complexity of signal transduction
networks is overwhelming because of the large numbers of interacting constituents, and
because of their complicated circuitry, involving feed forward, negative feedback and
crosstalk, as well as the fact that the constituents are highly diverse (kinases, phos-
phatases, adaptors, G-proteins etc.). Due to this complexity, apparently simple but
highly important questions remain hitherto unsolved. For instance, is a small number of
reactions responsible for the behaviour of the entire system (and ultimately, for cellular
behaviour) and if so, which reactions are they? Is the control of signal transduction and
hence of proliferation, differentiation and apoptosis always evenly distributed within the
network?
Such questions may be answered by detailed and extensive quantitative experiments
with inhibitors and activators of signal transduction proteins. However, the arsenal and
the specificity of these are limited. Mathematical modelling can assist in such cases.
Previously, modelling efforts have significantly enhanced the understanding of control
mechanisms of signal transduction pathways (Heinrich et al. [2002]), Lee et al. [2003]).
It is known that mutations may result in a constitutive activation of the mitogen-
activated protein kinase (MAPK) pathway, for example in many human tumour cells
(Hoshino et al. [1999]). The analysis of which proteins and reactions are in control of
a signalling pathway is of vital importance not only for understanding of the system,
but also for drug design, since it helps choosing potential drug targets according to the
magnitude of their control on cell proliferation. Decisive for the type of cellular response
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that is evoked by MAPK signalling are the magnitude and duration (transient versus
sustained) of ERK activation (Cook et al. [1999]; Marshall [1995]; Tombes et al. [1998]).
Therefore, it is of importance to understand which processes and proteins determine the
dynamic time profile of ERK activity and hence the choice between proliferation and
differentiation.
Metabolic Control Analysis (MCA) was developed with steady states situations in
mind (Heinrich and Rapoport [1974]; Kacser and Burns [1973]) but for signal trans-
duction steady state levels may be less relevant and the important features are the
amplitude of a transient peak, the duration of signalling and the integrated response. In
this chapter, MCA is applied to investigate these dynamic properties considering various
models of signalling systems.
In a first step, the control properties of kinases and phosphatases towards the time
profile of active ERK are investigated using kinase and phosphatase inhibitors. Exper-
imental data from Hornberg, J. and colleagues1 are used for a direct comparison of a
simple model of signalling cascades with the results from these inhibitor experiments.
The model is employed to simulate different activating and inhibitory interventions of
the involved reaction rates. This analysis is based on and confirms results from theoret-
ical studies presented in Heinrich et al. [2002].
In a second step, the method is applied to a specific model of EGF signalling pub-
lished by Schoeberl et al. [2002]. The importance of each reaction in this complex
network is determined with respect to its biologically relevant output, the transient
phosphorylation profile of ERK. It is shown that only a small proportion of reactions
within the network exhibit control. Control coefficients of key values like signal ampli-
tude, signal duration and the integrated response take the central role in this analysis.
Effects of mutations and changes in gene expression are also examined by calculating
response coefficients of reasonable enzyme concentrations.
Last, the question is addressed if there is an optimal design of signalling cascades
with respect to the sensitivity of the signal amplitude. Sensitivity is defined within the
framework of MCA by considering the standard deviation of all control coefficients for
the signal amplitude. Taking this measure as an objective function to be maximised, cas-
cades of different length n and phosphorylation mechanisms (mono/dual) are evaluated.
This more general approach is inspired by investigations of the “zero-order ultrasensi-
tivity” of signalling cascades (Goldbeter and Koshland [1981]; Goldbeter and Koshland
[1982]; Huang and Ferrell [1996]).
1Department of Molecular Cell Physiology, Institute of Molecular Cell Biology, Vrije Universiteit
Amsterdam
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3.1 Control coefficients and summation theorems for
transient activation profiles
Metabolic control analysis (MCA) is a phenomenological sensitivity analysis which can
be used to describe quantitatively how enzymes in a metabolic pathway control fluxes
and metabolite concentrations. In MCA one studies the relative control exerted by each
step (enzyme) on the system’s variables. By applying a perturbation to the step being
studied the effect on the variable of interest is measured after the system has settled
to a new steady state. MCA has been extensively applied to metabolism where mainly
steady states are of interest. In signal transduction steady state concentrations of se-
lected components have also been successfully considered (Lee et al. [2003]; Kholodenko
et al. [1997]). However, the important operating regime of signalling pathways is dif-
ferent; here, signal amplitude, signal duration and the integrated response are relevant
characteristics (see Figure 3.1). The integrated response I of a time profile of a compo-
of selected components 
Effects of small changes of parameters
MCA applied to signal transduction pathways
on signal characteristics of selected components
upon
on levels
transient stimulation
steady state
C
Xj
i =
∂ lnXj
∂ ln vi
= kiXj ·
∂Xj
∂ki
; C
{A,d,I}
i =
∂ ln{A,d,I}
∂ ln vi
= ki{A,d,I} · ∂{A,d,I}∂ki
Figure 3.1: Control theory in signal transduction. Under steady state condition the
control of a reaction vi on the concentration of a selected component Xj is of interest.
Upon transient stimulation well defined features like signal amplitude A, signal duration
d and integrated response I of the selected component Xj are important. For reaction
rates depending linearly on rate constants ki, the second equalities hold: vi ∝ ki ⇒
∂ ln vi = ∂ ln ki.
nent Xj(t) is defined in Eq. (2.15), where – as an specific example – the concentration of
a phosphorylated kinase is considered. Signal amplification and signal duration can be
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defined in several ways. In chapter 2 definitions of these characteristics are used which
are adequate for analysing large sets of networks designs analytically. For the numerical
calculations of control coefficients in this chapter it is more convenient to choose defi-
nitions different from Eq. (2.13) and Eq. (2.15). The amplitude of an activation profile
is taken as the maximum value that the profile attains and the duration is defined as
the total time for which Xj(t) exceeds a certain fixed value. For example in the cascade
model of section 3.2 this value is chosen as 5% of the total concentration of the ERK
kinase and in section 3.3 the duration is quantified at a level of 10% of the amplitude
of the ERK activation profile. To indicate the difference to the previous definitions,
the letters A and d are chosen for amplitude and duration, respectively. Figure 3.7
illustrates the employed definitions for these quantities.
As part of the theory, MCA embodies summation theorems for control coefficients.
Summation theorems relate the sum of the all control coefficients of a certain systemic
property to a constant value. In Appendix B.1 summation laws for the control of time
dependent phenomena are given. For the control coefficients of the time dependent
profiles Xj(t) at a certain time point t = t0 one derives:∑
i
C
Xj
i −
∂ lnXj(t)
∂ ln t
∣∣∣
t=t0
= 0 , (3.1)
where the second term is the (scaled) derivative of Xj(t) at time t = t0. This term is
zero for the maximum of the time profile Xj(t), i.e. for Xj(t0) = A. For the control
coefficients of A, d and I of Xj(t) one arrives at the following summation theorems:
A :
∑
i
CAi = 0 ; d :
∑
i
Cdi = −1 ; I :
∑
i
CIi = −1. (3.2)
It is, however, worth mentioning that the summation laws are not restricted to these
specific definitions for amplitude, duration and integrated response. In particular they
are also valid for the quantities defined in Eqs. (2.13–2.15) (see Appendix B.1).
The summation laws dictate that the control coefficients for the rates vi of all pro-
cesses i add up to constant values, e.g. the sum of all control coefficients on the amplitude
equals 0. This implies that all reactions of the network with positive control coefficients,
taken together, are exactly as important for the amplitude as all reactions with nega-
tive control, i.e. each of these two groups have the same quantitative impact on the
amplitude. All control coefficients on the duration of signalling and the integrated re-
sponse must add up to −1. This implies that the inactivating reactions which cause
shorter duration and therefore have negative control coefficients exert more control on
these properties than activating reactions which cause longer duration and therefore
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have positive control coefficients. For simple linear cascades with kinases as activating
and phosphatases as inactivating processes, the basis of these control principles was
analytically tracked down in Heinrich et al. [2002].
In section 2.1.5 the structural robustness of signalling networks is analysed. Within
the framework of MCA one can define a measure for robustness and sensitivity of a
signalling property based on changes of kinetic parameters (Lee et al. [2003]). The larger
the control coefficients, the higher the corresponding sensitivity of a signalling property
becomes. As an appropriate metric the standard deviation of control coefficients from
their mean value is considered as a measure for the sensitivity. In the following analysis,
the focus lies on the sensitivity of the signal amplitude. According to the summation
theorem the mean value of control coefficients is zero in this case. Therefore the overall
sensitivity for a signal amplitude is given as follows:
σA =
√
1
n
∑
i
(CAi )
2
, (3.3)
where the summation is performed over all reaction steps. High values of σA indicate
that the given amplitude is on average very sensitive with respect to changes of rate
constants. Based on the sensitivity, one can easily define a measure for robustness ρA:
ρA =
1
1 + σA
. (3.4)
As σA may vary between zero and infinity, the range of ρA is confined to the interval
1 ≥ ρA ≥ 0. High values of ρA resulting from low σA values indicate that the amplitude
is robust against parameter perturbations. Other definitions of robustness via control
coefficients might be applicable as well, e.g. the function ρA = exp(−σA) also takes
values confined to the interval 1 ≥ ρA ≥ 0.
In the next three sections control mechanisms of signalling pathways are studied by
(1) reproducing the results of inhibitor experiments aimed at kinases and phosphatases
with simulated inhibitions of these components in a simple kinase cascade model, (2)
applying the concept of “transient” MCA to a comprehensive computational model of
EGF signalling, (3) evaluating a possible optimal length of cascades with respect to a
high efficiency of controlling the amplitude of the signal output (overall sensitivity).
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3.2 Control principles of phosphatases and kinases:
modelling inhibitor experiments
General control principles that govern signalling cascades can be validated by exam-
ining effects of kinase and phosphatase inhibition on a MAP kinase pathway. In this
section inhibitor experiments and a simple model which mimic the results are described.
Quantitative measures for the control of signal amplitude, duration, integrated response
and the final signal strength (final steady state level) confirm the principles which are
reflected in the summation theorems for control coefficients (see Eq. 3.2): Total control
on signal amplitude and on final signal strength amounts to zero, and total control on
signal duration and on integrated response is −1. Therefore, there is a tendency that
the impact of processes with positive control (e.g. kinases) on duration and integrated
response remains lower compared to processes with negative control (e.g. phosphatases).
These principles which are studied analytically in Heinrich et al. [2002] are illustrated
by a direct comparison of experimental results with a simple in silico model described
in the next section.
For the experiments rat kidney (NRK) fibroblasts are used, because the cell cycle
of these cells can be synchronised relatively easily, causing all cells to behave similarly
in response to external stimuli. They are used frequently as a model system to study
cellular alterations that accompany oncogenic transformation (van Zoelen [1991]). Ac-
tivation of the ERK pathway is required for the proliferation of fibroblasts (Page`s et al.
[1993]). The pathway under consideration consists of three kinases in succession (Raf,
MEK and ERK) and can be activated by various extracellular stimuli, including the
epidermal growth factor (EGF). The experiments were carried out by Hornberg, J. and
colleagues at the Department of Molecular Cell Physiology, Institute of Molecular Cell
Biology, Vrije Universiteit Amsterdam.
3.2.1 Model description
The mathematical model consists of a receptor and three consecutive kinase/phosphatase
monocycles (Figure 3.2A).
The receptor is activated instantaneously at time t = 0 by added EGF and then
inactivated over time (Ri). The inactive form of the receptor is re-circulated slowly
to become active once again because EGF remains present. The active form of the
receptor phosphorylates and thereby activates the first kinase to become X∗1 . Through
phosphorylation this kinase then activates the second kinase, which in turn activates a
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Figure 3.2: Schematic model representation and time profiles of the active model com-
ponents. A) Active receptor with concentration R activates a cascade of three ki-
nase/phosphatase monocycles. The ligand remains present and, therefore, the inactive
receptor is taken to slowly recycle, in order to become active again (v2). B) Time profiles
of the four active components. The receptor is inactivated relatively quickly to attain a
very low steady state concentration. The active kinases reach maximal peak concentra-
tions and then decrease to low steady state concentrations. Definitions of amplitude A,
duration d and integrated response are given in the text.
third kinase.
All reaction steps follow Michaelis-Menten kinetic rate equations, with Vmax = 1.0
and Km = 0.1 for the activating reactions (v3, v5, v7) and the receptor inactivation
reaction (v1); Vmax = 0.3 and Km = 1.0 for the deactivating phosphatase reactions (v4,
v6, v8); and Vmax = 0.01 and Km = 0.1 for the receptor re-circulation reaction. The
initial concentrations for Ri and the active kinases X
∗
1 , X
∗
2 and X
∗
3 are set to 0 and
for the active receptor R to 0.5. The initial concentrations for the inactive kinases X1,
X2 and X3 are chosen to be 1. All concentrations are in mM. The kinase reactions
depend proportionally on the concentration of their corresponding activators, i.e. the
preceding phosphorylated kinases. The model and the specific parameters are chosen not
to accurately describe the MAPK pathway but to analyse control principles of signalling
cascades by comparing the model behaviour due to perturbations of reactions with the
according performance of inhibitor experiments. The model equations are as follows (for
58
details see Appendix B.4):
R˙ = v2 − v1 = 0.01 ·Ri
0.1 +Ri
− R
0.1 +R
(3.5)
X˙∗1 = v3 − v4 =
R ·X1
0.1 +X1
− 0.3 ·X
∗
1
1 +X∗1
(3.6)
X˙∗2 = v5 − v6 =
X∗1 ·X2
0.1 +X2
− 0.3 ·X
∗
2
0.1 +X∗2
(3.7)
X˙∗3 = v7 − v8 =
X∗2 ·X3
0.1 +X3
− 0.3 ·X
∗
3
1 +X∗3
(3.8)
In Figure 3.2B the activation profiles for the active components are shown. Whilst the
concentration of the active receptor R declines over time, the three consecutive kinases
are activated, i.e. phosphorylated, reach a peak value and subsequently decline to levels
that exceeds the level before receptor activation. These time-patterns for activation
of the components of the MAPK cascade are commensurate with what is reported
experimentally for many cell types and with the experimental results which will be
presented here. Therefore, this model is used to examine how these time patterns are
controlled by the kinases and the phosphatases.
For a later quantification of control via control coefficients, signalling characteristics
are defined similarly to section 3.3: (i) signalling amplitude A, which is taken as the
maximal X∗3 concentration; (ii) duration of signalling d that is defined as the time point
at which the X∗3 concentration drops below an arbitrarily chosen value of 5% of the
total concentration of the third kinase (= 0.05); (iii) the “integrated response”, i.e. the
integral of the X∗3 time profile until this duration time point d; (iv) the final signalling
level, i.e. the steady state of X∗3 .
In order to examine how the second kinase in the cascade determines the time depen-
dence of the activity of the third kinase, only Vmax of the second kinase reaction (v5)is
varied stepwise and for each value of Vmax the system is recalculated. This modulation
corresponds to the experiment to be described below in which MEK, the second kinase of
the MAPK pathway, will be inhibited by the non-competitive inhibitor PD98059 (Alessi
et al. [1995]). The effect of such an inhibitor is studied by decreasing the Vmax-value from
1.0 (kinase inhibition 0%) to 0.4 (kinase inhibition 60%) by 20% intervals. The result is
shown in Figure 3.3A. The duration of the peak also decreases, but much less so; e.g. an
inhibition that decreases the amplitude by 25%, advances the time at which the signal
returns to below 0.05 by about 10%. The final level of X∗3 decreases substantially when
calculated in relative terms: The final level is already low before the kinase is inhibited.
The effect of signal transduction on transcription of downstream genes might be less a
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Figure 3.3: Effect of kinase and phosphatase inhibition in the X∗3 time profile. A: The
second kinase reaction in the model (v5) is increasingly inhibited, having a large de-
creasing effect on the amplitude and a less pronounced effect on duration. B: Increasing
inhibition of the third phosphatase (v8) which causes an increase in both amplitude and
duration of signalling. Apparently, both, kinase and phosphatase inhibition, also affect
the integrated response and steady state X∗3 concentration.
function of the amplitude of X∗3 than of the integrated concentration of this factor. For
the area under the curve (integrated response) one finds that kinase inhibition has a
considerable effect on this, too.
Essentially, it can be seen that in this example model, the activity of the second
kinase exerts substantial control on signalling amplitude, both, in the initial phase of
signalling and much later, and exerts less control on the duration of signalling.
To examine the influence of phosphatases on signalling kinetics an inhibitor with
concentration Y is introduced. The inhibitor is supposed to competitively inhibit the
dephosphorylation of X∗3 . In this way an experiment is anticipated (see below) in which
protein tyrosine phosphatases are inhibited. For such an inhibitor the rate equation v8
in Eq. (3.8) changes as follows: v8 → v8 = 0.3 ·X
∗
3
1 +X∗3 + Y
. To demonstrate the effect of
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inhibition of the third phosphatase in the model, the concentration Y is increased from
0 to 2, 4 and 6, respectively.
With increasing inhibitor concentration, the X∗3 amplitude becomes substantially
higher (Figure 3.3B). In addition, the inhibitor increases the duration of the peak dra-
matically, prolonging X∗3 signalling. For instance an inhibitor concentration that in-
creases the peak height by one third, doubles the time required for the X∗3 concentration
to drop below (an arbitrarily chosen value) 0.1. As can be seen in Figure 3.3B phos-
phatase inhibition also increases the final level of X∗3 and the integrated response quite
substantially.
For this example model, the calculations show that phosphatases and kinases are
equally important for two characteristics of signal transduction, the peak amplitude and
the final activation level, whereas the duration of signalling, and the integrated response
might be more the control domain of the phosphatases exclusively.
For a further quantification of control exerted by the individual kinases and phos-
phatases the concept of control coefficients can be used. Normalised control coefficients,
calculated with 1% perturbations, are shown in the Table B.5 in the Appendix B.4.
3.2.2 Experimental validation of control principles
For the stimulation experiments the NRK fibroblast cells are grown in culture dishes
to sub-confluency and then serum-starved for three days in order to be arrested in the
G0-phase of the cell cycle. Subsequently cells are stimulated with 10 ng/ml EGF for
the indicated periods of time. Where indicated MEK is inhibited by preincubation for 1
hour with various concentrations of the non-competitive inhibitor PD98059 (Alessi et al.
[1995]). For the phosphatase inhibition (PTPs) cells are pre-incubated for 1 hour with
0.20 mM sodium orthovanadate (Huyer et al. [1997]). Western blot analalysis is used to
quantify the time profiles of the kinase activations.
Stimulation with EGF is carried out in the presence of various concentrations of
the non-competitive MEK inhibitor PD98059. A biphasic ERK-PP time profile can
be observed, consisting of a rapid high peak followed by a low quasi-steady state (Fig-
ure 3.4A). Increasing MEK inhibitor concentrations results in decreased peak heights.
Adding an inhibitor do not much affect the duration (width) of the peak. These results
confirm the model predictions that kinase inhibition affects signalling amplitude much
more than signalling duration.
In the model simulation, phosphatases control the signalling amplitude, signalling
duration, final signal level and integrated response. To test these control principles ex-
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Figure 3.4: Experimental validation of the theoretical results. A: Inhibition of MEK,
the second kinase in the MAPK pathway to ERK, using the non-competitive inhibitor
PD098059, leads to a decrease in the peak ERK-PP concentration. B: Protein tyrosine
phosphatase inhibition, using orthovanadate, significantly increases the duration of the
ERK-PP activation profile.
perimentally, the protein tyrosine phosphatase (PTP) inhibitor sodium orthovanadate is
applied to the cells which are subsequently stimulated with EGF. PTP inhibition results
in a broader peak followed by a relatively high final quasi-steady ERK-PP concentration
(Figure 3.4B), both in consonance with the model predictions.
The amplitude in the presence of the phosphatase inhibitor is no higher than that
in control cells. This result corresponds closely to high kinase activations leading to
saturation effects of the ERK-PP activation profile. A higher agreement with the out-
come of the inhibitor experiments (saturation effects) can be achieved by using higher
activities for all kinases in the model. Thefore, the model simulation is repeated with
increased reaction rates for the kinases: The Vmax-values of the kinase reactions are set
to 1.2. These higher kinase activations cause virtually all X3 to be activated. The result
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is depicted in Figure 3.5. Inhibition of the second kinase reaction (v5) again decreased
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Figure 3.5: Simulations for different magnitudes of the kinetic parameters (Vmax = 1.2)
for all kinases. The activation reactions are more active, leading to a higher peak X∗3
concentration.
the amplitude of signalling (A). Inhibition of the third phosphatase reaction (v8) had
some effect on the amplitude (B), but this is significantly smaller than in the case of
Figure 3.3, since now virtually all X3 is phosphorylated in the peak. Indeed, it has
previously been shown that in NRK cells, this EGF concentration causes virtually all
ERK to become doubly phosphorylated (Lahaye et al. [1998]).
The results of the present section show that general control principles that govern
signalling cascades can be tracked down with inhibitor experiments and can moreover be
described with a simple model. These findings correspond closely with those reported
previously (Heinrich et al. [2002]). The control principles – different extent of control
of kinases and phosphatases towards the ampltiude and duration of the signal output –
are reflected in the summation theorems for the control coefficients.
The used model of a MAPK pathway is highly simplified. Many important compo-
nents (e.g. adaptor and scaffold proteins) and processes (e.g. receptor internalisation)
which are known to play a role in signalling are neglected. In the next section a more
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elaborated model of the EGF-induced MAPK signalling pathway is studied with respect
to the distribution of control among the processes involved in the cascade.
3.3 Control coefficients for a large EGF signalling
model
3.3.1 Model description
The model published by Schoeberl et al. [2002] describes the dynamics of the mitogen-
activated protein kinase (MAPK) cascade activated by the epidermal growth factor
(EGF) receptor. The network is depicted in Figure 3.6. Signalling through the network
is initiated by the binding of epidermal growth factor (EGF) to its receptor (EGFR).
The signal is subsequently propagated by a series of events such as the recruitment
of adaptor proteins, G-protein activation, and (de-)phosphorylation reactions, which
ultimately lead to the activation of the extracellular signal-regulated kinase (ERK).
This network stands at the root of many cellular processes, such as cell division (Cobb
[1999]), and is constitutively activated in many human tumours (Hoshino et al. [1999]).
Active ERK has several cytoplasmic and nuclear targets, such as transcription factors
that influence expression of genes involved in cell cycle progression, and it is required
for the proliferation of fibroblasts (Page`s et al. [1993]).
This detailed analysis of a specific signalling model asks whether control is as disperse
as it can be in principle over the participating processes and components. The results
are much less random than might expected and may contribute to explain oncogene
distributions.
Since the model is continuously being improved and enlarged by the original authors,
a detailed description of the version used here is provided in Appendix B.2. It is an
updated version of previous models (Kholodenko et al. [1999]; Schoeberl et al. [2002])
and should be close to containing the best available experimental data on the pathway.
The latest available version can be obtained from a website2.
The computer replica of EGF-induced signalling through the MAPK cascade that
is used here contains 148 molecular processes and 103 molecular species represented
by system variables. It describes signal transduction all the way from EGF binding at
the cellular membrane to the phosphorylation of ERK. The molecular processes include
association, dissociation, as well as covalent (de–)modification and degradation events
2http://www.mpi-magdeburg.mpg.de/people/schoeberl/schoeberl.html
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and have all been described with mass-action kinetics.
Signalling is initiated by binding of EGF to EGFR, followed by the dimerisation and
subsequent auto-phosphorylation of EGFR. Signal propagation involves either of two
routes, both leading to the activation of the small G-protein Ras. One route starts with
the binding of the “Src homology and collagen domain protein” (Shc) to the phospho-
rylated, ligand-bound, dimerised receptor followed by the binding of the growth factor
receptor-binding protein 2 (Grb2). The other commences directly with the binding of
Grb2. In both routes the association of Grb2 with the complex that includes EGFR
recruits Sos to the cytoplasmic surface of the membrane. The recruitment of Sos brings
the latter in close proximity to its membrane-anchored target Ras. Contact between
Sos and Ras leads to the activation of the latter through the formation of Ras-GTP.
Ras-GTP dissociates from the receptor complex, which then dissociates further. The
inactivation of Ras-GTP involves the activity of a GTPase activating protein (GAP).
Although Raf phosphorylation is subject to an ongoing discussion in the literature,
the present model assumes that a free Ras-GTP molecule directly phosphorylates Raf.
Phosphorylated Raf has kinase activity and does phosphorylate the kinase MEK which,
in its doubly phosphorylated form, phosphorylates ERK. Raf, MEK and ERK are de-
phosphorylated by various phosphatases; in the model this is described in terms of the
different phosphatase activities, one for each kinase. The model includes the negative
feedback loop from doubly phosphorylated ERK (ERK-PP) to Sos, which causes the
dissociation of Grb2-Sos from the receptor complex. Also included is an elaborate de-
scription of the processes involved in the internalisation and degradation of the various
receptor complexes.
In the absence of stimulation by EGF the system is in a stable steady state, in
which ERK is not phosphorylated (for other characteristics of this reference state, see
Table B.2 in Appendix B.2). The model distinguishes between two pools of ERK-PP:
one is located freely in the cytoplasm; the other is associated with the internalised
receptor. A closer look reveals that this internalised ERK-PP makes up at most 1.2% of
the total ERK-PP concentration. Figure 3.7 displays the computed transient profile of
the total ERK-PP concentration, i.e. the sum of the two pools. Upon addition of EGF
at t = 0 in a step function manner, the total concentration of ERK-PP rapidly increases
to attain about 50% of the total concentration of ERK within about 5 minutes. Then,
the ERK-PP concentration slowly decays to zero, passing 10% of its maximal activation
level at about 65 minutes.
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Figure 3.7: Transient activation profile of ERK-PP as function of time after the addition
of EGF at time zero calculated with the kinetic model. The definitions of the three
quantities that characterise the transient profile are depicted.
3.3.2 Results
The model is implemented in Mathematica 5.0. In order to calculate the control co-
efficients for the processes in the network, the reaction rates are perturbed by a small
fractional change (numerically: ∂k/k = 10−6). The forward and backward rate constants
for the process are changed simultaneously to ascertain that the activity as a whole is
perturbed with the same fractional change. In this way, the equilibrium constant re-
mains fixed which is necessary to fulfil thermodynamic constraints. Control coefficients
defined in MCA are calculated by infinitesimal perturbations. Since perturbations in
living cells are generally larger than differentially small (e.g. as a result of a mutation),
larger perturbations of the molecular activities are also applied (∆k/k = ±0.5).
The individual sums of the control coefficients (for small perturbations) on amplitude,
duration and integrated response are in good accordance with the summation theorems
of Eqs. (3.2):
Amplitude of ERK-PP:
∑
i
CAi = 1.4 · 10−6.
Duration of ERK-PP:
∑
i
Cdi = −1.00008.
Integrated Response of ERK-PP:
∑
i
CIi = −0.9998.
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A paradigm of classical biochemistry was that pathways should have a single controlling
step. To examine how the control is distributed in EGF–ERK signal transduction, Fig-
ure 3.8 displays the control coefficients on amplitude, duration and integrated response.
The abscissa describes the reactions (v1, . . . , v148) and the ordinate indicates the values
of the control coefficients. It can been seen that calculated control is far from uniformly
−0.05
0
0.05
CA i
−0.5
0
0.5
Cd i
0 50 100 150
−0.5
0
0.5
reactions,
CI i
A 
B
C 
kinases 
phosphatases 
vi
Figure 3.8: Distribution of the three types of control coefficients for ERK-PP calculated
for the differentially small perturbations: for the amplitude (A), for the duration (B)
and for the integrated response (C). Some control coefficients for reactions involving
kinases and phosphatases are indicated in panel A.
distributed over all processes. Most reactions have a control coefficient that is very close
to zero and only a small group of reactions show much control. Moreover, the control
coefficients for amplitude are about one order of magnitude smaller than the coefficients
for duration and integrated response.
For practical purposes a control coefficient is defined to be “substantial” if it is not
smaller in absolute value than 10% of the largest control coefficient. That particular
threshold value ensures that a moderate number of control coefficients fall into this
category and may therefore be considered in more detail. Table 3.1 displays the sub-
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stantial positive (marked in red) and the substantial negative (marked in blue) control
coefficients for control on the amplitude, the duration, and the integrated response. For
instance, with respect to the control on amplitude (small perturbations), only eight out
of the 148 processes are found to display substantial control coefficients. These include
five reactions with positive control (v27, v44, v46, v54, v55) since their control coefficients
are not smaller than 10% of CA55 = 0.066. Similarly, only the three reactions (v42, v43,
v57) exert substantial negative control since the absolute values of their control coeffi-
cients are larger than 10% of the absolute value of CA57 = −0.08. In Appendix B.3 the
control coefficients of Table 3.1 are depicted superimposed on the biochemical scheme
of the signalling network. The trend that becomes apparent is that many of the largest
control coefficients are associated with reactions that involve Raf, MEK and ERK. This
is irrespective of the system property for which the control distribution is calculated.
A phenomenon which is already discussed for linear signalling cascades in Heinrich
et al. [2002] can also be confirmed for the complex model under consideration: Ki-
nases have positive control on different characteristics of the signalling output whereas
phosphatases exhibit negative control. An exception is reaction v55 (ERK activation
by MEK) which exhibits negative control on duration and integrated response. As a
reason for this deviation from the control bahaviour of components of linear cascades
one might think of the negative feedback which introduces a considerable nonlinearity
into the system. However, calculations without this negative feedback mechanism reveal
that all control coefficients have the same sign and about the same absolute value (data
not shown).
Another aspect which is studied in Heinrich et al. [2002] concerns the question of
crosstalk between signalling pathways. Crosstalk is modelled by considering the tem-
porary inhibition of a phosphatase of a pathway by another pathway. There, it can be
shown that amplification and short signal duration (spike-like behaviour) can only coex-
ist with this type of crosstalk. Moreover, the further upstream the temporarily inhibited
phosphatase is located the more pronounced is this effect. The MAPK model under
consideration shows a similar tendency, i.e. the further upstream the phosphatases (see
v42/43, v49/51 and v57/59 in Table 3.1), the more control impact on duration and integrated
response of ERK they possess.
An further question to address is: Do reactions, which exert a high degree of control
on one of the three characteristics of signalling output, tend also to exert a similar
influence on the other two characteristics? To address this point, the values of the three
types of control coefficients are plotted against each other in Figure 3.9. Figure 3.9C
shows that the reactions that have a high control on the duration of the ERK-PP signal
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Figure 3.9: Correlations between control coefficients on the three signalling character-
istics. A: signal amplitude and signal duration, B: signal amplitude and integrated
response, C: signal duration and integrated response. In each case regression lines are
depicted (dashed lines), and their linear function and the R-squared value (correlation
coefficient) are shown.
do indeed, in addition, tend to exert considerable control on the integrated response
of the ERK-PP profile. This is reflected by a relatively high correlation coefficient
of R2 = 0.88. In Heinrich et al. [2002] it is shown analytically that in simple linear
cascades (without crosstalk effects) a high signal amplitude always coincides with a
high signal duration of the output kinase. This implies that both characteristics can
not be controlled independently in such cases. In the more complex signalling network
under consideration here, these two control coefficients are no longer covariant, as is
illustrated by a small correlation coefficient of R2 = 0.08 (see Fig. 3.9A). This indicates
that, in contrast to linear cascades, the considered model system possesses the ability
to decouple the control of signal amplification and duration.
With respect to drug design the sensitivities of different characteristics of the signal
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output might represent an important item of information. To decide if the overall sensi-
tivity of, for example, the amplitude of ERK-PP is significant, this value is compared to
the amplitude sensitivities of components which lie further upstream of ERK. To analyse
how sensitive or robust the amplitude of a component is on average in terms of param-
eter perturbations, the measures introduced in Eq. (3.3) and Eq. (3.4) are calculated
for amplitudes of various components. Figure 3.10 depicts the distributions of control
coefficients for the amplitudes of RasGTP (A), Raf* (B), MEK-P (C), MEK-PP (D),
ERK-P (E) and ERK-PP (F). For the six different components, values for σA and ρA
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Figure 3.10: Distributions of control coefficients on the amplitude of active Ras (A),
Raf* (B), MEK-P (C), MEK-PP (D), ERK-P (E) and ERK-PP (F). Values for overall
sensitivities σA and overall robustness’ ρA are shown.
are also indicated. In every case, only few coefficients possess considerably high values.
In that respect the distributions of the control coefficients look qualitatively similar.
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However, there are big differences in the absolute values. Whereas the signal output
ERK-PP is highly robust having very small control coefficients for the amplitude, the
active MEK kinase (MEK-PP) has the most sensitive amplitude. The control coeffi-
cients of the MEK-PP amplitude vary considerably in the range of −4.0 < CAi < 2.5.
To focus on the processes which yield such a high sensitivity of the amplitude of the
active MEK kinase, Figure 3.11 shows a smaller sector of reactions (40 ≤ i ≤ 60) of
dual and mono phosphorylated MEK. The control coefficient with the highest value in
40 45 50 55 60
−5
0
5
reaction number,
CA i
40 45 50 55 60
−1
0
1
CA i
MEK−P 
MEK−PP 
       :  [Raf*]+[Phosphatase1]          [Raf*−Phosphatase1]
vi
v42
Figure 3.11: Control coefficients for the amplitude of the mono and dual phosphorylated
MEK kinase exerted by reactions v40 − v60. The strongest effect on the amplitude of
MEK-PP exhibits reaction v42 which is the binding of the first phosphatase to the active
Raf component (CA42 = −4.0).
absolute terms shows reaction v42 describing the binding of active Raf to its specific
phosphatase.
The results of this sensitivity analysis carried out with the methods defined in the
framework of MCA are as follows: (1) Robust amplitude of the signal output (ρA = 0.99),
i.e. very small control coefficients of the ERK-PP amplitude compared to other kinases
and active Ras. (2) The highest overall sensitivity (σA = 0.5) of the cascade “Ras-Raf-
MEK-ERK” can be found for the active MEK kinase. (3) Raf* binding to its specific
phosphatase exhibits the strongest control on the amplitude of the MEK activation
profile (CA42 = −4.0).
The control coefficients are calculated by applying small perturbations to the rate
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constants. To investigate how strongly the size of the perturbation affects the distribu-
tion of control, the relationships between the large and small perturbations are plotted in
Figure 3.12. The filled circles indicate the relationship of perturbations with ∆k/k = 0.5
and ∂k/k = 10−6, the blank circles accordingly the interrelation between perturbations
with ∆k/k = −0.5 and ∂k/k = 10−6. Were the control coefficients invariant with re-
spect to the size of the perturbation (which would hold for linear systems), these plots
would show a linear relationship with a slope of 1. Here, the slope of the relation is not
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Figure 3.12: Relationship between large and differentially small perturbations. For each
process, the value of the control coefficient calculated by large perturbations (blank
circles for ∆k/k = −0.5, filled circles for ∆k/k = +0.5) is plotted against the value
of the control coefficient calculated by a small perturbation (∂k/k = 10−6): amplitude
(A and B), duration (C), integrated response (D). Figure B is a magnification of the
dashed box in Figure A. The correlation between both ways of calculating the control
coefficients is determined by linear regression (dashed lines), which yields in each case
a R-squared value.
1, but the points approximate a straight line and the correlation between the control
coefficients calculated by small and those calculated by large perturbations is close to
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1, except for the coefficients for the amplitude (Figure 3.12A). However, this is caused
by a few outliers with high values. If these are not taken into account, the correlation
for amplitude is also fairly reasonable (Figure 3.12B). This means that the size of the
control coefficients is indeed affected by the size of the perturbation, but, importantly,
the order in which the processes are ranked on the basis of their control coefficients does
not change.
The control considered so far is that by molecular and biochemical processes. This
does not necessarily indicate the importance of proteins. The question of how changes in
the concentration of the proteins (caused by e.g. changes in gene expression) influence
signalling through the network is also addressed. For this, the fractional change in the
three signalling characteristics caused by a fractional change in the total concentration
of any protein Ptotal is calculated. This measure corresponds to the response coefficient
of Metabolic Control Analysis:
RyPtotal =
∂ ln y
∂ lnPtotal
for y ∈ {A, d, I}.
A further application to another specific signal transduction pathway is given in Lee
et al. [2003]. Table 3.2 shows the coefficients quantifying the responses of the three
characteristics of signalling to ERK to changes in the concentrations of the proteins in
the network.
Again a “substantial” response coefficient is defined as one for which the absolute
value exceeds 10% of the highest response coefficient. Signalling duration and the in-
tegrated output are affected most by changes in the concentrations of Ras, MEK and
ERK (positive effect) and the phosphatases 1, 2 and 3 (negative effect). When small
changes in protein concentrations are applied, the amplitude is, surprisingly, sensitive
solely to the concentration of ERK and its phosphatase. When large changes in protein
concentrations are considered, the amplitude also becomes sensitive to an increase in
the concentration of Phosphatase1 (negative effect) as well as to a decrease in the con-
centrations of Ras and MEK (positive effect). Changes in the concentrations of EGF,
the adaptor proteins and Raf do not seriously affect the output of MAPK signalling.
Hitherto, specific signalling pathways have been considered. In section 3.4 a broader
perspective is adopted by systematically investigating cascades of varying lengths and
phosphorylation mechanisms due to a hypothetical objective function (overall sensitivity
of the amplitude of the signal output).
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small pertubations +50% pertubations −50% pertubations
protein A d I A d I A d I
EGF 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EGFR 0.01 0.17 0.28 0.00 0.11 0.20 0.02 0.27 0.40
Prot -0.02 -0.32 -0.49 -0.02 -0.25 -0.37 -0.01 -0.51 -0.78
shc 0.00 -0.01 0.00 0.00 -0.03 -0.03 0.00 0.02 0.03
Grb2 0.00 -0.01 -0.01 0.00 -0.01 -0.01 0.00 -0.01 -0.01
Sos 0.00 0.01 0.02 0.00 0.01 0.01 0.00 0.02 0.03
RasGDP 0.08 0.84 1.30 0.03 0.73 1.12 1.95 1.07 1.97
GAP 0.02 0.21 0.32 0.01 0.10 0.18 0.06 0.40 0.56
grb2sos 0.00 -0.02 0.00 0.00 -0.02 -0.02 0.01 0.01 0.04
Raf 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.02 0.03
Phosphatase1 -0.09 -0.95 -1.47 -1.25 -0.56 -1.40 -0.03 -1.64 -2.57
MEK 0.05 0.90 1.24 0.02 0.88 1.18 1.14 0.85 1.49
Phosphatase2 -0.01 -1.03 -1.12 -0.01 -0.70 -0.76 -0.01 -1.94 -2.08
ERK 1.91 0.70 2.74 1.91 0.53 3.15 1.85 1.18 1.94
Phosphatase3 -0.94 -0.49 -1.67 -1.02 -0.53 -1.35 -0.93 -0.47 -2.10
Table 3.2: Response coefficients RA,d,IPtotal . The relative importance of the concentration
of each protein or protein complex is calculated with small (actual response coefficient,
∂Ptotal/Ptotal = 10
−6) and large (∆Ptotal/Ptotal = ±0.5) perturbations. The substantially
positive and negative response coefficients are displayed in red and blue, respectively.
3.4 Sensitivity and optimal length of signalling cas-
cades
In the present section the concept of an overall sensitivity defined within the framework
of MCA (Eq. 3.3) is applied systematically on kinase cascades. A different kind of sensi-
tivity analysis of kinase cascades has already been performed for steady states (Goldbeter
and Koshland [1981]; Goldbeter and Koshland [1982]; Huang and Ferrell [1996]). Partic-
ularly, the impact of multistep effects (Goldbeter and Koshland [1982]) and distributive
dual phosphorylation (Huang and Ferrell [1996]; Ferrell and Bhatt [1997]) on an ul-
trasensitive response of the signal output have been investigated in these studies. One
result states that the longer the kinase cascades are, the stronger they exhibit zero-order
ultra-sensitivity.
The aim of the approach presented here concerns about a possible optimal length n of
a cascade in which optimality is quantified as a maximum overall sensitivity measured
in terms of control coefficients for the signal amplitude of the last kinase. The basic
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question is, if the average overall sensitivity σA of the amplitude of the signal output is
an appropriate objective function for signalling cascades. Concerning the dependence
of σA on the cascade length, a special focus lies moreover on differences between mono
phosphorylation cascades and more realistic designs, i.e. dual phosphorylation cascades.
Such an approach implicitly associates a high overall sensitivity of the signal output with
a high controllability thereof.
3.4.1 Model description
Linear signal transduction pathways each consisting of a receptor with concentration
R(t) (≡ X0(t)) and up to n kinases and phosphatases are considered. Similarly to
chapter 2, mass action kinetics are used and phosphatases are not modeled explicitly
within the different pathway models. The calculations are performed for monocyclic
cascades schematically depicted in Figure 3.13A and for dual phosphorylation cycles
depicted in Figure 3.13B. However, also for dual phosphorylation cascades the very first
cycle is always assumed to be a mono phosphorylation step. The reason for this is that
“real”MAPK cascades indeed show this particular property of a single phosphorylation
of the first kinase (MAPKKK) to be active. Furthermore, this assumption enables a
better comparison between both types of cascades when enlarging them from a one step
pathway, having the same sensitivity properties, to longer pathways (2 ≤ n ≤ 5).
The pathways are modeled with ODEs similarly to the rate equations introduced in
section 2.1.1. Provided that the kinases obey conservation relations within the phos-
phorylation/dephosphorylation cycles one gets the following equations for kinases in
monocycle cascades:
dX∗i
dt
= αiX
∗
i−1(1−
X∗i
Ci
)− βiX∗i for i = 1 . . . n. (3.9)
The model quantities are as follows:
- X∗i , Xi: concentrations of activated (mono phosphorylated) and inactivated ki-
nases (unphosphorylated), respectively.
- Ci = Xi +X
∗
i : total concentration of kinase i.
- αi, βi: rate constants for kinases and phosphatases, respectively.
The dual phosphorylation steps are assumed to occur by a distributive mechanism.
This means that the dual phosphorylation of all kinases (except the first kinase) proceeds
through a two-collision mechanism rather than a single-collision processive mechanism
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Figure 3.13: Linear signalling pathways of different length n with mono phosphorylation
(A) and dual phosphorylation (B) cycles. System variables for pathways of type A are
Xi and X
∗
i indicating the concentrations of activated (mono phosphorylated) and inac-
tivated (unphosphorylated) kinases, respectively. System variables for pathways of type
B are Xi, X
∗
i and X
∗∗
i , representing the concentrations of activated (dual phosphory-
lated) and inactivated kinases (mono phosphorylated, unphosphorylated), respectively.
In either case the first activation step is modeled as a mono phosphorylation step. A
transient stimulation of the receptor is described by R(t) = 1 · exp(−λt), with λ = 1.
(Ferrell and Bhatt [1997]). The arising scheme of such a cascade is depicted in 3.13B
and the equation system is given as
dX∗1
dt
= v1 − v−1 = α1X0(1− X
∗
1
C1
)− β1X∗1 ,
dX∗2
dt
= v21 − v22 − v−21 + v−22
= α21X
∗
1 (1−
X∗2 +X
∗∗
2
C2
)− α22X∗2X∗1 − β21X∗2 + β22X∗∗2 ,
dX∗∗2
dt
= v22 − v−22 = α22X∗2X∗1 − β22X∗∗2 , (3.10)
dX∗i
dt
= vi1 − vi2 − v−i1 + v−i2
= αi1X
∗∗
i−1(1−
X∗i +X
∗∗
i
Ci
)− αi2X∗iX∗∗i−1 − βi1X∗i + βi2X∗∗i ,
dX∗∗i
dt
= vi2 − v−i2 = αi2X∗iX∗∗i−1 − βi2X∗∗i for i = 3 . . . n,
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where the model quantities are as follows:
- X∗∗i , X
∗
i , Xi: concentrations of activated (dual phosphorylated) and inactivated
kinases (mono phosphorylated, unphosphorylated), respectively.
- C1 = X1+X
∗
1 , Ci = Xi+X
∗
i +X
∗∗
i : total concentrations of the first kinase (i = 1)
and all other kinases (i ≥ 2), respectively.
- αi1, αi2, βi1, βi2: rate constants of kinases and phosphatases.
The impact of the structural design (mono/dual phosphorylation and cascade length
n) on the sensitivity of the signal amplitude (σA) is considered, whereas appropriately
the amplitude is defined as the maximum activation level of X∗n in the case of monocylces
and X∗∗n in the case of dual phosphorylation steps. To simplify this structural analysis
of signalling cascades, the total concentrations of all kinases and the rate constants are
assumed in either case to be equal (Ci = C = 100 and αi(j) = α, βi(j) = β). Therefore,
one can rescale the time in the equation systems dividing all equations by α which leaves
only one kinetic parameter in the systems (β/α ≡ β). The receptor R(t) = X0(t) is
assumed to be initially activated at time t = 0 and then decays exponentially: X0(t) =
1 · exp(−λt) with λ = 1.
3.4.2 Results
The number of reaction rates and therefore the number of control coefficients of a given
cascade depend on the length n (1 < n < 5) and on the phosphorylation mechanism.
For each cascade design, control coefficients are calculated numerically (∂v/v = 10−6).
Figure 3.14 depicts how the overall sensitivity of the amplitude of the output kinase
depends on the cascade length n, the scaled phosphatase rate constant β and the phos-
phorylation mechanism.
The left panels (Fig. 3.14A) refer to mono phosphorylation cascades and the right
panels (Fig. 3.14B) depict the situation for dual phosphorylation pathways. As exam-
ples, on top of each row the activation profiles of the last activated kinases of five-step
cascades, i.e. X∗5 (left) andX
∗∗
5 (right) are depicted for three different β-values. The bars
in the histograms show the overall sensitivity of the last kinase (X∗n or X
∗∗
n ) in a pathway
with length n. Two gray shadings indicate different amplification characteristics of a
given pathway. The amplification/dampening criteria are the same as in section 3.1: If
the activation profile of the last kinase X
∗(∗)
n of a given pathway has a maximum value
higher than the initial value of the receptor which is set to X0(t = 0) ≡ 1, the pathway
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Figure 3.14: Dependence of overall amplitude sensitivity σA of mono phosphorylation
cascades (A) and dual phosphorylation cascades (B) on length n and β. In each case
the first activation step is a mono phosphorylation cycle. The upper two panels show
as examples the activation profiles of the last activated kinases of five-step cascades, i.e.
X∗5 (left) and X
∗∗
5 (right), in each case for three different β-values. Other parameters
are: Ci = C = 100 and λ = 1. Dark gray shaded bars indicate that a given cascade
amplifies signals: max{X∗(∗)n } ≥ X0(t = 0).
is assumed to be amplifying. Otherwise the pathway is dampening. Dark gray color
indicates an amplifying and light gray a dampening cascade with length n.
Overall sensitivities σA are calculated for three different β-values for each of the two
phosphorylation mechanisms. For both mechanisms, β1 and β2 are chosen such that the
cascade ultimately becomes amplifying the longer it gets. If the phosphatase activity is
too high (e.g. β3), the cascades get more and more dampening the longer they become.
It can be seen that for mono phosphorylation cascades (panels in Figure 3.14A) the
sensitivity of the amplitude depends only moderately on the cascade length n. This is
irrespective of the β value. In contrast to that, dual phosphorylation cascades show a
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qualitatively different behaviour. Here, the sensitivity depends much stronger on the
cascade length. A maximum sensitivity for moderate cascade length exists (nmax = 4
in the depicted examples) for β-values which enable the cascade to amplify signals, but
it is most significant for β = 0.25. In fact, if phosphatase activities are too high (e.g.
β = 0.45), the sensitivity increases monotonically with increasing length n (lower panel
of Figure 3.14B). However, the signalling cascades for such high β-values become more
and more dampening and are therefore not considered as values proper for functioning
signalling cascades.
The existence of a cascade length nmax (in an appropriate range of β-values) with
a pronounced maximum sensitivity is related to the property of dual phosphorylation
cascades to strongly amplify signals. In contrast to the signal output of mono phospho-
rylation cascades, for small n the amplitude of the last kinase X∗∗n gets rapidly more
amplified provided that the β-values allow for amplification (see upper panel of Fig-
ure 3.14B). Depending on the values for β and the total concentration of kinases, a
cascade length exists (in the examples of Figure 3.14B one derives n = nmax + 1 = 5)
for which the signal is highly amplified and almost all molecules of the last kinase are
activated (X∗∗n ≈ Cn). This makes the cascade on average less sensitive if it is enlarged
further, because the control coefficients on the amplitude of the signal output are getting
smaller in this case. Together with an increase of σA-values for n-values until nmax, one
derives a distinct maximum for the overall sensitivity of the amplitude.
3.5 Discussion
In this chapter, principles behind the multifarious control of signal transduction are
investigated. The demonstrated principles confirm and elaborate on previous predictions
that have been made on the basis of a theoretical analysis of a simple model of signal
transduction (Heinrich et al. [2002]). For the approach used in the present chapter, the
application of Metabolic Control Analysis to transient activation profiles of signalling
pathways plays a central role .
In a first step, the combined analysis of a simple kinetic model of a signalling pathway
with mathematics and with quantitative experimentation is described. Using such a
mathematical model, the effects of kinase and phosphatase inhibitors can be simulated
and compared with the results of inhibitor experiments. An important question of this
approach is how the control of kinases and phosphatases, exerted on the activation profile
of the signal output, differs. Of particular interest are four features of the activity of a
signalling cascade: the amplitude, the final steady state level, the duration of signalling
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and the integrated response.
The experimental results and the simulations correspond well, particularly when high
kinase activations that lead to saturation effects, are considered. The findings illustrate
that a kinase (MEK) inhibitor affects the amplitude of signalling through MAPK, while
leaving duration rather unaffected. A (protein tyrosine) phosphatase inhibitor influences
both the duration of the MAPK activation profile and its final level in the steady state.
The effect of the phosphatase inhibitor to the ERK-PP amplitude is considerably lower.
In the case of saturation, this property is more pronounced which can be attributed to the
fact that EGF stimulation causes virtually all ERK molecules to be dual phosphorylated
when the maximum is reached. Phosphatase inhibition can therefore not further elevate
the amplitude in the peak. The findings that phosphatases and kinases have different
control effects on amplitude and duration of the signal output, are closely related to
the summation laws of these two dynamic properties. Since the control coefficients of
the signal duration sum up to -1, components with negative control (e.g. phosphatases)
cause a higher effect thereon.
In a second step, control analysis is applied to a detailed kinetic model of EGF-
induced MAPK signalling (Schoeberl et al. [2002]). Some components of the MAPK
network are well-known oncogenes, such as Ras and Raf, causing the pathway to be
constitutively active in tumour cells (Hoshino et al. [1999]), and have therefore been
taken to be promising targets for rationalised therapies against cancer (Sebolt-Leopold
[2000]). For each of the 148 processes in the network, it is calculated to what extent the
process controls the shape of the ERK-PP profile in terms of amplitude, duration and
integrated response. Most reactions do not control these characteristics at all or only
to a very small extent. This striking result might help identifying candidate reactions
suitable as targets for cancer therapy.
The reactions with the highest control coefficients with respect to all characteristics
of the ERK-PP profile involve binding of Raf, MEK and ERK to each other and to
their respective phosphatases. Furthermore, it can be observed that upstream dephos-
phorylation processes exhibit higher control on the duration and integrated response of
ERK-PP than downstream dephosphorylation processes. This phenomenon might be
of interest in the context of possible crosstalk effects, specifically the temporary inhibi-
tion of a phosphatase, resulting from a pathway running in parallel to the MAP kinase
cascade. Heinrich et al. [2002] shows analytically that amplification and short signal
duration (spike-like behaviour) can only coexist with this type of crosstalk. Addition-
ally, under certain conditions (strongly activated pathways), the more upstream a slow
phosphatase is located, the stronger the control effect on signal duration. It might be of
interest for future projects to figure out appropriate target phosphatases for inhibition,
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either for a deeper understanding of crosstalk principles or for drug design.
In contrast to the high robustness of the ERK-PP amplitude, reflected by very small
control coefficients, the MEK kinase is highly sensitive. It remains to be elucidated, if
there is a connexion between this property and the well-known fact that MAPK kinases
are comparable specific activators for their target kinases (Cowan and Storey [2003]).
Last, the systematic analysis of signalling pathways with respect to the sensitivity
of the signal output represents a first step towards extending previous investigations
(Goldbeter and Koshland [1981]; Goldbeter and Koshland [1982]; Huang and Ferrell
[1996]; Ferrell and Bhatt [1997]) in two directions:
- Instead of considering steady states, the more interesting operation regime of signal
transduction represented by transient activation profiles is analysed.
- As an objective function, the overall sensitivity σA (in contrast to zero-order ul-
trasensitivity) is considered to assess why longer, dual phosphorylation cascades
are advantageous compared to mono phosphorylation cascades.
So far, the longer the cascades are, the more they have been considered to be advan-
tageous regarding their ultrasensitive behaviour. Therefore, another basic question is,
whether there is an optimal length with respect to the criteria chosen in the present
study. It is still a matter of debate why there are exactly three kinases in sequence in
a MAP kinase cascade. The strategy followed here is open for at least two particular
further investigations:
- Other objective functions like sensitivity/robustness of signal duration, signalling
time, integrated response, etc. might be considered. Since response coefficients of-
ten play an important role in signalling, objective functions may also be considered
based on them.
- As the total concentrations of participating kinases Ci play an intriguing role for
the overall sensitivity of signalling pathways, it might be of particular interest to
analyse the impact of the ratios of these total kinase concentrations. This may be
done by investigating, whether optimal ratios of Ci-values exist. Such values might
then be compared to kinase concentrations found in the literature or databases.
The latter aspect has already been investigated for two-component signal transduction
systems which are frequently used by bacteria to sense environmental conditions. These
systems consist of a sensor and a response kinase. For the KdpD/KdpE system of E. coli,
an optimal signal transduction is guaranteed, if the concentration of the second kinase
(response kinase) is about 30 times higher than the first (sensor) kinase (Saez-Rodriguez
et al. [2004]).
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Chapter 4
Conclusions
In contrast to chemical reaction systems of inanimate nature, biochemical reaction sys-
tems as metabolic networks, signal transduction or gene regulatory networks are the
outcome of evolution. This means that their design is not arbitrary, but such that the
networks may fulfill their specific functions for living cells in an optimal way (Heinrich
et al. [1991]; Stephani et al. [1999]). It is therefore of interest to analyse which kind of
structures bring about certain advantageous dynamic features. Hitherto, studies of that
kind have been performed only for metabolic networks (Stephani et al. [1999]; Ebenho¨h
and Heinrich [2003]) resulting in conclusions concerning an optimal ordering of reac-
tions in pathways of energy metabolism as well as concerning their robustness against
elimination or exchange of reactions.
The present work extends this kind of studies to signalling networks. Two approaches
are presented following a similar perspective. They are directed to examine the struc-
tural design and control properties of signal transduction systems using various criteria
to evaluate certain design and control principles.
In chapter 2, large sets of alternative structural designs for signalling networks of
small size (n ≤ 7) have been analysed analytically. The objective is to find out what kind
of interrelations exist between specific dynamic properties such as signal amplification
or dynamic stability and design principles. One finds several hundred kinases in living
cells. Therefore, the aim of the strategy based on small networks is to predict an optimal
design – in terms of network connectivity and number of cycles – of such large signalling
networks. It can be demonstrated that a large kinase network has to exhibit a low
network connectivity and a low number of cycles in order to avoid autoactivation due
to spurious receptor or kinase stimulations. Networks retrieved from the TRANSPATH
database indeed display these features.
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Investigations of the structural robustness are carried out for networks with four
kinases. Two values of phosphatase activities (β/α), for which an ensemble of amplifying
networks is most robust, can be determined. It would be interesting for future projects
to extend these calculations to larger networks. This would yield β/α-values that might
then be compared to real ratios of phosphatase and kinase activities.
The TRANSPATH network exhibits many characteristics which differ significantly
from according features in random networks of the same size. This includes the number
of pathways and the composition of pathway lengths which can be encountered. Fur-
thermore, it can be shown that the type of crosstalk between pathways is different in the
TRANSPATH network compared to random networks, where one finds a normal distri-
bution of frequencies of crosstalk strengths. It seems as if in a real signalling network,
crosstalk strengths among pathways are not chosen arbitrarily. Concerning the use of
random networks as null hypothesis, other methods for creating these networks might
be considered in future projects as well.
Regarding the dynamic characteristics of the design of the TRANSPATH network,
there is a tendency that kinase amplitudes are less homogeneously distributed as ex-
pected from random simulations. Only few exhibit a considerable signal amplification
which can be associated with kinases involved in protein translation.
The TRANSPATH network is also evaluated regarding its capacity to avoid feedback
cycles that may occur during an evolutionary process. For this purpose, random net-
works with the same node degree are generated where small cycles have been avoided.
Random networks of such type are not interpreted as null hypothesis, but as structural
designs which prevent successfully the emergence of feedback cycles at all by avoiding
small cycles with certain mechanisms. Scaffold proteins might be the basis for such
a mechanism. The design of other biological networks may be analysed with respect
to their potential to avoid feedback cycles. For example, in gene regulation systems,
positive feedback cycles seem to play a more pronounced role and therefore emerge by
mutations more easily.
The presented strategy for analysing signalling networks is a new conceptual ap-
proach. It can be demonstrated that design principles of the TRANSPATH network
are indeed distinguishable from those of random networks. The plan is to extend the
theory and its applications to networks including multiple phosphorylation of kinases
and to consider their interaction with scaffolds or transcription factors. More recent
information from TRANSPATH and other databases (e.g. Gough [2002]) shall be taken
into account to update the present network structure.
The approach presented in chapter 3 contributes to the comprehension of control
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principles within signalling networks. For this purpose, the framework of Metabolic
Control Theory is used.
The outcome of inhibitor experiments for kinases and phosphatases are compared
with a simple EGF signalling model. Here, it can be demonstrated that phosphatases
have a strong effect on the signal duration of ERK and kinases exert high control on the
amplitude.
Furthermore, control coefficients of the transient activation profiles of kinases and
the G-protein Ras are calculated on the basis of a large EGF model. Regarding the
distribution of coefficients, only few processes exert significant control on the signal
characteristics (amplitude, duration, integrated response) of these components. Whereas
the signal output (ERK-PP) possesses a quite robust amplitude, which is expressed in
very small control coefficients, the MEK kinase is much more sensitive to parameter
perturbations. It might be of interest to analyse, whether the latter result (highly
sensitive MEK) correlates with the finding that MAPK kinases are more specific towards
their target substrates than upstream and downstream kinases. Generally, phosphatases
exert higher control on signal duration of the signal output than kinases. The impact
on duration is more pronounced, the more upstream the phosphatase is. Many control
principles which are revealed analytically for linear cascades in Heinrich et al. [2002] can
be confirmed for the complex model on hand.
In section 3.4, the question is raised, if appropriate objective functions can be concep-
tualized for signalling pathways equivalent to objective functions in metabolic systems
(e.g. flux). It is systematically tested, whether the overall sensitivity of certain char-
acteristics of the signal output is an appropriate objective function. In this respect,
there are qualitative differences between monocycle cascades and dual phosphorylation
cascades. The latter exhibit indeed – under certain conditions – extreme values of the
sensitivity for moderate cascade lengths. These studies are still preliminary and should
be extended to more complex structural designs as well as other possible objective func-
tions.
The insight gained concerning the fundamental design and control principles of cel-
lular signalling may serve as a foundation for future studies in a variety of research areas
in the field of signal transduction.
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Appendix A
Additional topics to chapter 2
A.1 Explicit solutions for signalling characteristics
in low activated networks
Under conditions of weakly activation (X∗i /Ci → 0, for each i = 1 . . . n), Eq. (2.3)
simplifies to
dX∗i
dt
= ρiR(t) +
n∑
k 6=i
αikX
∗
k − βiX∗i . (A.1)
For αik = α and βi = β this equation can be written in a more compact form as follows
~˙X∗ = ~R(t) +AT · ~X∗ − β
α
~X∗, (A.2)
where the vector ~R(t) has only entries at positions i for those kinases i which do not
possess an activation input from other kinases. This specific receptor attachment guar-
antees all kinases to be activated after receptor stimulation. AT is the transposed of
the unweighted adjacency matrix with entries aik = 1 if kinase i activates kinase k.
The signalling network is in an off-state at the beginning (t = 0) and the receptor
(Ri(t) = Ri(0)e
−λt) declines exponentially for t→∞. Integration of Eq. (A.2) yields a
recurrent formula for the integrated response:∫ ∞
0
~˙X∗dt =
~R(0)
λ
+AT ·
∫ ∞
0
~X∗dt− β
α
∫ ∞
0
~X∗dt
0 =
~R(0)
λ
+A′T ~I, (A.3)
where A′T now describes the transposed adjacency matrix of the underlying directed
graph with additional β/α-values as entries on the diagonal. For the integrated response
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~I one calculates the following expression:
~I = −(A′T )−1
~R(0)
λ
. (A.4)
Multiplication of Eq. (A.2) with time t and t2 and subsequent integration yield the
expressions ∫ ∞
0
t ~˙X∗dt =
~R(0)
λ2
+A′T ·
∫ ∞
0
t ~X∗dt︸ ︷︷ ︸
≡ ~T
−
∫ ∞
0
~X∗dt = −~I =
~R(0)
λ2
+A′T · ~T
⇒ ~T = −
(
~R(0)
λ2
+ ~I
)
· (A′T )−1 (A.5)
and ∫ ∞
0
t2 ~˙X∗dt =
~R(0)
λ3
+A′T ·
∫ ∞
0
t2 ~X∗dt︸ ︷︷ ︸
≡ ~Q
−2 ·
∫ ∞
0
t ~˙X∗dt = −2 · ~T =
~R(0)
λ3
+A′T · ~Q
⇒ ~Q =
(
−2 · ~T −
~R(0)
λ2
)
· (A′T )−1, (A.6)
respectively. On the left side integrations by parts have been applied.
For a given network design (via the adjacency matrix A) and a given kinetic param-
eter (β/α) one can calculate ~I, ~T and ~Q with Eqs. (A.4–A.6). Signalling amplitude,
signalling time and signalling duration of activation profiles of all kinases in the net-
work may then be calculated without using the explicit solutions X∗i of the differential
equation system A.1:
τi =
Ti
Ii
, ϑi =
√
Qi
Ii
− τ 2i , Si =
Ii
2ϑi
. (A.7)
The numbers of all possible network designs of a given size n are listed in the next
section A.2.
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A.2 Numbers of network designs
We are interested in network designs without isolated nodes (kinases) and where the
edges (representing activations) are directed. If in such networks it is possible to reach
any node starting from any other node by traversing edges in some direction (i.e., not
necessarily in the direction they point) they are called weakly connected graphs. There-
fore, the nodes in a weakly connected graph must all have either outdegree or indegree
of at least 1. The numbers of weakly connected graphs with n nodes and e edges can be
calculated according to Po`lya’s enumeration theorem (Harary [1994]). They are listed
in the following Table A.1.
e n = 2 n = 3 n = 4 n = 5 n = 6 n = 7
1 1 0 0 0 0 0
2 1 3 0 0 0 0
3 4 8 0 0 0
4 4 22 27 0 0
5 1 37 108 91 0
6 1 47 326 582 350
7 38 667 2,432 3,024
8 27 1,127 7,694 17,314
9 13 1,477 19,646 74,676
10 5 1,665 42,148 266,364
11 1 1,489 77,305 808,620
12 1 1,154 122,953 2,144,407
13 707 170,315 5,020,543
14 379 206,982 10,490,367
15 154 220,768 19,667,480
16 61 207,301 33,269,008
17 16 171,008 50,927,106
18 5 124,110 70,762,906
19 1 78,813 89,382,317
20 1 43,862 102,797,259
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21 21,209 107,693,823
22 8,951 102,832,176
23 3,242 89,457,910
24 1,043 70,886,056
25 288 51,098,059
26 76 33,476,837
27 17 19,889,497
28 5 10,699,652
29 1 5,194,349
30 1 2,271,935
31 890,959
32 313,312
33 98,161
34 27,649
35 6,940
36 1,637
37 346
38 79
39 17
40 5
41 1
42 1
sum 2 13 199 9,364 1,530,843 880,471,142
Table A.1: Number of structural designs with different
numbers of kinases n and interactions e.
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A.3 Existence of autoactivated states for networks
containing cycles
For R = 0 the time independent solutions of Eq. (2.3) can be attained by solving the
equation system
~˙X∗ = 0 = AT · ~X∗ ·D− β
α
~X∗, with 0 ≤ X∗i < Ci ∀i ∈ {1, 2, . . . , n}. (A.8)
The matrix D = diag(C1 −X∗1 , . . . , Cn −X∗n) is a diagonal matrix and AT is the trans-
posed of the adjacency matrix.
The nodes of any graph can be sorted such that the topology of the graph is not
affected. Applying this topological sorting to a directed graph without cycles one can
arrange the nodes such that the resulting isomorphic graph has an adjacency matrix
Aord with entries only in the upper-triangle part. This is due to the fact that the lower
triangle represents “backward” edges from higher numbered to lower numbered nodes
and those edges do not exist in a directed acyclic graph (DAG). Considering a network
without feedback cycles, Eq. (A.8) can be rewritten with an ordered adjacency matrix:
0 = ATord · ~X∗ ·D−
β
α
~X∗, with ATord =

0 0 . . . 0
α12 0 . . . 0
...
...
. . .
...
α1n a2n . . . 0
 .
Since D is a diagonal matrix and it holds X∗i < Ci, the inverse of D exists and one may
divide this equation by D:
β
α
~X∗ = ATord · ~X∗ ·D
⇔ β
α
~X∗ ·D−1 = ATord · ~X∗, (A.9)
retrieving explicit solutions for the kinase concentrations X∗i in networks without cycles:
β
α
· X
∗
1
C1 −X∗1
= 0 ·X∗1 + 0 ·X∗2 + . . .+ 0 ·X∗n = 0 ⇒ X∗1 = 0
β
α
· X
∗
2
C2 −X∗2
= α12 ·X∗1 + 0 ·X∗2 + . . .+ 0 ·X∗n = 0 ⇒ X∗2 = 0
...
β
α
· X
∗
n
Cn −X∗n
= α1n ·X∗1 + α2n ·X∗2 + . . .+ 0 ·X∗n = 0 ⇒ X∗n = 0.
⇒For networks without feedback cycles the only steady state solution is the signal off-
state: ~X∗ = 0.
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Appendix B
Additional topics to chapter 3
B.1 Summation laws for control of time dependent
phenomena
Summation laws in control theory are based on Euler’s theorem on homogeneous func-
tions, which can be stated as follows. Let f be a function of p1, . . . , pn such that for all
pi and for all λ > 0
f(λβ1p1, . . . , λ
βnpn) = λ
γ · f(p1, . . . , pn) for some β1, . . . , βn, γ ∈ R. (B.1)
After differentiation of Eq. (B.1) with respect to λ and setting λ = 1 one ends up with
the following equation:
n∑
i=1
βi
ln f
ln pi
= γ. (B.2)
This theorem is used to examine the signalling charateristics, e.g. signalling amplitude,
signalling time, signalling duration and integrated response, as homogeneous functions
of different variables. For this, one may inspect the system equations that define the
time evolution of the signalling components.
The dynamic reaction systems discused here exhibit spatial homogeneity. In those
systems, r reactions, numbered with the index i, take place, each at a rate ei·vi. Through
vi, the rates are functions of concentrations (Xj) of m reactive molecules in the system,
and they are each further characterised by an activity ei. In some systems these ei
correspond with enzyme concentrations, such as the concentration of a protein kinase
or a protein phosphatase. A chemical reaction vi leads to a time-dependent increase in
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the concentration of substance Xj:
dXj
dt
=
r∑
i=1
nji · ei · vi( ~X) (B.3)
Here nji is a stoichiometric number which is positive when Xj is a product of the
reaction and negative when it is a substrate. The equations define the dynamics of the
system in time. We shall assume that the above differential has a unique solution that
is asymptotically stable in the sense of Lyapunoff.
Since the reaction rates depend linearly on the enzyme concentrations (activities),
simultaneous transformation of these activities and of time
e˜i = λei , t˜ = t/λ (B.4)
leads to a new equation system which coincides with the initial system. Therefore, if
the initial conditions are the same, concentrations Xj of the transformed system at the
moment t/λ will coincide with concentrations of the initial system at the moment t:
Xj(t/λ, λ~e) = Xj(t, ~e) = λ
0Xj(t, ~e) (B.5)
This shows that the concentrations are homogeneous functions of order zero. By dif-
ferentiating Eq. (B.5) with respect to the arbitrarily chosen parameter λ one can apply
Euler’s theorem for homogeneous functions. This leads to the formulation of the sum-
mation law for control coefficients of time-dependent concentrations:
r∑
i=1
C
Xj
i (t)−
∂ lnXj
∂ ln t
= 0. (B.6)
At time points where the control by time is zero, e.g. in steady state or at an extreme
point in the transient dynamics, the second term is zero. Therefore, the control coeffi-
cients on the maximum level of the ERK activation profile (signal amplitude A) sum up
to zero:
r∑
i=1
CAi = 0. (B.7)
The integrated response (“area under the curve”) of a component Xj is defined as:
Ij(t, ei) =
∫ τ=t
τ=0
Xj(τ, ei)dτ. (B.8)
Again Ij is considered under transformations of time and enzyme activities given in
Eq. (B.5):
Ij(t/λ, λei) =
∫ τ=t/λ
τ=0
Xj(τ, λei)dτ
τ=τ ′/λ
↓
=
∫ τ ′=t
τ ′=0
Xj(τ
′/λ, λei)︸ ︷︷ ︸
=Xj(τ ′,ei)
1
λ
dτ ′ = λ−1Ij(t, ei) (B.9)
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Application of Euler’s theorem gives
r∑
i=1
C
Ij(t)
i − CIj(t)t = −1. (B.10)
If Ij(t) converges for infinite times, this yields the summation law for the integrated
response of signalling component Xj:
r∑
i=1
C
Ij(∞)
i = −1. (B.11)
To establish the summation law for the signalling duration two time points t1/2
are considered where the concentration Xj attains a certain value Xj after pathway
stimulation. For example in the calculations in chapter 3.3 Xj is chosen as 10% of the
signalling amplitude. After integration of Eq. (B.3) these times t1/2 are given implicitly
by the equations:
0 =
∫ τ=t1/2
τ=0
r∑
i=1
nji · ei · vi( ~X)dτ −Xj ⇒ t1/2 = t1/2(ei). (B.12)
Consider now the transformation where all enzyme activities are activated. The times
t′1/2 at which the concentration reaches the same magnitude is then found by solving the
equation:
0 =
∫ τ=t′
1/2
τ=0
r∑
i=1
nji ·λ ·ei ·vi( ~X)dτ−Xj
τ=τ ′/λ
↓
=
∫ τ ′=t′
1/2
·λ
τ ′=0
r∑
i=1
nji ·ei ·vi( ~X)dτ ′−Xj (B.13)
which proves that:
λ · t′1/2 = λ · t1/2(λei) = t1/2(ei) ⇒ t1/2(λei) = λ−1t1/2(ei), (B.14)
i.e., times at which a certain concentration is attained are homogeneous functions of the
order −1 of the enzyme activities. Therefore, also the signalling duration d = t1 − t2 is
a homogeneous function of the order −1. This gives rise to the summation law for the
signalling duration of a component Xj:
r∑
i=1
C
dj
i = −1. (B.15)
Although the summation laws are derived for specific definitions of amplitude, sig-
nalling time and duration, they are also valid for other definitions of these quantities.
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Interrelations between design principles and dynamic properties of large sets of networks
(chapter 2) are most convenient studied by means of Eq. (2.13) and Eq. (2.15). Sim-
ilar to a time point where a certain concentration X is considered, the average signal
propagation time τ of a profile X(t) is a homogeneous function of the order −1:
τ(λei) =
1
I(λei)
∫ ∞
0
tX(t, λei) dt
t=t′/λ
↓
=
1
I(λei)
∫ ∞
0
t′/λ ·X(t′/λ, λei) λ−1dt′
=
1
λ−1I(ei)
λ−2
∫ ∞
0
t′X(t′, ei) dt′ = λ−1 · τ(ei) , (B.16)
where the fact is used that for the transformations with respect to λ the functionsX(t, ei)
and I(ei) are homogeneous functions of order zero and −1, respectively. Accordingly,
for the signal duration ϑ of X(t) one derives:
ϑ(λei) =
√
1
I(λei)
∫ ∞
0
t2Xi(t, λei) dt− τ(λei)2
t=t′/λ
↓
=
√
1
I(λei)
∫ ∞
0
t′2 · λ−2Xi(t′/λ, λei) λ−1dt′ − τ(λei)2
= λ−1
√
1
I
∫ ∞
0
t′2 ·Xi(t′, ei) dt′ − τ(ei)2
= λ−1ϑ(ei). (B.17)
Applying Euler’s theorem gives
r∑
i=1
Cτi =
r∑
i=1
Cϑi = −1. (B.18)
The amplitude S ofX(t) is defined in Eq. (2.13) as S = I/2ϑ. The logarithmic derivative
with respect to reaction rate vi and the subsequent summation over all processes gives
∂ lnS
∂ ln vi
=
∂ ln I
∂ ln vi
− ∂ lnϑ
∂ ln vi
⇒ CSi = Cϑi − CIi
⇒
r∑
i=1
CSi =
r∑
i=1
CIi −
r∑
i=1
Cϑi = −1− (−1) = 0. (B.19)
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B.2 Components, reactions and parameters for the
large EGF model
The following Table lists the 103 model components and their inital values (in molecules
per cell).
components initial concentrations
x1 EGF 0.00000005
x2 EGFR 50000
x3 EGF-EGFR 0
x4 (EGF-EGFR)2 0
x5 (EGF-EGFR*)2 0
x6 EGFRi 0
x7 (EGF-EGFR*)2-GAP-Grb2-Prot 0
x8 (EGF-EGFRi*)2 0
x9 Proti 0
x10 EGF-EGFRi 0
x11 (EGF-EGFRi)2 0
x12 Prot 81000
x13 EGFideg 0
x14 GAP 12000
x15 (EGF-EGFR*)2-GAP 0
x16 EGFi 0
x17 (EGF-EGFRi*)2-GAP 0
x18 (EGF-EGFRi*)2-GAP-Grb2 0
x19 (EGF-EGFRi*)2-GAP-Grb2-Sos 0
x20 (EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-GDP 0
x21 (EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-GTP 0
x22 Grb2 11000
x23 (EGF-EGFR*)2-GAP-Grb2 0
x24 Sos 26300
x25 (EGF-EGFR*)2-GAP-Grb2-Sos 0
x26 Ras-GDP 72000
x27 (EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GDP 0
x28 Ras-GTP 0
x29 (EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GTP 0
x30 Grb2-Sos 40000
x31 Shc 101000
x32 (EGF-EGFR*)2-GAP-Shc 0
x33 (EGF-EGFR*)2-GAP-Shc* 0
x34 (EGF-EGFR*)2-GAP-Shc*-Grb2 0
x35 (EGF-EGFR*)2-GAP-Shc*-Grb2-Sos 0
x36 (EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GDP 0
x37 (EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GTP 0
x38 Shc*-Grb2-Sos 0
96
x39 Shc*-Grb2 0
x40 Shc* 0
x41 Raf 40000
x42 Raf-Ras-GTP 0
x43 Ras-GTP* 0
x44 Phosphatase1 40000
x45 Raf* 0
x46 Raf*-phosphatase1 0
x47 MEK 21000000
x48 MEK-Raf* 0
x49 MEK-P 0
x50 MEK-P-Raf* 0
x51 MEK-PP 0
x52 MEK-PP-phosphatase2 0
x53 phosphatase2 40000
x54 MEK-P-phosphatase2 0
x55 ERK 22100000
x56 ERK-MEK-PP 0
x57 ERK-P 0
x58 ERK-P-MEK-PP 0
x59 ERK-PP 0
x60 phosphatase3 10000000
x61 ERK-PP-phosphatase3 0
x62 ERK-P-phosphatase3 0
x63 (EGF-EGFRi*)2-GAP-Shc 0
x64 (EGF-EGFRi*)2-GAP-Shc* 0
x65 (EGF-EGFRi*)2-GAP-Shc*-Grb2 0
x66 (EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos 0
x67 (EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-Ras-GDP 0
x68 (EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-Ras-GTP 0
x69 Ras-GTPi 0
x70 Raf-Ras-GTPi 0
x71 Ras-GTPi* 0
x72 Rafi* 0
x73 Rafi*-phosphatase1 0
x74 MEK-Rafi* 0
x75 MEKi-P 0
x76 MEK-P-Rafi* 0
x77 MEKi-PP 0
x78 MEKi-PP-phosphatase2 0
x79 MEKi-P-phosphatase2 0
x80 ERKi-MEKi-PP 0
x81 ERKi-P 0
x82 ERKi-P-MEKi-PP 0
x83 ERKi-PP 0
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x84 ERKi-PP-phosphatase3 0
x85 ERKi-P-phosphatase3 0
x86 EGFRideg 0
x87 (EGF-EGFRi*)2deg 0
x88 (EGF-EGFR*)2-GAP-Grb2-Sos-Prot 0
x89 (EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GDP-Prot 0
x90 (EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GTP-Prot 0
x91 (EGF-EGFR*)2-GAP-Shc*-Grb2-Prot 0
x92 (EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Prot 0
x93 (EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GDP-Prot 0
x94 (EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GTP-Prot 0
x95 (EGF-EGFR*)2-GAP-Grb2-Sos-ERK-PP 0
x96 (EGF-EGFRi*)2-GAP-Grb2-Sos-ERKi-PP 0
x97 (EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-ERK-PP 0
x98 (EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-ERKi-PP 0
x99 (EGF-EGFR*)2-GAP-Grb2-Sos deg 0
x100 (EGF-EGFR*)2-GAP-Grb2-Sos deg 0
x101 Sos-ERK-PP 0
x102 Sos-ERKi-PP 0
x103 Sosi 0
Rate constants of the model are listed in the following Table. First order rate con-
stants are given in [1/s] and second order rate constantsAˆ in [M−1s−1].
parameter value parameter value
k1 30000000 kd33 0.2
kd1 0.00384 k33 0.000035
k10 140000 kd34 0.03
k10b 0.054264 kd35 0.0015
kd10b 0 k35 0.0000075
kd10 0.011 k36 0.005
k2 0.0000166 kd36 0
kd2 0.1 kd37 0.3
k3 1 k37 0.0000015
kd3 0.01 k40 0.00005
k4 0.000000173 kd40 0.064
kd4 0.00166 k41 0.00005
kd5 0.0146 kd41 0.0429
k5 0 k42 0.00011833
k6 0.0005 kd42 0.2
kd6 0.005 kd43 1
k8 0.00000166 k43 0
kd8 0.2 kd44 0.01833
k13 42767 kd45 38110
kd13 0 k45 0
k15 10000 kd47 38232
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kd15 0 k47 0
k16 0.0000166 k48 0.23833
kd16 0 kd48 0.8
k17 0.0000166 kd49 0.058
kd17 0.06 k49 0
k18 0.000025 k50 0.00000045
kd18 38047 kd50 0.5
k19 0.000000166 kd52 0.033
kd19 0.5 kd53 16
k20 0.0000035 k53 0
kd20 0.4 kd55 38173
k21 0.000000366 k55 0
kd21 0.023 kd56 0.6
k22 0.000035 k56 0.0000235
kd22 0.1 kd57 0.246
k23 6 k57 0
kd23 0.06 k58 0.083333
kd24 0.55 kd58 0.5
k25 0.0000166 k52 0.89072
kd25 0.0214 k44 0.19546
k28 0.00000166 k60 0.0055
kd28 0.0053 kd60 0
k29 0.011667 k61 0.00067
kd29 1 kd61 0
kd32 0.1 kd63 0.275
k32 0.0000004 k63 0
k126 0.000000166 kd126 2
kd127 0.0001 k127 0
The 148 biochemical reactions and the corresponding reaction rates are listed below.
v reactions rate equations
1 [EGFR]+[EGF]−→ [EGF-EGFR] k1·c1·c2 -kd1·c3
2 [EGF-EGFR]+[EGF-EGFR]−→[(EGF-EGFR)2] k2·c3·c3 -kd2·c4
3 [(EGF-EGFR)2]−→[(EGF-EGFR*)2] k3·c4·1 -kd3·c5
4 [(EGF-EGFR*)2-GAP-Grb2]+[Prot]−→[(EGF-EGFR*)2-GAP-Grb2-Prot] k4·c23·c12 -kd4·c7
5 [(EGF-EGFR*)2-GAP-Grb2-Prot]−→ [ (EGF-EGFRi*)2-GAP-Grb2]+[Proti] k5·c18·c9 -kd5·c7
6 [EGFR]−→[EGFRi] k6·c2·1 -kd6·c6
7 [(EGF-EGFR*)2] −→ [(EGF-EGFRi*)2] k6·c5·1 -kd6·c8
8 [(EGF-EGFR*)2]+[GAP]−→[(EGF-EGFR*)2-GAP] k8·c5·c14 -kd8·c15
9 [(EGF-EGFR*)2-GAP]−→ [(EGF-EGFRi*)2-GAP] k6·c23·1 -kd6·c18
10 [EGFRi]+[EGFi]−→[EGF-EGFRi] k10b·c6·c16 -kd10·c10
11 [EGF-EGFRi]+[EGF-EGFRi]−→[(EGF-EGFRi)2] k2·c10·c10 -kd2·c11
12 [(EGF-EGFRi)2]−→[(EGF-EGFRi*)2] k3·c11·1 -kd3·c8
13 −→ [EGFR] k13·1·1 -kd13·c2
14 [(EGF-EGFRi*)2]+ [GAP]−→[(EGF-EGFRi*)2-GAP] k8·c8·c14 -kd8·c17
15 [Proti]−→ [Prot] k15·c9·1 -kd15·c12
16 [(EGF-EGFR*)2-GAP]+[Grb2]−→[(EGF-EGFR*)2-GAP-Grb2] k16·c22·c15 -kd63·c23
99
17 [(EGF-EGFR*)2-GAP-Grb2]+[Sos]−→ [(EGF-EGFR*)2-GAP-Grb2-Sos] k17·c24·c23 -kd17·c25
18 [(EGF-EGFR*)2-GAP-Grb2-Sos]+[Ras-GDP] −→[(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-
GDP]
k18·c26·c25 -kd18·c27
19 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GDP]−→[(EGF-EGFR*)2-GAP-Grb2-Sos]+[Ras-
GTP]
k19·c28·c25 -kd19·c27
20 [Ras-GTP*]+[(EGF-EGFR*)2-GAP-Grb2-Sos] −→ [(EGF-EGFR*)2-GAP-Grb2-Sos-
Ras-GTP]
k20·c25·c43 -kd20·c29
21 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GTP] −→[(EGF-EGFR*)2-GAP-Grb2-Sos]+[Ras-
GDP]
k21·c25·c26 -kd21·c29
22 [(EGF-EGFR*)2-GAP]+[Shc]−→ [(EGF-EGFR*)2-GAP-Shc] k22·c31·c15 -kd22·c32
23 [(EGF-EGFR*)2-GAP-Shc] −→[(EGF-EGFR*)2-GAP-Shc*] k23·c32·1 -kd23·c33
24 [(EGF-EGFR*)2-GAP-Shc*]+[Grb2]−→ [(EGF-EGFR*)2-GAP-Shc*-Grb2] k16·c22·c33 -kd24·c34
25 [(EGF-EGFR*)2-GAP-Shc*-Grb2]+[Sos]−→ [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos] k25·c24·c34 -kd25·c35
26 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos]+[Ras-GDP]−→ [(EGF-EGFR*)2-GAP-Shc*-
Grb2-Sos-Ras-GDP]
k18·c26·c35 -kd18·c36
27 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GDP] −→ [(EGF-EGFR*)2-GAP-Shc*-Grb2-
Sos] + [Ras-GTP]
k19·c35·c28 -kd19·c36
28 [Raf]+[Ras-GTP] −→[Raf-Ras-GTP] k28·c28·c41 -kd28·c42
29 [Raf-Ras-GTP] −→[Raf*]+[Ras-GTP*] k29·c43·c45 -kd29·c42
30 [Ras-GTP*]+[(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos]−→[(EGF-EGFR*)2-GAP-Shc*-
Grb2-Sos-Ras-GTP]
k20·c35·c43 -kd20·c37
31 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GTP] −→ [(EGF-EGFR*)2-GAP-Shc*-Grb2-
Sos]+[Ras-GDP]
k21·c35·c26 -kd21·c37
32 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos] −→ [(EGF-EGFR*)2-GAP]+[Shc*-Grb2-Sos] k32·c15·c38 -kd32·c35
33 [Shc*-Grb2-Sos] −→ [Grb2-Sos]+[Shc*] k33·c40·c30 -kd33·c38
34 [(EGF-EGFR*)2-GAP-Grb2-Sos]−→ [(EGF-EGFR*)2-GAP]+[Grb2-Sos] k34·c15·c30 -kd34·c25
35 [Grb2-Sos]−→[Grb2] +[Sos] k35·c24·c22 -kd35·c30
36 [Shc*]−→ [Shc] k36·c40·1 -kd36·c31
37 [(EGF-EGFR*)2-GAP-Shc*]−→ [(EGF-EGFR*)2-GAP]+[Shc*] k37·c15·c40 -kd37·c33
38 [Shc*]+[Grb2]−→ [Shc*-Grb2] k16·c22·c40 -kd24·c39
39 [(EGF-EGFR*)2-GAP-Shc*-Grb2] −→ [(EGF-EGFR*)2-GAP]+[Shc*-Grb2] k37·c15·c39 -kd37·c34
40 [Shc*-Grb2]+[Sos]−→[Shc*-Grb2-Sos] k40·c24·c39 -kd40·c38
41 [(EGF-EGFR*)2-GAP-Shc*] + [Grb2-Sos]−→[(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos] k41·c30·c33 -kd41·c35
42 [Raf*]+[Phosphatase1]−→ [Raf*-Phosphatase1] k42·c44·c45 -kd42·c46
43 [Raf*-Phosphatase1] −→ [Raf]+[Phosphatase1] k43·c41·c44 -kd43·c46
44 [MEK] + [Raf*] −→[MEK-Raf*] k44·c47·c45 -kd52·c48
45 [MEK-Raf*] −→[MEK-P] +[Raf*] k45·c49·c45 -kd45·c48
46 [MEK-P]+[Raf*] −→[MEK-P-Raf*] k44·c49·c45 -kd52·c50
47 [MEK-P-Raf*]−→[MEK-PP] + [Raf*] k47·c51·c45 -kd47·c50
48 [MEK-PP]+[Phosphatase2]−→[MEK-PP-Phosphatase2] k48·c51·c53 -kd48·c52
49 [MEK-PP-Phosphatase2] −→[MEK-P] + [Phosphatase2] k49·c49·c53 -kd49·c52
50 [MEK-P]+[Phosphatase2]−→ [MEK-P-Phosphatase2] k50·c53·c49 -kd50·c54
51 [MEK-P-Phosphatase2] −→ [MEK]+[Phosphatase2] k49·c47·c53 -kd49·c54
52 [ERK]+[MEK-PP] −→ [ERK-MEK-PP] k52·c55·c51 -kd44·c56
53 [ERK-MEK-PP]−→[ERK-P]+[MEK-PP] k53·c51·c57 -kd53·c56
54 [ERK-P]+[MEK-PP] −→ [ERK-P-MEK-PP] k52·c51·c57 -kd44·c58
55 [ERK-P-MEK-PP] −→ [ERK-PP]+[MEK-PP] k55·c59·c51 -kd55·c58
56 [ERK-PP]+[Phosphatase3]−→[ERK-PP-Phosphatase3] k56·c59·c60 -kd56·c61
57 [ERK-PP-Phosphatase3] −→[ERK-P]+[Phosphatase3] k57·c57·c60 -kd57·c61
58 [ERK-P] + [Phosphatase3]−→ [ERK-P-Phosphatase3] k58·c60·c57 -kd58·c62
59 [ERK-P-Phosphatase3]−→ [ERK]+[Phosphatase3] k57·c55·c60 -kd57·c62
60 [EGFRi]−→ [EGFRideg] k60·c6·1 -kd60·c86
61 [EGFi] −→ [EGFideg] k61·c16·1 -kd61·c13
62 [(EGF-EGFRi*)2]−→[(EGF-EGFRi*)2deg] k60·c8·1 -kd60·c87
63 [(EGF-EGFRi*)2-GAP]+[Grb2]−→[(EGF-EGFRi*)2-GAP-Grb2] k16·c17·c22 -kd63·c18
64 [(EGF-EGFRi*)2-GAP-Grb2]+[Sos]−→ [(EGF-EGFRi*)2-GAP-Grb2-Sos] k17·c24·c18 -kd17·c19
65 [(EGF-EGFRi*)2-GAP-Grb2-Sos]+[Ras-GDP] −→[(EGF-EGFRi*)2-GAP-Grb2-Sos-
Ras-GDP]
k18·c26·c19 -kd18·c20
66 [(EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-GDP]−→[(EGF-EGFRi*)2-GAP-Grb2-Sos]+[Ras-
GTPi]
k19·c69·c19 -kd19·c20
67 [Ras-GTPi*]+[(EGF-EGFRi*)2-GAP-Grb2-Sos] −→ [(EGF-EGFRi*)2-GAP-Grb2-Sos-
Ras-GTPi]
k20·c71·c19 -kd20·c21
68 [(EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-GTP] −→[(EGF-EGFRi*)2-GAP-Grb2-Sos]+[Ras-
GDP]
k21·c19·c26 -kd21·c21
100
69 [(EGF-EGFRi*)2-GAP]+[Shc]−→ [(EGF-EGFRi*)2-GAP-Shc] k22·c31·c17 -kd22·c63
70 [(EGF-EGFR*)2-GAP-Shc] −→[(EGF-EGFR*)2-GAP-Shc*] k23·c63·1 -kd23·c64
71 [(EGF-EGFRi*)2-GAP-Shc*]+[Grb2]−→ [(EGF-EGFRi*)2-GAP-Shc*-Grb2] k16·c22·c64 -kd24·c65
72 [(EGF-EGFRi*)2-GAP-Shc*-Grb2]+[Sos]−→ [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos] k25·c24·c65 -kd25·c66
73 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos]+[Ras-GDP]−→ [(EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos-Ras-GDP]
k18·c26·c66 -kd18·c67
74 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-Ras-GDP] −→ [(EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos] + [Ras-GTPi]
k19·c66·c69 -kd19·c67
75 [Raf]+[Ras-GTPi] −→[Raf-Ras-GTPi] k28·c69·c41 -kd28·c70
76 [Raf-Ras-GTPi] −→[Rafi*]+[Ras-GTPi*] k29·c71·c72 -kd29·c70
77 [Ras-GTPi*]+[(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos]−→[(EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos-Ras-GTP]
k20·c71·c66 -kd20·c68
78 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-Ras-GTP] −→ [(EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos]+[Ras-GDP]
k21·c66·c26 -kd21·c68
79 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos] −→ [(EGF-EGFRi*)2-GAP]+[Shc-Grb2-Sos] k32·c17·c38 -kd32·c66
80 [(EGF-EGFRi*)2-GAP-Grb2-Sos]−→ [(EGF-EGFRi*)2-GAP]+[Grb2-Sos] k34·c17·c30 -kd34·c19
81 [(EGF-EGFRi*)2-GAP-Shc*]−→ [(EGF-EGFRi*)2-GAP]+[Shc*] k37·c17·c40 -kd37·c64
82 [(EGF-EGFRi*)2-GAP-Shc*-Grb2] −→ [(EGF-EGFRi*)2-GAP]+[Shc*-Grb2] k37·c17·c39 -kd37·c65
83 [(EGF-EGFRi*)2-GAP-Shc*] + [Grb2-Sos]−→[(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos] k41·c30·c64 -kd41·c66
84 [Rafi*]+[Phosphatase1]−→ [Rafi*-Phosphatase1] k42·c44·c72 -kd42·c73
85 [Rafi*-Phosphatase1] −→ [Raf]+[Phosphatase1] k43·c41·c44 -kd43·c73
86 [MEK] + [Rafi*] −→[MEK-Rafi*] k44·c47·c72 -kd52·c74
87 [MEK-Rafi*] −→[MEKi-P] +[Rafi*] k45·c75·c72 -kd45·c74
88 [MEKi-P]+[Rafi*] −→[MEK-P-Rafi*] k44·c72·c75 -kd52·c76
89 [MEK-P-Rafi*]−→[MEKi-PP] + [Rafi*] k47·c72·c77 -kd47·c76
90 [MEKi-PP]+[Phosphatase2]−→[MEKi-PP-Phosphatase2] k48·c77·c53 -kd48·c78
91 [MEKi-PP-Phosphatase2] −→[MEKi-P] + [Phosphatase2] k49·c75·c53 -kd49·c78
92 [MEKi-P]+[Phosphatase2]−→ [MEKi-P-Phosphatase2] k50·c53·c75 -kd50·c79
93 [MEKi-P-Phosphatase2] −→ [MEK]+[Phosphatase2] k49·c47·c53 -kd49·c79
94 [ERK]+[MEKi-PP] −→ [ERK-MEKi-PP] k52·c55·c77 -kd44·c80
95 [ERK-MEKi-PP]−→[ERKi-P]+[MEKi-PP] k53·c81·c77 -kd53·c80
96 [ERKi-P]+[MEKi-PP] −→ [ERKi-P-MEKi-PP] k52·c77·c81 -kd44·c82
97 [ERKi-P-MEKi-PP] −→ [ERKi-PP]+[MEKi-PP] k55·c83·c77 -kd55·c82
98 [ERKi-PP]+[Phosphatase3]−→[ERKi-PP-Phosphatase3] k56·c83·c60 -kd56·c84
99 [ERKi-PP-Phosphatase3] −→[ERKi-P]+[Phosphatase3] k57·c81·c60 -kd57·c84
100 [ERKi-P] + [Phosphatase3]−→ [ERKi-P-Phosphatase3] k58·c60·c81 -kd58·c85
101 [ERKi-P-Phosphatase3]−→ [ERK]+[Phosphatase3] k57·c55·c60 -kd57·c85
102 [(EGF-EGFR*)2-GAP]−→ [(EGF-EGFRi*)2-GAP] k6·c15·1 -kd6·c17
103 [(EGF-EGFR*)2-GAP-Shc]−→ [(EGF-EGFRi*)2-GAP-Shc] k6·c32·1 -kd6·c63
104 [(EGF-EGFR*)2-GAP-Shc*]−→ [(EGF-EGFRi*)2-GAP-Shc*] k6·c33·1 -kd6·c64
105 [(EGF-EGFR*)2-GAP-Grb2-Sos]−→ [(EGF-EGFRi*)2-GAP-Grb2-Sos] k6·c25·1 -kd6·c19
106 [(EGF-EGFR*)2-GAP-Grb2-Sos]+[Prot]−→[(EGF-EGFR*)2-GAP-Grb2-Sos-Prot] k4·c25·c12 -kd4·c88
107 [(EGF-EGFR*)2-GAP-Grb2-Sos-Prot]−→ [ (EGF-EGFRi*)2-GAP-Grb2-Sos]+[Proti] k5·c9·c19 -kd5·c88
108 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GDP]−→ [(EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-
GDP]
k6·c27·1 -kd6·c20
109 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GDP]+[Prot]−→[(EGF-EGFR*)2-GAP-Grb2-Sos-
Ras-GDP-Prot]
k4·c27·c12 -kd4·c89
110 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GDP-Prot]−→ [ (EGF-EGFRi*)2-GAP-Grb2-Sos-
Ras-GDP]+[Proti]
k5·c9·c20 -kd5·c89
111 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GTP]−→ [(EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-
GTP]
k6·c29·1 -kd6·c21
112 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GTP]+[Prot]−→[(EGF-EGFR*)2-GAP-Grb2-Sos-
Ras-GTP-Prot]
k4·c29·c12 -kd4·c90
113 [(EGF-EGFR*)2-GAP-Grb2-Sos-Ras-GTP-Prot]−→ [ (EGF-EGFRi*)2-GAP-Grb2-Sos-
Ras-GTP]+[Proti]
k5·c9·c21 -kd5·c90
114 [(EGF-EGFR*)2-GAP-Shc*-Grb2]−→ [(EGF-EGFRi*)2-GAP-Shc*-Grb2] k6·c34·1 -kd6·c65
115 [(EGF-EGFR*)2-GAP-Shc*-Grb2]+[Prot]−→[(EGF-EGFR*)2-GAP-Shc*-Grb2-Prot] k4·c34·c12 -kd4·c91
116 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Prot]−→ [ (EGF-EGFRi*)2-GAP-Shc*-Grb2]+[Proti] k5·c9·c65 -kd5·c91
117 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos]−→ [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos] k6·c35·1 -kd6·c66
118 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos]+[Prot]−→[(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-
Prot]
k4·c35·c12 -kd4·c92
119 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Prot]−→ [ (EGF-EGFRi*)2-GAP-Shc*-Grb2-
Sos]+[Proti]
k5·c9·c66 -kd5·c92
101
120 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GDP]−→ [(EGF-EGFRi*)2-GAP-Shc*-Grb2-
Sos-Ras-GDP]
k6·c36·1 -kd6·c67
121 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GDP]+[Prot]−→[(EGF-EGFR*)2-GAP-Shc*-
Grb2-Sos-Ras-GDP-Prot]
k4·c36·c12 -kd4·c93
122 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GDP-Prot]−→ [ (EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos-Ras-GDP]+[Proti]
k5·c9·c67 -kd5·c93
123 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GTP]−→ [(EGF-EGFRi*)2-GAP-Shc*-Grb2-
Sos-Ras-GTP]
k6·c37·1 -kd6·c68
124 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GTP]+[Prot]−→[(EGF-EGFR*)2-GAP-Shc*-
Grb2-Sos-Ras-GTP-Prot]
k4·c37·c12 -kd4·c94
125 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-Ras-GTP-Prot]−→ [ (EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos-Ras-GTP]+[Proti]
k5·c68·c9 -kd5·c94
126 [(EGF-EGFR*)2-GAP-Grb2-Sos]+[ERK-PP] −→[(EGF-EGFR*)2-GAP-Grb2-Sos-ERK-
PP]
k126·c59·c25 -kd126·c95
127 [(EGF-EGFRi*)2-GAP-Grb2-Sos]+[ERKi-PP] −→[(EGF-EGFRi*)2-GAP-Grb2-Sos-
ERKi-PP]
k126·c83·c19 -kd126·c96
128 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos]+[ERK-PP] −→[(EGF-EGFR*)2-GAP-Shc*-
Grb2-Sos-ERK-PP]
k126·c59·c35 -kd126·c97
129 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos]+[ERKi-PP] −→[(EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos-ERKi-PP]
k126·c83·c66 -kd126·c98
130 [Sos]+[ERK-PP]−→[Sos-ERK-PP] k126·c59·c24 -kd126·c101
131 [Sos]+[ERKi-PP]−→[Sos-ERKi-PP] k126·c83·c24 -kd126·c102
132 [(EGF-EGFRi*)2-GAP]−→[(EGF-EGFRi*)2deg] k60·c17·1 -kd60·c87
133 [(EGF-EGFRi*)2-GAP-Grb2]−→[(EGF-EGFRi*)2deg] k60·c18·1 -kd60·c87
134 [(EGF-EGFRi*)2-GAP-Grb2-Sos]−→[(EGF-EGFRi*)2deg] k60·c19·1 -kd60·c87
135 [(EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-GDP]−→[(EGF-EGFRi*)2deg] k60·c20·1 -kd60·c87
136 [(EGF-EGFRi*)2-GAP-Grb2-Sos-Ras-GTP]−→[(EGF-EGFRi*)2deg] k60·c21·1 -kd60·c87
137 [(EGF-EGFRi*)2-GAP-Shc]−→[(EGF-EGFRi*)2deg] k60·c63·1 -kd60·c87
138 [(EGF-EGFRi*)2-GAP-Shc*]−→[(EGF-EGFRi*)2deg] k60·c64·1 -kd60·c87
139 [(EGF-EGFRi*)2-GAP-Shc*-Grb2]−→[(EGF-EGFRi*)2deg] k60·c65·1 -kd60·c87
140 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos]−→[(EGF-EGFRi*)2deg] k60·c66·1 -kd60·c87
141 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-Ras-GDP]−→[(EGF-EGFRi*)2deg] k60·c67·1 -kd60·c87
142 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-Ras-GTP]−→[(EGF-EGFRi*)2deg] k60·c68·1 -kd60·c87
143 [(EGF-EGFR*)2-GAP-Grb2-Sos-ERK-PP] −→[(EGF-EGFR*)2-GAP-Grb2-
Sos]deg+[ERK-PP]
k127·c59·c99 -kd127·c95
144 [(EGF-EGFR*)2-GAP-Shc*-Grb2-Sos-ERK-PP] −→[(EGF-EGFR*)2-GAP-Shc*-Grb2-
Sos]deg+[ERK-PP]
k127·c59·c99 -kd127·c97
145 [Sos-ERK-PP]−→[Sosi]+[ERK-PP] k127·c59·c103 -kd127·c101
146 [(EGF-EGFRi*)2-GAP-Grb2-Sos-ERKi-PP] −→[(EGF-EGFRi*)2-GAP-Grb2-
Sos]deg+[ERKi-PP]
k127·c83·c100 -kd127·c96
147 [(EGF-EGFRi*)2-GAP-Shc*-Grb2-Sos-ERKi-PP] −→[(EGF-EGFRi*)2-GAP-Shc*-
Grb2-Sos]deg+[ERKi-PP]
k127·c83·c100 -kd127·c98
148 [Sos-ERK-PPi]−→[Sosi]+[ERK-PPi] k127·c83·c103 -kd127·c102
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B.3 Localisation of control coefficients for the sig-
nal amplitude, signal duration and integrated
response of the ERK-PP activation profile
According to Table 3.1 eight most substantial control coefficients (for small perturbation)
on the amplitude of the ERK-PP activation profile are found. The locations of these
(five positive and three negative) coefficients within the EGF signalling network are
depicted in Fig. B.1. The positive and negative control coefficients are displayed in red
and blue, respectively.
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Figure B.1: Localisation of most significant control coefficients for the signal amplitude.
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There are 18 (nine positive and nine negative) most substantial control coefficients
for the duration of the ERK-PP activation profile. How they are distributed in the
network is shown in Fig. B.2.
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Figure B.2: Localisation of most significant control coefficients for signal duration.
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Figure B.3 depicts how the most substantial control coefficients of the integrated
response (eight positive and seven negative) are arranged in the network.
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Figure B.3: Localisation of most significant control coefficients for integrated response.
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B.4 Kinase cascade model for a direct comparison
with inhibitor experiments
The model describes a linear signal transduction cascade containing the following eight
irreversible reactions. Reaction velocities are given by Michaelis-Menten kinetics. The
model is also available on the website: http://www.bio.vu.nl/hwconf/supplements/.
The reaction rates with the initial set of parameters used for each reaction are given in
Table B.4.
process rate equation initial concentration
R→ Ri v1 = R0.1 +R R = 0.5
Ri → R v2 = 0.01 ·Ri0.1 +Ri Ri = 0
X1 → X∗1 v3 = R ·X10.1 +X1 X1 = 1
X∗1 → X1 v4 = 0.3 ·X
∗
1
1 +X∗1
X∗1 = 0
X2 → X∗2 v5 = X
∗
1 ·X2
0.1 +X2
X2 = 1
X∗2 → X2 v6 = 0.3 ·X
∗
2
0.1 +X∗2
X∗2 = 0
X3 → X∗3 v7 = X
∗
2 ·X3
0.1 +X3
X3 = 1
X∗3 → X3 v8 = 0.3 ·X
∗
3
1 +X∗3 + Y
X∗3 = 0, Y = 0
Table B.4: Reaction rates and initial set of parameters for the kinase cascade model
including receptor deactivation, receptor recycling, kinase and phosphatase reactions.
The initial concentrations at t = 0 are also given.
Y represents the concentration of a competitive inhibitor of the phosphatase of X∗3 .
The concentration Y is normally set to 0. In the case where the effect of inhibition of
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the third phosphatase is demonstrated, Y is set from 0 to 2, 4 and 6, respectively (cf.
Figure 3.3B). The effect of a non-competitive kinase inhibitor is studied by decreasing
the Vmax of v5 from 1 to 0.8, 0.6 and 0.4, respectively (cf. Figure 3.3A).
The signal is taken to reside in the extent of phosphorylation of the third kinase
in the model MAPK pathway (Figure 3.2). The characteristics of that signal are its
maximum (amplitude), its ultimate value (final strength), its duration and its time-
integrated concentration. Control coefficients are calculated by increasing the rate of a
reaction by 1% and then divide the relative effect on the characteristics by the relative
change in reaction rate.
For the initial set of parameters (Figure 3.3) the control coefficients are given in
Table B.5.
reaction v1 v2 v3 v4 v5 v6 v7 v8
∑
amplitude −1.20 0.03 1.21 −0.81 1.15 −0.77 1.06 −0.64 0.02
duration −0.44 0.17 0.44 −0.60 0.42 −0.62 0.38 −0.70 -0.96
int. response −1.41 0.12 1.43 −1.25 1.35 −1.24 1.22 −1.16 -0.94
final strength −1.03 1.04 1.03 −1.02 1.03 −1.02 1.02 −1.02 0.04
Table B.5: Control of any out of four characteristics of the time dependent signal, by
any of the processes in the cascade. The kinases have control coefficients on the X∗3
amplitude which are about three times higher than their coefficients on X∗3 duration.
Their control coefficients on duration are moreover smaller (in absolute values) than the
duration coefficients from the phosphatases.
B.5 Experimental setup for inhibitor experiments
and western blot analysis
For the cell culture NRK fibroblasts are cultured in Dulbecco’s modified Eagle’s medium
(Biowhittaker Europe), supplemented with 10% fetal bovine serum (Gibco), 0.10 g/l
penicillin and 0.10 g/l streptomycin in a humidified 5% CO2 incubator at 37 degree
celsius. For serum-starvation, cells are washed then with 1x Hank’s buffered salt so-
lution (Gibco) and then used the same medium, but with 0.5% bovine serum albumin
(Applichem) instead of serum.
107
For the stimulation experiments the cells are grown in culture dishes to sub-confluency
and then serum-starved for three days in order to be arrested in the G0-phase of the
cell cycle. Subsequently cells are stimulated with 10 ng/ml EGF (Becton Dickinson)
for the indicated periods of time. Where indicated MEK is inhibited by preincubation
for 1 hour with various concentrations of the non-competitive inhibitor PD98059 (Alessi
et al. [1995]). For the phosphatase inhibition (PTPs) cells are pre-incubated for 1 hour
with 0.20 mM sodium orthovanadate (Huyer et al. [1997]).
Western blot analysis is used to quantify the time profiles of the kinase activations.
After stimulation, cells are washed twice with ice-cold phosphate-buffered saline (17
mM NaH2PO4, 38.5 mM NaH2PO4, 68 mM NaCl, pH 7.4) and incubated on ice with
’lysis buffer’ (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 0.1% NonidetP40,
0.1% sodium deoxycholate, 50 mM NaF, 1 mM sodium-orthovanadate, 1x Complete
protease inhibitor mix (Roche)) for 20 minutes. Cell lysates are scraped using a cell
scraper (25cm/1.8cm, Costar), collected, vortexed for 10 seconds, frozen in liquid nitro-
gen and stored at -80 degree celsius. Protein contents in the cell lysates are determined
with the BCA assay (Pierce). Proteins are separated by SDS-polyacrylamide gel elec-
trophoresis, using a 12% resolving gel. Exactly 10µg of total protein of each sample is
loaded onto the gel in ’loading buffer’ (0.25 M Tris (HCl) pH 7.6, 8% SDS, 40% glyc-
erol, 0.05% bromophenol blue, 20 mM dithiothreitol). Proteins are electro-transferred to
Immun-BlotTM polyvinylidene difluoride membranes (Bio-Rad) using a current of 0.40A
overnight at 4 degree celsius. Membranes are washed in Tris-buffered saline (TBS: 20
mM Tris-HCl, pH 7.6, 150 mM NaCl) supplemented with 0.05% Tween 80 (TBS-T),
pre-incubated for 1 hour at room temperature with blocking buffer (5% skim milk pow-
der (Oxoid) in TBS-T), supplemented with 0.5 mM Na3VO4, and incubated overnight at
4 degree celsius with anti-phospho-p44/42 MAP kinase monoclonal antibody (Cell Sig-
nalling) in blocking buffer (1:2000), supplemented with 0.5 mM Na3VO4. After washing,
membranes are incubated for 1 hour at room temperature with horse-radish peroxidase-
conjugated goat anti-mouse IgG (Bio-Rad) in blocking buffer (1:3000). Membranes are
washed again and then incubated for 5 minutes with Lumi-LightPLUS Western Blotting
Substrate (Roche). Signals are detected with a FluorSTM MultiImager (Bio-Rad) and
quantified using the Multi-Analist software (Bio-Rad).
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